A few notes about viewing Plunkett Research books in PDF format… • • • • •
When in Adobe Acrobat Reader, press the [F5] key on your keyboard to display a list of "bookmarks," which are a very thorough table of contents with links to pages within the PDF. Click a bookmark to jump to a particular chapter, table or section. For easiest viewing, increase or decrease the zoom percentage (lower left corner of the page window) as necessary. Press the [F5] key again to hide the list of bookmarks as necessary. In order to use this PDF, you must agree to the terms of the End User License Agreement that follows on page 9 of this PDF.
A few notes about the following pages… • • • • •
The pages immediately following tell you more about our book titles and how to purchase them. We suggest you print out the Customer Support form on the next page and fax it to us at 713.932.7080. You will receive a free CD-ROM version of this book's database of companies. To order other books, print the order form on page 7 of this PDF and fax it to 713.932.7080 or visit our website at www.plunkettresearch.com. The book in its entirety begins on or about page 8 of this PDF. Thank you for interest.
Plunkett’s 2003-2004 Books / CD-ROMS / eBooks in PDF / Online Subscriptions Trends, Statistics Market Research and Industry Analysis in:
Your key to Business & Looking for a job? Industry Research Doing market research?
• Advertising & Branding - NEW
• Apparel & Textiles - NEW Looking for business prospects? • Consulting Industry - NEW • Nanotechnology - NEW Writing a business plan? • Real Estate &
Planning a business strategy?
Plunkett Research, Ltd. When You Need Accurate, Timely, Innovative Information
www.plunkettresearch.com 713.932.0000
•
Construction - NEW Transportation & Logistics - NEW
• Airline, Hotel & Travel • Automobile • Computers & Internet • Energy • Consulting Industry • Engineering & Research • Entertainment & Media • Food • Health Care & Biotech • Job Seekers & Careers • Retail • Telecommunications
• Looking for a job? • Doing market research? • Looking for business
prospects? • Writing a business plan? • Planning a business strategy? Get Market Research, Industry Analysis and Corporate Profiles in One Resource! Each exciting industry title contains all of the information you need to fully understand the trends, technologies, finances and leading companies of a specific industry. Whatever field you are researching, from InfoTech to Energy to Retailing, you’ll find all of the answers you need in one value-packed, industry-specific resource.
Get Reference Titles Packed with 400 to 700 Pages of Valuable Information! Here’s what you’ll find inside each industry book: • Glossary • Industry Overview and Trends • Segment by Segment Analysis • Statistics, Charts, Tables • Technology and Research Trends • Industry Contacts and Associations • Finances • Profiles of Hundreds of Leading Companies • Thorough Indexes and Cross-Indexes
More Industry Reference Books Coming Soon! Now accepting pre-publications order for: Plunkett’s Consulting Industry Almanac 1-593920-02-4 $249.99 APPROX. PUBLICATION DATE: NOV. 2003 INCLUDES CD-ROM
Covers the prestigious consulting industry from one end to the other. Statistics, trends, mergers, finances. Includes profiles of the Consulting Industry 300 Firms, the leading companies providing consulting in marketing, information technology, management, manufacturing, health care and more.
Plunkett’s Real Estate & Construction Industry Almanac 1-593920-03-2 $249.99 APPROX. PUBLICATION DATE: JAN. 2004 INCLUDES CD-ROM
Provides detailed analysis and statistics of all facets of this industry, including architecture, engineering, property management, finance, operations, mortgages, REITs, brokerage, construction and development. Profiles of the leading 300 firms.
Plunkett’s Nanotechnology & MEMS Industry Almanac 1-593920-04-0 $249.99 APPROX. PUBLICATION DATE: MAR. 2004 INCLUDES CD-ROM
This exciting new industry will enhance technologies of all types. Nanotech has applications within biotechnology, manufacturing, aerospace and information systems. This book covers micro-electro-mechanical (MEMS), microengineering, microsystems, microsensors, carbon tubes and much more. Trends, finances and profiles of the 300 leading firms.
Plunkett’s Advertising & Branding Industry Almanac 1-593920-05-9 $249.99 APPROX. PUBLICATION DATE: JUN. 2004 INCLUDES CD-ROM
Vital to businesses of all types, advertising and branding are covered in-depth in this important volume, from media to direct mail, from online advertising to branding and image. Analysis of trends, globalization, technologies, finances and more. Profiles of the 300 leading companies.
Plunkett’s Apparel & Textiles Industry Almanac
Get Detailed Profiles and Useable Information on Hundreds of Leading Firms: • Leading Companies Profiled and Ranked by Sales and Profits • Thorough Business Descriptions • Up to 24 Executive Contacts per Company • Address, Phone, Fax, Web Sites • Growth Plans • Competitive Advantage Statements • Salaries, Benefits and Hiring Plans • Divisions and Subsidiaries
1-593920-06-7 $249.99 APPROX. PUBLICATION DATE: JUL. 2004 INCLUDES CD-ROM
An exciting, global industry, apparel and textiles are covered indepth in this book, from clothing, shoes and accessories to designers, retail stores and manufacturers. Statistics, trends and market analysis. Profiles of the 300 leading firms.
Plunkett’s Transportation & Logistics Industry Almanac 1-593920-07-5 $249.99 APPROX. PUBLICATION DATE: SEP. 2004 INCLUDES CD-ROM
This immense, global sector is vital to all businesses. This book covers exciting trends in supply chain and logistics management, transportation, intermodal shipment systems and advanced technologies. Market analysis, statistics and trends. Profiles of the 300 leading firms.
www.plunkettresearch.com
713.932.0000
TRAVEL & AIRLINES
ENGINEERING & RESEARCH
FINANCE & INVESTMENTS
Plunkett’s Airline, Hotel & Travel Industry Almanac
Plunkett’s Engineering & Research Industry Almanac 2003-2004
Plunkett’s Financial Services Industry Almanac 2002-2003
1-891775-74-X $249.99 NOVEMBER 2002 INCLUDES CD-ROM
450 pg. The only complete reference to the global travel industry, including airlines, hotels, tour operators; travel agencies; e-commerce firms, cruise lines and car rentals. Includes a trends analysis, glossary, statistics, industry contacts, thorough indexes and in-depth profiles of the 300 leading companies in the industry.
AUTOMOBILE Plunkett’s Automobile Industry Almanac 1-891775-76-6 $249.99 MARCH 2003 INCLUDES CD-ROM
412 pg. A key reference tool. Provides industry analysis, statistical tables, an automobile industry glossary, industry contacts, thorough indexes and in-depth profiles of the 300 leading automotive industry firms.
1-891775-24-3 $249.99 JULY 2003 INCLUDES CD-ROM
680 pg. Profiles of 500 leading corporations in research, engineering and development in biotech, electronics, aerospace, medicine. "...The convenience for a typical user makes this volume very attractive for the support of job-seekers and investors." – American Reference Books Annual
RETAIL Plunkett’s Retail Industry Almanac 2003 1-891775-55-3 $229.99 ANNUAL EDITION DEC 2002 INCLUDES CD-ROM
540 pg. Thorough analysis of trends, careers, suppliers, finances, shopping centers and Internet-based retailing. Profiles of 400 leading, fast-growing retailers of all types. “Consider this reference essential...covering everything from malls and superstores to mail order business.” – Midwest Book Review
FOOD & BEVERAGE
COMPUTERS & INTERNET
Plunkett’s Food industry Almanac
Plunkett’s E-Commerce & Internet Business Almanac 2003-2004
1-891775-75-8 $249.99 MAY 2003 INCLUDES CD-ROM
450 pg. Covers the entire food and beverage industry, including food producers, retailers, technologies and distributors. Provides a thorough market analysis, dozens of statistical tables, glossary, contacts, and profiles of the 340 leading companies in the global food industry.
HEALTH CARE & BIOTECH Plunkett’s Health Care Industry Almanac 2003 1-891775-54-5 $229.99 ANNUAL EDITION SEPT 2002 INCLUDES CD-ROM
716 pg. The only complete reference to the American health care industry. Profiles of the Health Care 500 firms. Academic Book of the Year Award Winner.
1-891775-58-8 $249.99 JUNE 2003 INCLUDES CD-ROM
500 pg. Complete access to the exploding Internet business. Profiles of leading corporations in e-commerce, equipment, Internet services and more.
713 pg. Profiles of 500 leading corporations in banking, insurance, mortgages, online finance, credit cards, investments, stocks. “Well researched and presented...excellent value in terms of information versus cost.” – American Reference Book Annual
Plunkett’s Online Trading, Finance & Investment Web Sites Almanac 1-891775-08-1 $149.99 JAN 2000 INCLUDES DISKETTE
547 pg. Save countless hours in your research for data on investments, stocks, bonds, commodities, banking, mortgages, economics, trends and more. Complete profiles of the 211 most vital web sites for investors and financial professionals. "Contains an abundance of useful information." – Journal of Business & Finance Librarianship
ENTERTAINMENT & MEDIA Plunkett’s Entertainment & Media Industry Almanac 2002-2003 1-891775-27-8 $229.99 MAY 2002 INCLUDES CD-ROM
515 pg. Profiles of 350 leading firms in film, radio, TV, cable, multimedia, magazines, books, newspapers and online publishing.
“Unique, well-researched.” – CHOICE Magazine
“A critically important reference.” – Midwest Book Review
Plunkett’s InfoTech Industry Almanac 2003
ENERGY
1-891775-57-X $229.99 ANNUAL EDITION APRIL 2003 INCLUDES CD-ROM
640 pg. In-depth analysis of the InfoTech Revolution. Profiles of the InfoTech 500 firms in computers, software, online, systems integration, networking and more. "Intriguing reference...interesting articles on the industry's trends." – Library Journal
"Highly recommended..." – CHOICE Magazine
TELECOMMUNICATIONS
Plunkett’s Biotech & Genetics Industry Almanac 2003-2004
Plunkett’s Telecommunications Industry Almanac 2003-2004
1-891775-28-6 $249.99 FEB 2003 INCLUDES CD-ROM
1-891775-22-7 $249.99 JULY 2002 INCLUDES CD-ROM
522 pg. Your guide to the technologies revolutionizing health care. Research, growth companies, proteomics, genomics. Vital details on the Biotech 400 firms.
533 pg. Complete guide to the rapidly evolving telecommunications industry. Profiles of leading firms in wireless, long-distance, networks, local service.
“For business researchers and job seekers, this almanac provides an overview of leading biotechnology firms and descriptions of emerging technology.” – CHOICE Magazine
1-891775-23-5 $229.99 MAR 2002 INCLUDES CD-ROM
“Essential for long-term business analysis and industry trends.” – Midwest Book Review
Plunkett’s Energy Industry Almanac 2002-2003 1-891775-20-0 $199.99 JULY 2001 INCLUDES CD-ROM
570 pg. Covers everything from major oil companies to electric and gas utilities, plus pipelines, refiners/retailers, oil field services and alternative energy. Profiles of Plunkett’s Energy 400 firms. “This impressive reference compendium covers all facets of the American energy industry...exhaustively researched...” – Midwest Book Review
Order Today! 713.932.0000 www.plunkettresearch.com
JOB SEEKERS & CAREERS Plunkett’s Employers’ Internet Sites with Careers Information 2002-2003
Each book comes with a complete database on CD-ROM...FREE.
1-891775-19-7 $199.99 JAN 2002 INCLUDES CD-ROM
• The CD-ROM database
696 pg. Profiles 500 Internet sites operated by major employers. Locate web sites with job openings and the ability to apply online. Saves countless hours of research. Indexes include international posts, internships, physically challenged and type of career.
will enable you to search by company, industry, sales, location and keywords • Create and print your own mailing lists addressed to the CEO, Humans Resources V.P. or 24 other executives by title • Build your own spread sheets and databases • Find each company’s website
“(It) will become a core addition to career centers and libraries everywhere...” – Joyce Lain Kennedy, columnist
The Almanac of American Employers 2003 1-891775-56-1 $199.99 ANNUAL EDITION DEC 2002 INCLUDES CD-ROM
718 pg. Fully updated for the job seeker and researcher. Includes salaries, benefits, corporate culture, special hiring/training programs, women and minorities in top posts, contacts. Profiles The American Employers 500. “Recommended for all libraries.” – CHOICE Magazine
Plunkett’s Companion to The Almanac of American Employers: Mid-Size Firms 2002-2003 1-891775-26-X $179.99 DEC 2001 INCLUDES CD-ROM
sample screens
684 pg. Profiles of 500 rapidly growing mid-size firms, from 200 to 2,300 employees. “The best places to work.” – USA Today
Check us out! See sample chapters at www.plunkettresearch.com
Ordering from Plunkett Research is easy. • Use the order form on the back of this brochure • Place your order online at www.plunkettresearch.com • Order by phone at 713.932.0000 • Order by fax at 713.932.7080 • Order by mail at P.O. Drawer 541737 Houston, TX 77254
Plunkett Research Online is your key to Market Research
New Plunkett’s online subscription plans
are available at value-packed prices.
Plunkett’s business, Internet and careers data is available online through subscription plans tailored to fit your organization. Access our online service by IP address, user name or other popular methods. Search and view our industry analysis, statistics and company profiles online.
Accessing our data online has many outstanding advantages. • You access the service via our server, which means that we do all of the maintenance and updating.
• All employees of a corporation, all students of a business school or even an entire university can have access to our online service’s unique data.
• Information on our online service is updated weekly. • Our newest editions and updates will be posted automatically – before they are available in print!
• Thousands of company profiles can easily be searched using a wide array of criteria.
• All profiles are easily printable, and you also have several options for exporting vital data.
• You have instant access to our updated databases of statistics, glossaries of key industry terms and contact lists of industry associations.
• Our online service is fully searchable by keyword so that users can quickly find the subject area and data they are seeking.
Online Pricing and Access Options By User Name and Password Includes online access to all of our publications and every industry covered by Plunkett Research. 1 to 5 seats . . . . . . . . .$1,995 6-20 seats . . . . . . . . . .$2,995
By IP Address Recognition, Organization-wide access Includes online access to all of our publications and every industry covered by Plunkett Research. University or School . . .$2,995 (one campus) Government or . . . . . .$2,995 Non-Profit (one agency) Public Library . . . . . . .$2,995 (one location) Corporation . . . . . . . . .$3,495 Access to Only One Industry Sector $950 You should purchase this subscription if you want access to only one of our main industry sectors, for example health care only or retail only. This subscription will provide you with organization-wide access, by your choice of user name or IP address recognition.
Order Today!
Plunkett Research, Ltd. • P. O. Drawer 541737 • Houston, Texas 77254 USA Phone: 713.932.0000 • FAX: 713.932.7080 • Online: www.plunkettresearch.com Quantity
Airline, Hotel & Travel Plunkett’s Airline, Hotel & Travel Industry Almanac ISBN 1-891775-74-X with CD-ROM
____ @ 249.99
Automobile Plunkett’s Automobile Industry Almanac ISBN 1-891775-76-6 with CD-ROM
____ @ 249.99
Computers & Internet Plunkett’s E-Commerce & Internet Business Almanac 2003-2004 ISBN 1-891775-58-8 with CD-ROM Plunkett’s InfoTech Industry Almanac 2003 ISBN 1-891775-57-X with CD-ROM Energy Plunkett’s Energy Industry Almanac 2002-2003 ISBN 1-891775-20-0 with CD-ROM Engineering & Research Plunkett’s Engineering & Research Industry Almanac 2003-2004 ISBN 1-891775-24-3 with CD-ROM Entertainment & Media Plunkett’s Entertainment & Media Industry Almanac 2002-2003 ISBN 1-891775-27-8 with CD-ROM Finance & Investments Plunkett’s Financial Services Industry Almanac 2002-2003 ISBN 1-891775-23-5 with CD-ROM Plunkett’s Online Trading, Finance & Investment Web Sites Almanac ISBN 1-891775-08-1 with Diskette Food Plunkett’s Food Industry Almanac ISBN 1-891775-75-8 with CD-ROM Health Care & Biotech Plunkett’s Health Care Industry Almanac 2003 ISBN 1-891775-54-5 with CD-ROM Plunkett’s Biotech & Genetics Industry Almanac 2003-2004 ISBN 1-891775-28-6 with CD-ROM Job Seekers & Careers The Almanac of American Employers 2003 ISBN 1-891775-56-1 with CD-ROM Plunkett’s Companion to The Almanac of American Employers: Mid-Size Firms 2002-2003 ISBN 1-891775-26-X with CD-ROM Plunkett’s Employers’ Internet Sites with Careers Information 2002-2003 ISBN 1-891775-19-7 with CD-ROM Retail Plunkett’s Retail Industry Almanac 2003 ISBN 1-891775-55-3 with CD-ROM Telecommunications Plunkett’s Telecommunications Industry Almanac 2003-2004 ISBN 1-891775-22-7 with CD-ROM
Also, we’re accepting pre-publication orders for these upcoming titles: Plunkett’s Consulting Industry Almanac 1-593920-02-4 with CD-ROM Approx. Publication Date: Nov. 2003
____ @ 249.99
____ @ 249.99 Plunkett’s Real Estate & Construction Industry Almanac ____ @ 229.99
____ @ 199.99
____ @ 249.99
____ @ 229.99
1-593920-03-2 with CD-ROM Approx. Publication Date: Jan. 2004
____ @ 249.99
Plunkett’s Nanotechnology & MEMS Industry Almanac 1-593920-04-0 with CD-ROM Approx. Publication Date: Mar. 2004
____ @ 249.99
Plunkett’s Advertising & Branding Industry Almanac 1-593920-05-9 with CD-ROM Approx. Publication Date: Jun. 2004
____ @ 249.99
____ @ 229.99 Plunkett’s Apparel & Textiles Industry Almanac ____ @ 149.99
____ @ 249.99
____ @ 229.99
1-593920-06-7 with CD-ROM Approx. Publication Date: Jul. 2004
____ @ 249.99
Plunkett’s Transportation & Logistics Industry Almanac 1-593920-07-5 with CD-ROM Approx. Publication Date: Sep. 2004
____ @ 249.99
____ @ 249.99
____ @ 199.99
Subtotal
$
Shipping/ Handling add $9.50 per book or
$
____ @ 179.99
Next day air in the US, add $23.50 per book or
$
____ @ 199.99
Airmail outside USA, add $50.00 per book.
$
FedEx outside USA, add $90.00 per book.
$
In Texas add 8.25% sales tax if you are not tax exempt.
$
TOTAL
$
____ @ 229.99
____ @ 249.99
STANDING ORDER l Check here for a standing order and receive a 10% discount on future editions of the book(s) you have ordered, which will be shipped to you automatically. You may cancel your standing order at any time.
METHOD OF PAYMENT (Our Federal ID number is 74-2440918) Purchase order number (if any): l Check enclosed l Bill me l Credit card (check one) l VISA l MasterCard l American Express Credit Card No.
Expiration Date:
SHIP TO: Name Title/Department Organization Address City Telephone E-mail
State Fax
Zip
Plunkett Research, Ltd. P. O. Drawer 541737 Houston, Texas 77254 USA 713.932.0000
PRSRT STD AUTO US POSTAGE PAID DALLAS TX PERMIT NO 6803
Customer Support Information Plunkett’s Engineering & Research Industry Almanac 2003-2004 Please register your book immediately… if you did not purchase it directly from Plunkett Research, Ltd. This will enable us to fulfill your replacement request if you have a damaged product, or your requests for assistance. Also it will enable us to notify you of future editions, so that you may purchase them from the source of your choice.
If you are an actual, original purchaser but did not receive a FREE CD-ROM version with your book…* you may request it by returning this form. ____ YES, please register me as a purchaser of the book. I did not buy it directly from Plunkett Research, Ltd. ____ YES, please send me a free CD-ROM version of the book. I am an actual purchaser, but I did not receive one with my book. (Proof of purchase may be required.) Customer Name ____________________________________________________ Title ______________________________________________________________ Organization _______________________________________________________ Address ___________________________________________________________ City_______________________________State________Zip_________________ Country (if other than USA) ___________________________________________ Phone_________________________Fax ________________________________ E-mail ____________________________________________________________
Mail or Fax to:
Plunkett Research, Ltd.
Attn: FREE CD-ROM and/or Registration P.O. Drawer 541737, Houston, TX 77254-1737 USA 713.932.0000 Fax 713.932.7080 http://www.plunkettresearch.com/ * Purchasers of used books are not eligible to register. Use of CD-ROMs is subject to the terms of their end user license agreements.
PLUNKETT’S ENGINEERING AND RESEARCH INDUSTRY ALMANAC 2003-2004 The Only Comprehensive Guide to the Engineering and Research Industry
Jack W. Plunkett Published by: Plunkett Research, Ltd., Houston, Texas http://www.plunkettresearch.com/
PLUNKETT’S ENGINEERING AND RESEARCH INDUSTRY ALMANAC 2003-2004 Editor and Publisher: Jack W. Plunkett Executive Editor and Database Manager: Martha Burgher Plunkett
E-Commerce Manager: Kevin Hinrichs
Senior Editors and Researchers: Elisa Gabbert Ghazal Siddiqi
Cover Design: Kim Paxson, Just Graphics Junction, TX
Editors, Researchers and Assistants: Elizabeth Lockett Christie Manck Ray Marumahoko Mariya Paterwic Daniel Shirley Jonathan Timms Suzanne Zarosky
Special Thanks to: National Science Foundation, Division of Science Resources Studies, Arlington, VA U.S. Patent and Trademark Office, Division of Technology, Assessment and Forecast, Alexandria, VA
Information Technology Director: Alex Preskovsky Plunkett Research, Ltd. P. O. Drawer 541737, Houston, Texas 77254 Phone: 713.932.0000 Fax: 713.932.7080 http://www.plunkettresearch.com/
Copyright 2003 by Plunkett Research, Ltd.
Published by: Plunkett Research, Ltd. P. O. Drawer 541737 Houston, Texas 77254-1737 USA Phone: 713.932.0000 Fax: 713.932.7080 Internet: www.plunkettresearch.com ISBN # 1-891775-33-2 End-User License Agreement, Limited Warranty & Limitation of Liability--Effective January 2003, Plunkett Research, Ltd. Important, read carefully: This agreement is a legal agreement between you (whether as an individual or an organization) and Plunkett Research, Ltd. By installing, copying, downloading, accessing or otherwise using the Plunkett Data, you agree to be bound by the terms of this Agreement. If you do not agree to the terms of this Agreement, do not install or use the Plunkett Data. The information (the "Data" or the "Plunkett Data") contained in this printed version or electronic file is the property of Plunkett Research, Ltd. Copyright laws and international copyright treaties, as well as other intellectual property laws and treaties, protect the Plunkett Data. LIMITED RIGHTS TO INSTALL DATA ON ELECTRONIC DEVICES: Plunkett Research, Ltd. grants you, as an individual or an organization, a non-exclusive license to use and and/or install this Data, including installation of electronic files on one individual desktop computer AND on one laptop computer AND one personal digital assistant or dedicated portable eBook reader (such as a Palm or iPaq). This is a limited license, which applies to a single user. Organizations desiring multi-user licenses may purchase additional rights at reasonable cost by contacting Plunkett Research, Ltd., 713.932.0000, http://www.plunkettresearch.com/, email:
[email protected]. LIMITED RIGHTS TO EXPORT OR COPY DATA, SUBJECT TO CONTINUED COPYRIGHT NOTICE: Limited exporting or copying of certain limited amounts of Data for creation of mailing lists, summaries and contact lists is allowed, PROVIDED THAT: 1) The exported Data is for use by one organization, company or individual only. 2) The exported Data will not be re-sold, posted to an Internet-based file, commercially published, or broadly distributed outside of the organization/corporation that has purchased the Plunkett Data. 3) Broad use, multi-premises use, or sharing outside of the organization that purchased the Plunkett Data is not allowed. 4) Violators will be subject to all penalties allowed by law. Rights under this license may not be sold or transferred. Data which may be exported or copied under the rights conferred through this paragraph may consist of any of the following: i. Up to 400 words of text; ii. Company names, addresses, telephone numbers,and executives with job titles; iii. Up to 2 tables or charts, PROVIDED THAT
said Data is immediately followed by this information in a font size that is clearly legible and of no less than 9 points in size: Copyright © Plunkett Research, Ltd., www.plunkettresearch.com, all rights reserved.
LIMITED WARRANTY: While Plunkett Research, Ltd. has made an effort to obtain the Data from sources deemed reliable, Plunkett Research, Ltd. makes no warranties, expressed or implied, regarding the accuracy, the installation or usability of an electronic file, or any aspect of the Data contained herein whether in print or electronic version. The Data is provided to the End-User “AS IS” without warranty of any kind. No oral or written information or advice given by Plunkett Research, Ltd. or its employees, distributors or representatives will create a warranty or in any way increase the scope of this Limited Warranty, and the Customer or End-User may not rely on any such information or advice. Among other things, this Limited Warranty applies to your ability to install an electronic file or software or such an installation's effects on your computer or other electronic devices. Plunkett Research, Ltd. assumes no liability and does not guarantee that this Data will install or function correctly on your computer or other electronic devices and further does not guarantee or accept any liability for the results of your attempt to install this Data, including any fault or dysfunction (including, but not limited to: computer viruses and/or alterations to computer files, registries or setups) to your computer or electronic devices that may be caused by installation or use. Customer Remedies: Plunkett Research, Ltd. and its suppliers' entire liability and your exclusive remedy shall be, at Plunkett Research Ltd.'s sole discretion, either (a) return of the price paid, if any, or (b) repair or replacement of the product that does not meet Plunkett Research, Ltd.'s Limited Warranty and that is returned to Plunkett Research, Ltd. with sufficient evidence of or receipt for your original purchase. NO OTHER WARRANTIES: TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, PLUNKETT RESEARCH, LTD. AND ITS SUPPLIERS AND DISTRIBUTORS DISCLAIM ALL OTHER WARRANTIES AND CONDITIONS, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT WITH REGARD TO THE PRODUCT, AND THE PROVISION OF OR FAILURE TO PROVIDE SUPPORT SERVICES. THIS LIMITED WARRANTY GIVES YOU SPECIFIC LEGAL RIGHTS. YOU MAY HAVE OTHERS, WHICH VARY FROM STATE/JURISDICTION TO STATE/JURISDICTION.
LIMITATION OF LIABILITY: TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL PLUNKETT RESEARCH, LTD. BE LIABLE FOR ANY SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES WHATSOEVER (INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOSS OF BUSINESS PROFITS, BUSINESS INTERRUPTION, LOSS OF BUSINESS INFORMATION, ABILITY TO OBTAIN OR RETAIN EMPLOYMENT OR REMUNERATION, ABILITY TO PROFITABLY MAKE AN INVESTMENT, OR ANY OTHER PECUNIARY LOSS) ARISING OUT OF THE INSTALLATION OF, USE OF, OR RELIANCE UPON THIS DATA, OR THE INABILITY TO USE THIS DATA (WHETHER IN ELECTRONIC OR PRINTED FORM) OR THE FAILURE OF PLUNKETT RESEARCH, LTD. TO PROVIDE SUPPORT SERVICES, EVEN IF PLUNKETT RESEARCH, LTD. HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IN ANY CASE, PLUNKETT RESEARCH, LTD.’S ENTIRE LIABILITY UNDER ANY PROVISION OF THIS END-USER LICENSE AGREEMENT SHALL BE LIMITED TO THE AMOUNT ACTUALLY PAID BY YOU FOR THE PRODUCT. BECAUSE SOME STATES/JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY, THE ABOVE LIMITATION MAY NOT APPLY TO YOU.
PLUNKETT'S ENGINEERING AND RESEARCH INDUSTRY ALMANAC 2003-2004 CONTENTS A Short Engineering and Research Industry Glossary Introduction How To Use This Book Chapter 1: Major Trends in the Engineering and Research Industry Company R&D Spotlights: IBM Lucent/Bell Labs Intel Microsoft Xerox Genentech Pfizer DuPont General Electric Chapter 2: Engineering and Research Industry Statistics Chapter 3: Engineering and Research Industry Contacts Addresses, Telephone Numbers and World Wide Web Sites Chapter 4: THE ENGINEERING 500: Who They Are and How They Were Chosen Industry List, With Codes Index of Rankings Within Industry Groups (The ENGINEERING 500 grouped by industry and ranked for sales and profits) Alphabetical Index Index of Headquarters Location by State Index of Headquarters Location by Country Index by Regions of the U.S. Where the ENGINEERING 500 Have Locations Index by Firms With International Operations Individual Profiles on each of THE ENGINEERING 500 Additional Indexes Index of Hot Spots for Advancement for Women/Minorities Index of Subsidiaries, Brand Names and Selected Affiliations List of Major Tables and Charts I. U.S. Research and Development Comparative Measures of Growth for Gross Domestic Product and R&D Federally Funded Research and Development Centers' R&D Expenditures: 2001 National Expenditures for Applied Research, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Applied Research, from Funding Sectors to Performing Sectors: 1993-2002 Continued on the next page
i 1 3 7 17 17 17 18 18 18 19 19 19 21 61 87 88 90 102 107 112 113 128 133 604 606
p. 23 p. 24 p. 25 p. 27 p. 28
Continued from the previous page
National Expenditures for Basic Research, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Basic Research, from Funding Sectors to Performing Sectors: 1993-2002 National Expenditures for Development, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Development, from Funding Sectors to Performing Sectors: 1993-2002 National Expenditures for R&D, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for R&D, from Funding Sectors to Performing Sectors: 1993-2002 Trends in Federal and Non-Federal R&D Expenditures as a Percentage of Total R&D: 1953-2002 Trends in U.S. Research & Development (R&D) and Federal Outlays: 1970, 1980, 1990, 2000 and 2002 U.S. Federal Basic Research Budget Authority, by Budget Function: Fiscal Years 1995–2001 U.S. Federal R&D Budget Authority, by Budget Function: FY 1980–2001
II. Research and Development by States-U.S. California Research & Development (R&D) Profile, 1999-2000 Illinois Research & Development (R&D) Profile, 1999-2000 Maryland Research & Development (R&D) Profile, 1999-2000 Massachusetts Research & Development (R&D) Profile, 1999-2000 Michigan Research & Development (R&D) Profile, 1999-2000 New Jersey Research & Development (R&D) Profile, 1999-2000 New York Research & Development (R&D) Profile, 1999-2000 Pennsylvania Research & Development (R&D) Profile, 1999-2000 Texas Research & Development (R&D) Profile, 1999-2000 Washington Research & Development (R&D) Profile, 1999-2000 State Distribution of Expenditures for R&D, by Performing Sector and Source of Funding: 2000 Top 10 U.S. States in Total R&D Performance, Size of R&D by Performer and R&D as a Percentage of Gross State Product: 2000 III. International Research and Patents International R&D Expenditures in Constant Dollars and as a Percentage of GDP: 1981–2001 Top 20 Global Patenting Organizations, Calendar Year 2001 Top 20 Patenting Countries, 2001
p. 29 p. 30 p. 31 p. 32 p. 33 p. 34 p. 35 p. 37 p. 38 p. 39
p. 41 p. 42 p. 43 p. 44 p. 45 p. 46 p. 47 p. 48 p. 49 p. 50 p. 51 p. 52 p. 54
p. 55 p. 56 p. 58 p. 59
Plunkett Research, Ltd.
A Short Engineering & Research Industry Glossary 510 K: The application filed with the FDA for a new medical device to show that the apparatus is “substantially equivalent” to one that is already marketed. 802.11a: A faster wireless network standard than 802.11b, 802.11a operates in the 5-GHz band at speeds of 50 Mbps or more. This standard may be affected by weather and is not as suitable for outdoor use. This standard may be of little importance if 802.11g becomes popular. 802.16: This very fast wireless network standard includes 802.16 and its extension of 802.16a. 802.16a operates in the 2 to 66 GHz band with speeds as high as 166 Mbps. This standard may eventually enable wireless to compete with T1 lines. Access Network: The network that connects a user's telephone equipment to the telephone exchange. Active Server Page (ASP): A specification for a web page with an ASP extension containing Java Script or Visual Basic code. (See "Java" below.) Active X: A set of technologies developed by Microsoft Corporation for sharing information across different applications. ADME: Absorption, Distribution, Metabolism and Excretion. In clinical trials, the bodily processes studied to determine the extent and duration of systemic exposure to a drug. ADN (Advanced Digital Network): See "IDN (Integrated Digital Network)" below. ADSL (Asymmetrical Digital Subscriber Line): High-speed technology that enables the transfer of data over existing copper phone lines, allowing more bandwidth downstream than upstream. AE (Adverse Event): In clinical trials, a condition not observed at baseline or worsened if present at baseline. Sometimes called Treatment Emergent Signs and Symptoms (TESS). Ambient: Any unconfined portion of the air. Also refers to open air.
www.plunkettresearch.com
Analog: A form of transmitting information characterized by continuously variable quantities. Digital transmission, on the other hand, is characterized by discrete bits of information in numerical steps. An analog signal responds to changes in light, sound, heat and pressure. Analog IC (Integrated Circuit): A semiconductor that processes a continuous wave of electrical signals based on real-world analog quantities such as speed, pressure, temperature, light, sound and voltage. ANDA (Abbreviated New Drug Application): An application filed with the FDA for a drug showing that the substance is the same as an existing, previously approved drug (i.e., a generic version). ANSI: American National Standards Institute. Applied Research: The application of compounds, processes, materials or other items discovered during “basic research” to practical uses. The goal is to move discoveries along to the final development phase. ARPANet: Advanced Research Projects Agency Network. The forefather of the Internet, ARPANet was developed during the latter part of the 1960s by the United States Department of Defense. ASCII: American Standard Code for Information Exchange. 128 standard ASCII codes exist that represent all Latin letters, numbers and punctuation. Each ASCII code is represented by a seven-digit binary number, such as 0000000 or 0000111. This code is accepted as a standard throughout the world. ASP (Application Service Provider): A web site that enables utilization of software and databases that reside permanently on the web site rather than having to be downloaded to the user's computer. Advantages include the fact that multiple remote users may access the same tools over the Internet and that the ASP provider is responsible for developing and maintaining the software. (ASP also refers to Active Server Page. See "Active Server Page" above.) Assay: A laboratory test to identify and/or measure the amount of a particular substance in a sample. Types of assays include endpoint assay, in which a single measurement is made at a fixed time; kinetic assay, in which increasing amounts of a product are formed with time and are monitored at multiple
Plunkett Research, Ltd.
points; microbiological assay, a measurement of the concentration of antimicrobials in biological material; and immunological assay, in which analysis or measurement is based on antigen-antibody reactions. Asynchronous Communications: A stream of data routed through a network as generated instead of in organized message blocks. Most personal computers use this format to send data. ATM (Asynchronous Transfer Mode): A digital switching and transmission technology based on high speed. ATM allows voice, video and data signals to be sent over a single telephone line at speeds from 25 million to 1 billion bits per second (bps). This digital ATM speed is much faster than traditional analog phone lines, which allow no more than 2 million bps. (See "Broadband" below.) Backbone: Traditionally, the part of a communications network that carries the heaviest traffic; the high-speed line or series of connections that forms a large pathway within a network or within a region. The combined networks of AT&T, Worldcom and other large telecommunications companies make up the backbone of the Internet. Bandwidth: The data transmission capacity of a network, measured in the amount of data (in bits and bauds) it can transport in one second. A full page of text is about 15,000 to 20,000 bits. Full-motion, fullscreen video requires about 10,000,000 bits per second, depending on compression. Baseline: A set of data used in clinical studies for control or comparison. Basic Research: Attempts to discover compounds, materials, processes or other items that may be largely or entirely new and/or unique. Basic research may start with a theoretical concept that has yet to be proven. The goal is to create discoveries that can be moved along to "applied research." Basic research is sometimes referred to as “blue sky” research. Baud: Refers to how many times the carrier signal in a modem switches value per second or how many bits a modem can send and receive in a second. Beams: The coverage and geographic service area offered by a satellite transponder. A global beam effectively covers one-third of the earth’s surface. A spot beam provides a very specific high-powered
www.plunkettresearch.com
downlink pattern that is limited to a particular geographical area to which it may be steered or pointed. Binhex: A means of changing non-ASCII (or nontext) files into text/ASCII files so that they can be used, for example, as e-mail. Bioavailability: In pharmaceuticals, the rate and extent to which a drug is absorbed or is otherwise available to the treatment site in the body. Bioequivalence: In pharmaceuticals, the demonstration that a drug’s rate and extent of absorption are not significantly different from those of an existing drug that is already approved by the FDA. Bioinformatics: Computer-simulated generation and testing of new chemical compounds for possible drug use. This method is much faster and more costeffective than manual methods. Biologic: Any virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic or analogous product or arsphenamine or one of its derivatives (or any other trivalent organic arsenic compound) applicable to the prevention, treatment or cure of disease or injury. Biotechnology: A set of powerful tools that employ living organisms (or parts of organisms) to make or modify products, improve plants or animals (including humans) or develop microorganisms for specific uses. Early uses of biotechnology included traditional animal and plant breeding techniques and the use of yeast in making bread, beer, wine and cheese. Today, biotechnology is most commonly thought of to include the development of human medical therapies and processes using recombinant DNA, cell fusion, other genetic techniques and bioremediation. Bit: A single digit number, either a one or a zero, which is the smallest unit of computerized data. Bluetooth: An industry standard for a technology that enables wireless, short-distance infrared connections between devices such as PCs, Palm Pilots or PDAs, laptops, cell phones and Internet appliances. It competes with 802.11b.
Plunkett Research, Ltd.
BPS (Bits Per Second): An indicator of the speed of data movement. Branding: A marketing strategy that takes a wellknown brand and utilizes brand capital in order to increase the brand's market share, sales and availability; establish credibility; improve satisfaction; raise the profile of the firm; and increase profits. Bridge: A device that links two local area networks together so they can share files and e-mail. Broadband: The high-speed transmission range for telecommunications and computer data. Broadband refers to any transmission at 2 million bps (bits per second) or higher (much higher than analog speed). A broadband network can carry voice, video and data all at the same time. Internet users enjoying broadband access typically connect to the Internet via DSL line, cable modem or T1 line. Browse: A term referring to the viewing of computerized data. Several Internet browsers support a browse mode that allows users to sort through data quickly. (See "Browser" below.) Browser: A program that allows a user to read Internet text or graphics and to navigate from one page to another. The most popular browsers are Microsoft Internet Explorer and Netscape Navigator. B-to-B, or B2B: See "Business-to-Business" below. B-to-C, or B2C: See "Business-to-Consumer" below.
www.plunkettresearch.com
Business-to-Government: An organization focused on selling products, services or data to government units, rather than commercial businesses or consumers. Byte: There are eight bits in a byte. This set stands for a single character. Cable Modem: An interface between a cable television system and a computer or router. Most cable modems are external devices that connect to the PC through a standard 10Base-T Ethernet card and twisted-pair wiring. External Universal Serial Bus (USB) modems and internal PCI modem cards are also available. The cable modem enables a computer to access the Internet via the TV cable. Cable modem access can be very high-speed and is much faster than traditional "dial-up" access via a standard telephone line. Cable modem speeds vary, depending on the cable modem system and current traffic load. From the Internet to the computer the modem may connect at speeds as high as 1 to 3 Mbps. From the computer to network, speeds typically run between 500 Kbps and 2.5 Mbps. Cable modem access competes with DSL access. Caching: Storing data in a temporary location closer to the user so that it can be retrieved quickly when requested. CAD (Computer-Aided Design): CAD software, which generally runs on workstations, is a tool used to provide three-dimensional, on-screen design for everything from buildings to automobiles to clothing. (See "CAM" and "CAE" below.) CAE: Computer-aided engineering.
B-to-G, or B2G: See "Business-to-Government" below. Buffer: A location for temporarily storing data being sent or received. Usually located between two devices that have different data transmission rates. Business-to-Business: An organization focused on selling products, services or data to commercial customers rather than individual consumers. Business-to-Consumer: An organization focused on selling products, services or data to individual consumers rather than commercial customers.
Call Automation: Part of the telephone equipment revolution, including voice mail, automated sending and receiving of faxes and the ability for customers to place orders and gather information using a touchtone telephone to access sophisticated databases. (See "Voice Mail" below.) CAM: Computer-aided manufacturing. CANDA (Computer-Assisted New Drug Application): An electronic submission of a new drug application (NDA) to the FDA. Capacitor: An electronic circuit device for temporary storage of electrical energy.
Plunkett Research, Ltd.
www.plunkettresearch.com
CAPLA (Computer-Assisted Product License Application): An electronic submission of a biological product license application (PLA) to the FDA.
CDMA (Code Division Multiple Access): A multiple-access scheme where stations use spreadspectrum modulations and orthogonal codes to avoid interfering with one another.
Cardiac Catheterization Laboratory: Facilities offering special diagnostic procedures for cardiac patients, including the introduction of a catheter into the interior of the heart by way of a vein or artery or by direct needle puncture. Procedures must be performed in a laboratory or a special procedure room.
CDRH (Center for Devices and Radiological Health): The branch of the FDA responsible for the regulation of medical devices. www.fda.gov/cdrh
Carrier: In communications, the basic radio, television or telephony center of transmit signal. The carrier in an analog signal is modulated by varying volume or shifting frequency up or down in relation to the incoming signal. Satellite carriers operating in the analog mode are usually frequency modulated. CASE (Computer Assisted Software Engineering): The application of computer technology to systems development activities, techniques and methodologies. Sometimes referred to as Computer Aided Systems Engineering. Catheter: A tubular instrument used to add or withdraw fluids. Heart or cardiac catheterization involves the passage of flexible catheters into the great vessels and chambers of the heart. IV catheters add intravenous fluids to the veins. Foley catheters withdraw fluid from the bladder. Significant recent advances in technology allow administration of powerful drug and diagnostic therapies via catheters. CATV: Cable television. CBER (Center for Biologics Evaluation and Research): The branch of the FDA responsible for the regulation of biological products, including blood, vaccines, therapeutics and related drugs and devices to ensure purity, potency, safety, availability and effectiveness. www.fda.gov/cber CDER (Center for Drug Evaluation and Research): The branch of the FDA responsible for the regulation of drug products. www.fda.gov/cder CDF (Channel Definition Format): Used in Internet-based broadcasting. With this format, a channel serves as a web site that also sends an information file about that specific site. Users subscribe to a channel by downloading the file.
CFR (Code of Federal Regulations): The CFR is a codification of the general and permanent rules published in the Federal Register by the executive departments and agencies of the federal government. The code is divided into 50 titles that represent broad areas subject to federal regulation. Title 21 of the CFR covers FDA regulations. CGI (Common Gateway Interface): A set of guidelines that determines the manner in which a web server receives and sends information to and from software on the same machine. CGI-BIN: The frequently used name of a directory on a web server where CGI programs exist. Class I Device: An FDA classification of medical devices. General controls are sufficient to ensure safety and efficacy. Class II Device: An FDA classification of medical devices. Performance standards and special controls are sufficient to ensure safety and efficacy. Class III Device: An FDA classification of medical devices. Pre-market approval is required to ensure safety and efficacy, unless the device is substantially equivalent to a currently marketed device. (See “510 K” above.) CLEC (Competitive Local Exchange Carrier): A newer company providing local telephone service that competes against larger, traditional firms known as ILECs (Incumbent Local Exchange Carriers). Client/Server: In networking, a way of running a large computer setup. The server is the host computer that acts as the central holding ground for files, databases and application software. The clients are all of the PCs connected to the network that share data with the server. This represents a vast change from past networks, which were connected to expensive, complicated “mainframe” computers.
Plunkett Research, Ltd.
Cloning (Reproductive): A method of reproducing an exact copy of an animal or, potentially, an exact copy of a human being. A scientist removes the nucleus from a donor's unfertilized egg, inserts a nucleus from the animal to be copied and then stimulates the nucleus to begin dividing to form an embryo. In the case of a mammal, such as a human, the embryo would then be implanted in the uterus of a host female. Also see "Cloning (Therapeutic)." Cloning (Therapeutic): A method of reproducing exact copies of cells needed for research or for the development of replacement tissue or organs. A scientist removes the nucleus from a donor's unfertilized egg, inserts a nucleus from the animal whose cells are to be copied and then stimulates the nucleus to begin dividing to form an embryo. However, the embryo is never allowed to grow to any significant stage of development. Instead, it is allowed to grow for a few hours or days and stem cells are then removed from it for use in regenerating tissue. Also see "Cloning (Reproductive)." CMOS (Complementary Metal-Oxide Semiconductor): Integrated-circuit technology used for processors and memory. Coaxial Cable: A type of cable widely used to transmit telephone and broadcast traffic. The distinguishing feature is an inner strand of wires surrounded by an insulator that is in turn surrounded by another conductor, which serves as the ground. Cable TV wiring is typically coaxial. Codec: Hardware or software that converts analog to digital and digital to analog (in both audio and video formats). Codecs can be found in digital telephones, set-top boxes, computers and videoconferencing equipment. The term is also used to refer to the compression of digital information into a smaller format. Co-Location: Refers to the hosting of computer servers at locations operated by service organizations. Co-location is offered by firms that operate specially designed co-location centers with high-levels of security, extremely high-speed telecommunication lines for Internet connectivity and reliable backup electrical power systems in case of power failure, as well as a temperature controlled environment for optimum operation of computer systems.
www.plunkettresearch.com
Commerce Chain Management (CCM): In ecommerce, this refers to Internet-based tools to facilitate sales, distribution, inventory management and content personalization. (See also "Supply Chain.") Compression: A technology in which a communications signal is squeezed so that it uses less bandwidth (or capacity) than it normally would. This saves storage space and shortens transfer time. The original data is decompressed when read back into memory. COMSAT: The Communications Satellite Corporation. COMSAT serves as the U.S. Signatory to INTELSAT and INMARSAT. Coordinator: In clinical trials, the person at an investigative site who handles the administrative responsibilities of a clinical trial, acts as a liaison between the investigative site and the sponsor and reviews data and records during a monitoring visit. COSTART: In medical and drug product development, a dictionary of adverse events and body systems used for coding and classifying adverse events. CPMP (Committee on Proprietary Medicinal Products): A committee, composed of two people from each EU Member State (see “EU” below), that is responsible for the scientific evaluation and assessment of marketing applications for medicinal products in the EU. The CPMP is the major body involved in the harmonization of pharmaceutical regulations within the EU and receives administrative support from the European Medicines Evaluation Agency. (See “EMEA” below.) CPU (Central Processing Unit): The part of a computer that interprets and executes instructions. It is composed of an arithmetic logic unit, a control unit and a small amount of memory. CRA (Clinical Research Associate): An individual responsible for monitoring clinical trial data to ensure compliance with study protocol and FDA GCP regulations. CRF (Case Report Form): In clinical trials, a standard document used by clinicians to record and report subject data pertinent to the study protocol.
Plunkett Research, Ltd.
CRO (Contract Research Organization): An independent organization that contracts with a sponsor of a clinical investigation to conduct part of the work on a clinical study. Drug makers and medical device makers frequently outsource work to CROs. CRT (Case Report Tabulation): In clinical trials, a tabular listing of all data collected on study case report forms. CT Scanner: In medicine, a computed tomographic scanner used for head or whole body scans. CVMP (Committee for Veterinary Medicinal Products): A committee that is a veterinary equivalent of the CPMP (see above) in the EU (see below). Cyberspace: Refers to the entire realm of information available through computer networks. Datanets: Private networks of land-based telephone lines, satellites or wireless networks that allow corporate users to send data at high speeds to remote locations while bypassing the speed and cost constraints of traditional telephone lines. Defibrillator: In medicine, an instrument used externally (as electrodes on the chest) or implanted (as a small device similar in size to a pacemaker) that delivers an electric shock to return the heart to its normal rhythm. Development: The phase of research and development in which researchers attempt to create new products from the results of discoveries and applications created during basic and applied research. Device: In medical product development, according to the FDA, an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent or other similar or related article, including any component, part or accessory, that 1) is recognized in the official National Formulary or United States Pharmacopoeia or any supplement to them, 2) is intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment or prevention of disease, in man or animals or 3) is intended to affect the structure of the body of man or animals and does not achieve any of its principal intended purposes through chemical action within or
www.plunkettresearch.com
on the body of man or animals and is not dependent upon being metabolized for the achievement of any of its principal intended purposes. Diagnostic Radioisotope Facility: In medicine, the use of radioactive isotopes (radiopharmaceuticals) as tracers or indicators to detect an abnormal condition or disease in the body. Dial-Up Access: The connection of a computer or other device to a network through a modem and a public telephone network. The only difference between dial-up access and a telephone connection is that computers are at each end of the connection rather than people. Dial-up access is slower than DSL, ISDN and other advanced connections. Digital: Transmission of a signal reducing all of its information to ones and zeros and then regrouping them at the reception end. Digital transmission vastly improves the carrying capacity of the spectrum while reducing noise and distortion of the transmission. Digital Local Telephone Switch: A computer that interprets signals (dialed numbers) from a telephone caller and routes calls to their proper destinations. A digital switch also provides a variety of calling features not available in older analog switches, such as call waiting. Digital Signal Processor: A chip that converts analog signals such as sound and light into digital signals. Disaster Recovery: A set of rules and procedures that allow a computer site to be put back in operation after a disaster has occurred. Moving backups off-site constitutes the minimum basic precaution for disaster recovery. The remote copy is used to recover data if the local storage is inaccessible after a disaster. Discrete Semiconductor: A chip with one diode or transistor. Disk Mirroring: A data redundancy technique in which data is recorded identically on multiple separate disk drives at the same time. When the primary disk is off-line, the alternate takes over, providing continuous access to data. Disk mirroring is sometimes referred to as RAID. Distributor: Distributors do not manufacture but may be involved in sales, marketing, warehousing or
Plunkett Research, Ltd.
www.plunkettresearch.com
shipping of drugs and/or medical devices. In medicine, distributors are subject to medical device incident reporting, record keeping, tracking and registration and certification requirements under the Safe Medical Devices Act (see “SMDA” below).
EDI (Electronic Data Interchange): An accepted standard format for the exchange of data between various companies’ networks. EDI allows for the transfer of e-mail as well as orders, invoices and other files from one company to another.
DMB (Data Monitoring Board): A committee that monitors the progress of a clinical trial and carefully observes the safety data.
EFGCP (European Forum for Good Clinical Practices): The organization dedicated to finding common ground in Europe on the implementation of Good Clinical Practices. (See “GCP” below.) www.efgcp.org
DOCSIS (Data over Cable Service Interface Specification): Standards for transferring data over cable television. Domain: A domain name that has server records associated with it. (See "Domain Name" below.) Domain (Top-Level): Either an ISO country code or a common domain name such as .com, .org or .net. DRM (Digital Rights Management): Enables control and maintenance of publishers’ rights by delivering encrypted information and, instead of providing the key (or using the recipient’s public key for encryption), in effect permitting the recipient to borrow the decryption key in a highly controlled fashion. Drug Utilization Review: A quantitative assessment of patient drug use and physicians’ patterns of prescribing drugs in an effort to determine the usefulness of drug therapy. DS-1: A digital transmission format that transmits and receives information at a rate of 1,544,000 bits per second. DSL (Digital Subscriber Line): See "Digital Subscriber Line" above. DSMB (Data and Safety Monitoring Board): See “DMB” above. Duplicate Host: A single host name that maps to duplicate IP addresses. Dynamic HTML: Web content that changes with each individual viewing. For example, the same site could appear differently depending on geographic location of the reader, time of day, previous pages viewed or the user’s profile. EC (European Community): See “EU” below.
EFT (Electronic Funds Transfer): A method of moving money from one account to another via computer. Withdrawing funds from an account using an ATM is a good example, as is paying bills using Quicken software on a PC. ELA (Establishment License Application): An ELA is required for the approval of a biologic (see "Biologic" above). It permits a specific facility to manufacture a biological product for commercial purposes. (Compare to “PLA” below.) E-Mail: The use of software that allows the posting of messages (text, audio or video) over a network. Email can be used on a LAN, a WAN or the Internet, as well as via online services such as America Online. It can be used to send a message to a single recipient or may be broadcast to a large group of people at once. EMEA (European Medicines Evaluation Agency): The European agency responsible for supervising and coordinating applications for marketing medicinal products in the European Union (see “EU” below and “CPMP” above). The EMEA is headquartered in the U.K. www.eudraportal.eudra.org Emission: The release or discharge of a substance into the environment; generally refers to the release of gases or particulates into the air. Endpoint: A clinical or laboratory measurement used to assess safety, efficacy or other trial objectives of a test article in a clinical trial. Environmental Audit: An independent assessment of a facility's compliance procedures, policies and controls. Many pollution prevention initiatives require an audit to determine where wastes may be reduced or eliminated or energy conserved.
Plunkett Research, Ltd.
ESWL (Extracorporeal Shock Wave Lithotripter): A medical device used for treating stones in the kidney or urethra. The device disintegrates kidney stones non-invasively through the transmission of acoustic shock waves directed at the stones. Ethernet: The standard format on which local area network equipment works. Abiding by Ethernet standards allows equipment from various manufacturers to work together. EU (European Union): Previously known as the European Community (EC), the EU is a consolidation of different European countries (Member States) functioning as one body to facilitate trade. There are currently 15 member states: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, The Netherlands, Portugal, Spain, Sweden and the United Kingdom. http://erupa.eu.int EU Competence: The jurisdiction in which the EU can taken legal action. Expert Systems: A practical development of AI (see "AI") that requires creation of a knowledge base of facts and rules furnished by human experts and uses a defined set of rules to access this information in order to suggest solutions to problems. Extensible Markup Language: See "XML" below. Extranet: A computer network that is accessible in part to authorized outside persons, as opposed to an intranet, which uses a firewall to limit accessibility.
www.plunkettresearch.com
commerce. The FDA’s mission is to protect the public from harm and encourage technological advances that hold the promise of benefiting society. www.fda.gov FDDI (Fiber Distributed Data Interface): A token ring passing scheme that operates at 100 Mbps over fiber-optic lines with a built in geographic limitation of 100 kilometers. This type of connection is faster than both Ethernet and T-3 connections. (See "Token Ring" below.) Fiber Optics: A type of telephone cable, made from glass, that can handle vast amounts of voice, data and video at once by carrying them along on beams of light. File Server: A computer that is modified to store and transfer large amounts of data to other computers. File servers often receive data from mainframes and store it for transfer to other micros, or from other micros to mainframes. Firewall: Hardware or software that keeps unauthorized users from accessing a server or network. Firewalls are designed to prevent data theft and unauthorized web site manipulation by "hackers." Frame Relay: An accepted standard for sending large amounts of data over phone lines and private datanets. Frame Relay refers to the fact that data is broken down into standard size "frames" prior to transmission.
FAQ: An acronym for "frequently asked questions," this kind of document answers inquiries about a given topic. Generally, FAQs come in the form of a help file or a hypertext document.
Frequency: The number of times that an alternating current goes through its complete cycle in one second. One cycle per second is referred to as one hertz; 1,000 cycles per second, one kilohertz; 1 million cycles per second, one megahertz; and 1 billion cycles per second, one gigahertz.
FCC (Federal Communications Commission): See "Federal Communications Commission" below.
Frequency Band: A term for designating a range of frequencies in the electromagnetic spectrum.
FD&C Act (Food, Drug and Cosmetic Act): The federal body of law that governs the manufacture, sale and distribution of food, drugs and cosmetics.
FTP (File Transfer Protocol): A widely used method of transferring data and files between two Internet sites.
FDA (Food and Drug Administration): The U.S. government agency responsible for the enforcement of the FD&C Act (see above), ensuring industry compliance with laws regulating products in
Fuel Cell: The fuel cell, in basic terms, consists of quantities of hydrogen and oxygen which are separated by a catalyst. Inside the cell, a chemical reaction within the catalyst generates electricity.
Plunkett Research, Ltd.
Byproducts of this reaction may include heat, carbon dioxide and water. Most fuel cells are based on hydrogen extracted from such sources as gasoline or methanol. Each source has its advantages and disadvantages. Eventually, stationary fuel cells may consume hydrogen extracted from biomass, natural gas or even water. Fuzzy Logic: Used in artificial intelligence, fuzzy logic recognizes that statements are not just "true" or "false," but also "more or less certain" or "very unlikely." Gateway: A device connecting two or more networks that may use different protocols and media. Gateways translate between the different networks and can connect locally or over wide area networks. GCP (Good Clinical Practices): FDA regulations and guidelines that define the responsibilities of the key figures involved in a clinical trial, including the sponsor, the investigator, the monitor and the Institutional Review Board. (See “IRB” below.) Gene Chips: See “DNA Chip” above. Genetically Modified (GM): Bioengineered food that is designed to resist herbicides and pests, has higher nutritional value than non-engineered food and/or lasts longer on the shelf. An example of GM food is a soybean that has been specially modified to be impervious to the application of a specific pesticide. Genomics: The study of genes, their role in diseases and our ability to manipulate them. Geostationary: A geosynchronous satellite angle with zero inclination, making a satellite appear to hover over one spot on the earth's equator. GIF (Graphic Interchange Format): A widely used format for image files. Gigabyte: A group of bytes generally defined as either 1,000 or 1,024 megabytes. Gigahertz (GHz): One billion cycles per second. See "Frequency" above. Global System for Mobile Communications (GSM): The standard cellular format used throughout Europe, making one type of cellular
www.plunkettresearch.com
phone usable in every nation on the continent and in the U.K. Globalization: The increased mobility of goods, services, labor, technology and capital throughout the world. Although globalization is not a new development, its pace has increased with the advent of new technologies, especially in the areas of telecommunications, finance and shipping. GLP (Good Laboratory Practices): A collection of regulations and guidelines to be used in laboratories where research is conducted on drugs, biologics or devices that are intended for submission to the FDA. GMP (Good Manufacturing Practices): A collection of regulations and guidelines to be used in manufacturing drugs, biologics and medical devices. Gopher: A way of making menus of material available over the Internet. This is a client/server form of program, meaning that the user must have a gopher client program in order to utilize it. HDML (Handheld Devices Markup Language): A text-based markup language designed for display on a smaller screen (e.g., cellular phone, PDA, pager). Enables the mobile user to send, receive and redirect e-mail as well as access the Internet (HDML-enabled web sites only). HDSL: High data rate digital subscriber line, delivering up to T1 or E1 speeds. Hertz: A measure of frequency equal to one cycle per second. Most radio signals operate in ranges of megahertz or gigahertz. Hit: A single request from a web browser for something from a web server, e.g., a request for text or graphics. Home Page: The main page of a web site. Usually, the home page features links to other pages within the site. Host: A host computer is any machine on a network that is responsible for services received by other machines on that network. Host Name: The first portion of a host's domain name. Also known as a firstname.
Plunkett Research, Ltd.
HotJava: This set of products, developed by Sun Microsystems, utilizes Java technology. A set of libraries intended for building applications and a Java-enabled web browser are among existing HotJava products. HTML (Hypertext Markup Language): A language for coding text for viewing on the World Wide Web. HTML is unique because it enables the use of hyperlinks from one site to another, creating a web. HTTP (Hypertext Transfer Protocol): The protocol used most frequently on the World Wide Web to move hypertext files between clients and servers on the Internet. Hub: In networking, a centralized switch box, or a common connection point, for devices in a network. Hubs contain multiple ports that can intertransmit information in order to maximize the viewing of data. Several types of hubs exist, including passive hubs (data conduits), intelligent or manageable hubs (with additional traffic-monitoring features) and switching hubs. Switching hubs read the destination address of each packet of information and then forward the packet to the correct location.
www.plunkettresearch.com
companies (CLECs, or Competitive Local Exchange Carriers) were enabled to compete against the ILECS and were granted access to their system wiring. Imaging: In medicine, the viewing of the body’s organs through external, high-tech means. This reduces the need for broad exploratory surgery. These advances, along with new types of surgical instruments, have made minimally invasive surgery possible. Imaging includes MRI (Magnetic Resonance Imaging), CT (Computed Tomography or “CAT scan”) and MEG (magnetoencephalography), improved x-ray technology, mammography, ultrasound and angiography. Immunoassay: An immunological assay. Types include agglutination, complement-fixation, precipitation, immunodiffusion and electrophoretic assays. Each type of assay utilizes either a particular type of antibody or a specific support medium (such as a gel) to determine the amount of antigen present. In Vitro: Laboratory experiments conducted in the test tube or otherwise, without using live animals and/or humans. In Vivo: Laboratory experiments conducted with live animals and/or humans.
Hyperlink: An element in an electronic document that links to another document or to another place in the same document. Generally, the user clicks on the hyperlink in order to follow it.
IND (Investigational New Drug Exemption): An IND must be filed with the FDA prior to initiating clinical trials of drugs or biologics.
ICANN: The Internet Corporation for Assigned Names and Numbers. It acts as the central coordinator for the Internet’s technical operations.
Inert Ingredients: Substances that are not active, such as water, petroleum distillates, talc, corn meal or soaps.
ICD9: International Classification of Diseases Version 9. A government coding system used for classifying diseases and diagnoses.
Informed Consent: Must be obtained in writing from people who agree to be clinical trial subjects prior to their enrollment in the study. The document must explain the risks associated with the study and treatment and describe alternative therapy available to the patient. A copy of the document must also be provided to the patient.
IDE (Investigational New Device Exemption): An IDE must be filed with the FDA prior to initiating clinical trials of medical devices considered to pose a significant risk to human subjects. IEEE (Institute of Electrical and Electronic Engineers): A standards body. ILEC (Incumbent Local Exchange Carrier): A traditional telephone company that was providing local service prior to the establishment of the Telecommunications Act of 1996, when upstart
Infrastructure: The telecommunications infrastructure is comprised of all of the cable and equipment installed in the worldwide telecommunications market. Most of today’s telecommunications infrastructure is connected by copper and fiber-optic cable, which represents a huge capital investment that telephone companies would
Plunkett Research, Ltd.
www.plunkettresearch.com
like to continue to utilize in as many ways as possible.
many types of Internet appliances will be of common use in homes in the near future.
INMARSAT: The International Maritime Satellite Organization operates a network of satellites used in international transmissions for all types of international mobile services, including maritime, aeronautical and land mobile.
Internet Telephony: This category of hardware and software enables users to utilize the Internet to make telephone calls, both local and long-distance. Also known as "voice over IP" or VoIP. Internet telephony is growing very rapidly, especially in such Asia Pacific nations as Japan and China.
Integrated Circuit (IC): Another name for a semiconductor, an IC is a piece of silicon on which thousands (or millions) of transistors have been combined. INTELSAT: The International Telecommunications Satellite Organization operates a network of 20 satellites, primarily for international transmissions, and provides domestic services to some 40 countries. Interactive TV: Allows two-way data flow between a viewer and the cable TV system. A user can exchange information with the cable system—for example, by ordering a product related to a show he/she is watching, or by voting in an interactive survey. Interexchange Carrier (IXC or IEC): Any company providing long-distance phone service between LECs and LATAs. (See "LEC" and "LATAs" below.) Interface: Refers to (1) a common boundary between two or more items of equipment or between a terminal and a communication channel, (2) the electronic device that interconnects two or more devices or items of equipment having similar or dissimilar characteristics or (3) the electronic device placed between a terminal and a communication channel to protect the network from the hazard of excess voltage levels. Internet: A global computer network that provides an easily accessible way for hundreds of millions of users to send and receive data electronically when appropriately connected via computers or wireless devices. Access is generally through HTML-enabled sites on the World Wide Web. Also known as "the Net." Internet Appliance: A non-PC device that connects users to the Internet for specific or general purposes. A good example is an electronic game machine with a screen and Internet capabilities. It is anticipated that
Intranet: A network protected by a firewall for sharing data and e-mail within an organization or company. Usually, intranets are used by organizations for internal communication. Investigator: In clinical trials, clinicians who agree to supervise the use of an investigational drug, device or biologic in humans. Responsibilities of the investigator include administering the drug, observing and testing the patient, collecting data and monitoring the care and welfare of the patient. Responsibilities of the investigator are defined in FDA regulations. IP Number/IP Address: A number or address with four parts that are separated by dots. Each machine on the Internet has its own IP (Internet protocol) number, which serves as an identifier. IRB (Institutional Review Board): This group of individuals is found in most medical institutions. The main function of the IRB is to review protocols for ethical consideration (to ensure the rights of the patients). Secondly, the IRB evaluates the benefit-torisk ratio of a new drug to see that the risk is acceptable for patient exposure. Responsibilities of the IRB are defined in FDA regulations. ISDN (Integrated Services Digital Networks): Internet connection services offered at higher speeds than standard "dial-up" service. While ISDN was considered to be an advanced service at one time, it has been eclipsed by much faster DSL, cable modem and T1 line service. ISO 9000, 9001, 9002: Standards set by the International Organization for Standardization for quality procedures. ISO 9000, 9001 and 9002 are the quality certifications for manufacturing. ISP (Internet Service Provider): A company that sells access to the Internet to individual subscribers. Leading examples are MSN and AOL.
Plunkett Research, Ltd.
IT (Information Technology): The systems, including hardware and software, that move and store voice, video and data via computers and telecommunications. ITU (International Telecommunications Union): The international body responsible for telephone and computer communications standards describing interface techniques and practices. These standards include those that define how a nation’s telephone and data systems connect to the worldwide communications network. Java: A programming language developed by Sun Microsystems that allows web pages to display interactive graphics. Java can be read by people using any type of computer or operating system. JPEG (Joint Photographic Experts Group): A widely used format for image files. Just-in-Time Delivery: Refers to a supply chain practice where manufacturers receive components on or just before the time that they are needed on the assembly line, rather than bearing the cost of maintaining several days' or weeks' supply in a warehouse. This adds greatly to the cost-effectiveness of a manufacturing plant and puts the burden of warehousing and timely delivery on the supplier of the components. Ka-Band: The frequency range from 18 to 31 GHz. The spectrum allocated for satellite communication is 30 GHz for the up-link and 20 GHz for the downlink. Kbps: One thousand bits per second. Kilobyte: A measure for 1,000 (to be exact, 1,024) bytes. Kilohertz (kHz): A measure of frequency equal to 1,000 Hertz. LAN (Local Area Network): A computer network that is generally within one office or one building. The LAN can be very inexpensive and efficient to set up when small numbers of computers are involved. It may require a network administrator and a serious investment if hundreds of computers are hooked up to the LAN. A LAN enables all computers within the office to share files and printers, to access common databases and to send e-mail to others on the network.
www.plunkettresearch.com
LATA (Local Access and Transport Area): Operational service areas established after the breakup of AT&T to distinguish local telephone service from long-distance service. The U.S. is divided into over 160 LATAs. Leased Line: A phone line that is rented for use in continuous, long-term data connections. LEC (Local Exchange Carrier): Any local telephone company, i.e., a carrier, that provides ordinary phone service under regulation within a service area. Also see "ILEC" and "CLEC." LINUX: An open, free operating system that is shared readily with millions of users worldwide. These users continuously improve and add to the software's code. It can be used to operate computer networks and Internet appliances as well as servers and PCs. LSI (Large-Scale Integration): The placement of thousands of electronic gates on a single chip. This makes the manufacture of powerful computers possible. MAN (Metropolitan Area Network): A data and communications network that operates over metropolitan areas and recently has been expanded to nationwide and even worldwide connectivity of highspeed data networks. A MAN can carry video and data. Managed Health Care: A system of prepaid plans providing comprehensive coverage to voluntarily enrolled members. Managed health care typically covers professional fees, hospital services, diagnostic services, emergency services, limited mental services, medical treatment for drug or alcohol abuse, home health services and preventive health care. Marketing: Includes all activities and expenses associated with the promotion of an item, such as selling and advertising costs, market research, public relations, royalties or commissions and souvenirs. Mbps (Megabits per second): One million bits transmitted per second. M-Commerce: Mobile e-commerce over wireless devices. Medical Device: See “Device” above.
Plunkett Research, Ltd.
Megabytes: A measure of 1 million bytes, or 1,024 kilobytes. Megahertz (MHz): A measure of frequency equal to 1 million Hertz. Metropolitan Area Network (MAN): See "MAN." Microprocessor: A computer on a digital semiconductor chip. It performs math and logic operations and executes instructions from memory. (Also known as a Central Processing Unit or CPU.) Microwave: Line-of sight, point-to-point transmission of signals at high frequency. Microwaves are used in data, voice and all other types of information transmission. The growth of fiber-optic networks has tended to curtail the growth and use of microwave relays. MIME (Multipurpose Internet Mail Extensions): A widely used method for attaching non-text files to e-mails. Modem: A device that allows a computer to be connected to a phone line, which in turn enables the computer to receive and exchange data with other machines via the Internet. Modulator: A device that modulates a carrier. Modulators are found in broadcasting transmitters and satellite transponders. The devices are also used by cable TV companies to place a baseband video television signal onto a desired VHF or UHF channel. Home video tape recorders also have built-in modulators that enable the recorded video information to be played back using a television receiver tuned to VHF channel 3 or 4. MPEG, MPEG-1, MPEG-2, MPEG-3: The Moving Picture Experts Group digital standards for the compression of motion or still video for transmission or storage. MRI (Magnetic Resonance Imaging): The use of a uniform magnetic field and radio frequencies to study the tissue and structure of the body. This procedure enables the visualization of biochemical activity of the cell in vivo without the use of ionizing radiation, radioisotopic substances or high-frequency sound.
www.plunkettresearch.com
MSP (Managed Service Provider): An outsourcer that deploys, manages and maintains the back-end infrastructure for Internet businesses. Multipoint Distribution System (MDS): A common carrier licensed by the FCC to operate a broadcastlike omni-directional microwave transmission facility within a given city. MDS carriers often pick up satellite pay-TV programming and distribute it, via their local MDS transmitter, to specially installed antennas and receivers. Nanotechnology: The science of designing, building or utilizing unique structures that are smaller than 100 nanometers. (A nanometer is one billionth of a meter.) Nanotechnology involves microscopic structures that might be no larger than the width of some cell membranes. NDA (New Drug Application): An application requesting FDA approval, after completion of Phase III studies, to market a new drug for human use in interstate commerce. Clinical trial results generally account for approximately 80% of the NDA. Network: In computing, a network is created when two or more computers are connected. Computers may be connected by wireless methods, using such technologies as 802.11b, or by a system of cables, switches and routers. Network Numbers: The first portion of an IP address, which identifies the network to which hosts in the rest of the address are connected. NIH (National Institutes of Health): A branch of the U.S. Public Health Service that conducts experimental research. www.nih.gov Node: Any single computer connected to a network or a junction of communications paths in a network. Nonclinical Studies: In vitro (laboratory) or in vivo (animal) pharmacology, toxicology and pharmacokinetic studies that support the testing of a product in humans. Usually at least two species are evaluated prior to Phase I clinical trials. Nonclinical studies continue throughout all phases of research to evaluate long-term safety issues.
Plunkett Research, Ltd.
www.plunkettresearch.com
NS (Nanosecond): A billionth of a second, a common unit of measure of computer operating speed.
Companies that market orphan drugs are granted a period of market exclusivity in return for the limited commercial potential of the drug.
NTIA (National Telecommunications and Information Administration): A unit of the Department of Commerce that addresses U.S. government telecommunications policy, standards setting and radio spectrum allocation. www.ntia.doc.gov
OS (Operating System): The software that allows applications like word processors or web browsers to run on a computer. For example, Windows 2000 is an operating system.
Nutraceutical: Nutrient + pharmaceutical – a food or part of a food that has been isolated and sold in a medicinal form and claims to offer benefits such as the treatment or prevention of disease. Object Technology: By merging data and software into "objects," a programming system becomes object-oriented. For example, an object called "weekly inventory sold" would have the data and programming needed to construct a flow chart. Some new programming systems–including Java–contain this feature. Object technology is also featured in many Microsoft products. (See "Java" above.) OC3, up to OC192: Very high-speed data lines that run at speeds from 155 to 9,600 Mbps. Online: When a device is online, it is turned on and connected to the Internet or to another device. Someone who is browsing a network or the Internet could be said to be online. Open Source: A software program for which the source code is openly available for modification and enhancement as various users and developers see fit. Open software is typically developed as a public collaboration and grows in usefulness over time. See "LINUX" above. Optical Character Recognition (OCR): An industry-wide classification system for coding information onto merchandise. Enables retailers to record information on each SKU when it is sold and to transmit that information to a computer. This is accomplished through computerized cash registers that include bar-code scanners (called point-of-sale terminals). Orphan Drug: A drug, biologic or antibiotic designated by the FDA as providing therapeutic benefit for an indication (disease or condition) affecting less than 200,000 people in the U.S.
OTC (Over-the-Counter): OTC drug products are FDA-regulated products that do not require a physician’s prescription. Some examples are aspirin, sunscreen, nasal spray and sunglasses. Packet Switching: A higher-speed way to move data through a network, in which files are broken down into smaller "packets" that are reassembled electronically after transmission. PC (Personal Computer): An affordable, efficient computer meant to be used by one person and frequently connected to a network as a client. PCMCIA: Personal Computer Memory Card International Association. Peer Review: The process used by the scientific community, whereby review of a paper, project or report is obtained through comments of independent colleagues in the same field. Perl (Practical Extraction and Report Language): A programming language geared towards text processing. Perl was developed by Larry Wall. Pharmacodynamics: The study of reactions between drugs and living systems. It can be thought of as the study of what a drug does to the body. Pharmacoeconomics: The study of the costs and benefits associated with various treatments. Pharmacokinetics (PK): The study of the processes of bodily absorption, distribution, metabolism and excretion of compounds and medicines. It can be thought of as the study of what the body does to a drug. (See “ADME” above.) Phase I Clinical Trials: Studies in this phase include initial introduction of an investigational drug into humans. These studies are closely monitored and are usually conducted in healthy volunteers. Phase I trials are conducted after the completion of extensive non-
Plunkett Research, Ltd.
clinical or pre-clinical trials not involving humans. Phase I studies include the determination of clinical pharmacology, bioavailability, drug interactions and side effects associated with increasing doses of the drug. Phase II Clinical Trials: Phase II studies include randomized, masked, controlled clinical studies conducted to evaluate the effectiveness of a drug for a particular indication(s). During Phase II trials, the minimum effective dose and dosing intervals should be determined. Phase III Clinical Trials: These studies consist of controlled and uncontrolled trials that are performed after preliminary evidence of effectiveness of a drug has been established. They are conducted to document the safety and efficacy of the drug, as well as to determine adequate directions (labeling) for use by the physician. A specific patient population needs to be clearly identified from the results of these studies. Trials during Phase III are conducted in a large number of patients to determine the frequency of adverse events and to obtain data regarding intolerance. Phase IV Clinical Trials: These studies are conducted after approval of a drug has been obtained to gather data supporting new or revised labeling, marketing or advertising claims. Pivotal Studies: In clinical trials, a Phase III trial that is designed specifically to support approval of a product. These studies are well-controlled (usually by placebo) and are generally designed with input from the FDA so that they will provide data that is adequate to support approval of the product. Two pivotal studies are required for drug product approval, but usually only one study is required for biologics. PLA (Product License Agreement): Required for the approval of a biologic, a PLA permits a manufacturer to produce a biological product for commercial purposes. (Compare to “ELA” above). Plug-In: Any small piece of software that adds extra functions to a larger piece of software. PMA (Pre-Market Approval): PMA is required for the approval of a new medical device or a device that is to be used for life-sustaining or life-supporting
www.plunkettresearch.com
purposes, is implanted in the human body or presents potential risk of illness or injury. POP: An acronym for both "Point of Presence" and "Post Office Protocol." Point of presence refers to a location that a network can be connected to (generally used to count the potential subscriber base of a cellular phone system). Post office protocol refers to the way in which e-mail software obtains mail from a mail server. Port: An interface (or connector) between the computer and the outside world. The number of ports on a communications controller or front-end processor determines the number of communications channels that can be connected to it. The number of ports on a computer determines the number of peripheral devices that can be attached to it. Portal: A comprehensive web site that is designed to be the first site seen when a computer logs on to the web. Portal sites are aimed at broad audiences with common interests and often have links to e-mail usage, a search engine and other features. Yahoo! and MSN.com are portals. Positron Emission Tomography (PET) Scanner : Nuclear medicine imaging technology that uses computers and radioactive (positron emitting) isotopes, which are created in a cyclotron or generator, to produce composite pictures of the brain and heart at work. PET scanning produces sectional images depicting metabolic activity or blood flow rather than anatomy. Post-Marketing Surveillance: The FDA’s ongoing safety monitoring of marketed drugs. Powerline: A method of networking computers, peripherals and appliances together via the electrical wiring that is built in to a home or office. Powerline competes with 802.11b and other wireless networking methods. Preclinical Studies: See “Nonclinical Studies” above. Protocol: A set of rules for communicating between computers. The use of standard protocols allows products from different vendors to communicate on a common network.
Plunkett Research, Ltd.
PSTN (Public Switched Telephone Network): A term that refers to the traditional telephone system. QOL (Quality of Life): In medicine, an endpoint of therapeutic assessment used to adjust measures of effectiveness for clinical decision-making. Typically, QOL endpoints measure the improvement of a patient’s day-to-day living as a result of specific therapy. R&D: Research and Development. Radiation Therapy: Frequently used to destroy cancerous cells, this branch of medicine is concerned with radioactive substances and the usage of various techniques of imaging, with the diagnosis and treatment of disease using any of the various sources of radiant energy. Services can include megavoltage radiation therapy, radioactive implants, stereotactic radiosurgery, therapeutic radioisotope facility or xray radiation therapy. Radioisotope: Radioisotopes have varying properties that allow them to penetrate objects at different rates. For example, a sheet of paper can stop an alpha particle, a beta particle can penetrate tissues in the body and a gamma ray can penetrate concrete. The varying penetration capabilities allow radioisotopes to be used in different ways. (Also called radioactive isotope or radionuclide.) RAM (Random Access Memory): Computer memory used to hold programs and data temporarily. RBOC (Regional Bell Operating Company): Former Bell system telephone companies (or their successors), created as a result of the breakup of AT&T by a Federal Court decree on December 31, 1983 (e.g., Southwestern Bell, now known as SBC). Real Time: A real-time system or software is one specially designed to acquire, process, store and display large amounts of rapidly changing information almost instantaneously, with microsecond responses as changes occur. Request for Bids (RFB): A firm that requires products or outsourced services sends a proposal outlining all requirements to various bidding companies. Proposing companies are asked to place a bid based on the requested goods or services.
www.plunkettresearch.com
Request for Qualifications (RFQ): Asks companies to submit qualifications to provide goods or perform a described level of service. It is used to screen who is qualified to respond to an RFB or RFP. Return on Investment (ROI): A measure of a company's profitability, expressed in percentage as: Net Profit (After Taxes)/Total Dollar Investment Router: An electronic link that enables two different local area networks to talk to each other, even though each network may be based on a different standard. S&R: Science and Research. SACD (Super Audio Compact Disc): A technology that offers high-resolution digital audio. SAN (Storage Area Network): Links host computers to advanced data storage systems. SBIR (Small Business Innovative Research): A three-phase program developed by the U.S. Department of Defense that allocates early-stage research and development funding to small technology companies. Scalable: Refers to a network that can grow and adapt as customer needs increase and change. Scalable networks can easily manage increasing numbers of workstations, servers, user workloads and added functionality. SCSI (Small Computer System Interface): A dominant, international standard interface used by UNIX servers and many desktop computers to connect to storage devices; a physical connection between devices. Semiconductor: A generic term for a device that controls electronic signals. It specifically refers to a material (such as silicon, germanium or gallium arsenide) that can be altered either to conduct electrical current or to block its passage. Server: A computer that performs and manages specific duties for a central network. It may include storage devices. Single Nucleotide Polymorphisms (SNPs): The most common type of genetic variation. SNPs are stable mutations consisting of a change at a single base in a DNA molecule. SNPs can be detected by
Plunkett Research, Ltd.
HTP analyses, for instance with gene chips, and they are then mapped by DNA sequencing. SLIP (Serial Line Internet Protocol): The connection of a traditional telephone line, or serial line, and modem to connect a computer to an Internet site.
www.plunkettresearch.com
Stem Cells: Found in human bone marrow, the blood stream and the umbilical cord, stem cells can be replicated indefinitely and can turn into any type of mature blood cell, including platelets, white blood cells or red blood cells. Also referred to as pluripotent cells. Study Coordinator: See “Coordinator” above.
SMDA (Safe Medical Devices Act): This Act became law in 1990 and amends the Food, Drug and Cosmetic Act to impose additional regulations on medical devices. SMDS (Switched Multimegabit Data Service): A method of extremely high-speed transference of data.
Supply Chain: The complete set of suppliers of goods and services required for a company to operate its business. For example, a manufacturer's supply chain may include providers of raw materials, components, custom-made parts and packaging materials.
SMTP (Simple Mail Transfer Protocol): The primary form of protocol used in the transference of e-mail.
Switch: A network device that directs packets of data between multiple ports, often filtering the data so that it travels more quickly.
SNMP (Simple Network Management Protocol): A set of communication standards for use between computers connected to TCP/IP networks.
T1: A standard for broadband digital transmission over phone lines. Generally, it can transmit at least 24 voice channels at once over copper wires, at a high speed of 1.5 million bps.
SNP: See “Single-Nucleotide Polymorphism” above. SONET (Synchronous Optical Network Technology): A mode of high-speed transmission meant to take full advantage of the wide bandwidth in fiber-optic cables. SPECT (Single Photon Emission Computerized Tomography): A nuclear medicine imaging technology that combines existing technology of gamma camera imaging with computed tomographic imaging technology to provide a more precise and clear image. Sponsor: The individual or company that assumes responsibility for the investigation of a new drug, including compliance with the FD&C Act and regulations. The sponsor may be an individual, partnership, corporation or governmental agency and may be a manufacturer, scientific institution or investigator regularly and lawfully engaged in the investigation of new drugs. The sponsor assumes most of the legal and financial responsibility of the clinical trial. SRDF (Symmetrix Remote Data Facility): A highperformance, host-independent business solution that enables users to maintain a duplicate copy of all or some of their data at a remote site.
T3: This type of transmission over phone lines supports data rates of 45 Mbps. T3 lines consist of 672 channels, and such lines are generally used by Internet service providers. These lines are also referred to as DS3 lines. (Also see “OC3.”) Target: The proteins involved in a specific disease. Drug compounds stick to specific targets in order to have the greatest positive effect and cut down on the incidence of side effects. Taste Masking: The creation of a barrier between a drug molecule and taste receptors so the drug is easier to take. It masks bitter or unpleasant tastes. TBT: Technical Barriers to Trade. TCP/IP (Transmission Control Protocol/Internet Protocol): The combination of a network and transport protocol developed by ARPANET for internetworking IP-based networks. TDMA (Time Division Multiple Access): A digital service for relatively large users of international public-switched telephony, data, facsimile and telex. TDMA also refers to a method of multiplexing digital signals that combines a number of signals passing through a common point by transmitting them
Plunkett Research, Ltd.
sequentially, with each signal sent in bursts at different times. Telecommunications: Systems of hardware and software used to carry voice, video and/or data between locations. This includes telephone wires, satellite signals, cellular links, coaxial cable and related devices. Telnet: A terminal emulation program for TCP/IP networks like the Internet, which runs on a computer and connects to a particular network. Directions entered on a computer that is connected using Telnet will be read and followed just as if they had been entered on the server itself. Through Telnet, users are able to control a server and communicate with other servers on the same network at the same time. Telnet is commonly used to control web servers remotely. TESS: See “AE” above. Token Ring: A local area network architecture in which a token, or continuously repeating frame, is passed sequentially from station to station. Only the station possessing the token can communicate on the network. Transistor: Device used for amplification or switching of electrical current. Trial Coordinator: See “Coordinator” above. UDDI: Universal Description, Discovery and Integration (UDDI), a vital protocol used in Web services. UDDI enables businesses to create a standard description of their activities so that they can be searched for appropriately by automatic software tools. Ultrasound: The use of acoustic waves above the range of 20,000 cycles per second to visualize internal body structures. Frequently used to observe a fetus.
www.plunkettresearch.com
UNIX: A multi-user, multitasking operating system that runs on a wide variety of computer systems, from PCs to mainframes. URL (Uniform Resource Locator): The address that allows an Internet browser to locate a homepage or web site. Utilization Review (or Utilization Management): A system where utilization case managers (frequently registered nurses with several years of hospital experience behind them) are assigned to each patient who receives hospitalization or extended treatment. These case managers constantly review the amount of care being provided to the patient in question, frequently resulting in significant cost savings. UWB: See "Ultrawideband" above. Validation of Data: The procedure carried out to ensure that the data contained in a final clinical trial report match the original observations. VDSL: Very high data rate digital subscriber line, operating at data rates from 12.9 to 52.8 MBPS. Vertical Integration: A business model in which one company owns many (or all) of the means of production of the many goods that comprise its product line. For example, Ford Motor Company's early River Rogue plant was designed by founder Henry Ford so that coal, iron ore and other needed raw materials arrived at one end of the plant and were processed into steel, which was then converted onsite into finished components. At the final stage of the plant, completed automobiles were assembled. Very Small Aperture Terminal (VSAT): A small Earth station terminal, generally 0.6 to 2.4 meters in size, that is often portable and primarily designed to handle data transmission and private-line voice and video communications. VOIP (Voice over IP): See "Internet Telephony."
Ultrawideband: A means of low-power, limitedrange wireless data transmission that takes advantage of bandwidth recently set aside by the FCC. Ultrawideband, or UWB, encodes signals in a dramatically different way, sending digital pulses in a relatively secure manner that will not interfere with other wireless systems that may be operating nearby.
VSAT (Very Small Aperture Terminal): A small Earth station terminal, generally between 0.6 and 2.4 meters in size, which is often portable and primarily designed to handle data transmission and private-line voice and video communications.
Plunkett Research, Ltd.
WAN (Wide Area Network): The other office network (see "LAN"), the WAN stretches over a long distance, usually connecting several buildings or locations. WAP (Wireless Access Protocol): A technology that enables the delivery of World Wide Web pages in a smaller format readable by screens on cellular phones. Web Page: A document on the World Wide Web that is identified by a URL. Web Site: A specific domain name location on the World Wide Web. Each site, which contains a homepage, usually consists of additional documents. Webcasting: The act of using the Internet (the World Wide Web, usually) to broadcast information or entertainment. Webmaster: Any individual who runs a web site. Webmasters generally perform maintenance and upkeep. WHO: World Health Organization. Assists governments in strengthening health services, furnishing technical assistance and aid in emergencies, working on the prevention and control of epidemics and promoting cooperation among different countries to improve nutrition, housing, sanitation, recreation and other aspects of environmental hygiene. Any country that is a member of the United Nations may become a member of the WHO by accepting its constitution. The WHO currently has 191 member states. Wi-Fi: A popular phrase that means 802.11b and other 802.11 specifications. See "802.11b" above. Wi-Fi5: A popular phrase that means 802.11a. See "802.11a" above. WLAN: A wireless local area network. WLANs frequently operate on 802.11-enabled equipment. Workstation: A high-powered desktop computer, usually used by engineers. World Wide Web: A computer system that provides enhanced access to various sites on the Internet through the use of hyperlinks. Clicking on a link displayed in one document takes you to a related
www.plunkettresearch.com
document. The World Wide Web is governed by the World Wide Consortium, located at www.w3.org. Also known as "the web." WSDL: An important protocol to web services, WSDL (web services description language) describes the web service being offered. XML (Extensible Markup Language): A programming language that enables designers to add extra functionality to documents that could not otherwise be utilized with standard HTML coding. XML was developed by the World Wide Web Consortium. It can communicate to various software programs the actual meanings contained in HTML documents. For example, it can enable the gathering and use of information from a large number of databases at once and place that information into one web site window. XML is an important protocol to web services.
Plunkett Research, Ltd.
www.plunkettresearch.com
INTRODUCTION
PLUNKETT'S ENGINEERING AND RESEARCH INDUSTRY ALMANAC, the second edition of our guide to the engineering and research field, is designed as a general source for researchers of all types. The data and areas of interest covered are intentionally broad, from the various types of businesses involved in engineering and research, to advances in biotechnology, to an in-depth look at the 500 major firms (which we call “THE ENGINEERING 500”) within the many sectors that make up the engineering and research industry, including energy, infotech, transportation and much more. This reference book is designed to be a general source for researchers. It is especially intended to assist with market research, strategic planning, employment searches, contact or prospect list creation (be sure to see the export capabilities of the accompanying CD-ROM that is available to book and eBook buyers) and financial research, and as a data resource for executives and students of all types. PLUNKETT'S ENGINEERING AND RESEARCH INDUSTRY ALMANAC takes a rounded approach for the general reader. This book presents a complete overview of the engineering and research field (see “How To Use This Book”). For example, advances in
design automation are discussed, as well as changes in research and development spending and patents. THE ENGINEERING 500 (the actual count is 468 firms) is our unique grouping of the biggest, most successful corporations in all segments of the engineering and research industry. Tens of thousands of pieces of information, gathered from a wide variety of sources, have been researched and are presented in a unique form that can be easily understood. This section includes thorough indexes to THE ENGINEERING 500, by geography, industry, sales, brand names, subsidiary names and many other topics. (See Chapter 4.) Especially helpful is the way in which PLUNKETT'S ENGINEERING AND RESEARCH INDUSTRY ALMANAC enables readers who have no business background to readily compare the financial records and growth plans of engineering companies and major industry groups. You’ll see the mid-term financial record of each firm, along with the impact of earnings, sales and strategic plans on each company’s potential to fuel growth, create new technologies and provide investment and employment opportunities. No other source provides this book’s easy-tounderstand comparisons of growth, expenditures, technologies, imports/exports, corporations, research and many other items of great importance. The
Plunkett Research, Ltd.
information within is crucial to people of all types who may be studying this, one of the most important industries in the world today.
www.plunkettresearch.com
•
This volume is intended to be a general guide to a quickly growing industry. That means that researchers should look to this book for an overview and, when conducting in-depth research, should contact the specific corporations or industry associations in question for the very latest changes and data. Where possible, we have listed contact names, toll-free telephone numbers and World Wide Web site addresses for the companies, government agencies and industry associations involved so that the reader may get further details without unnecessary delay.
•
Tables of industry data and statistics used in this book include the latest numbers available at the time of printing, generally through the end of 2001 or 2002.
•
We have used exhaustive efforts to locate and fairly present accurate and complete data. However, when using this book or any other source for business and industry information, the reader should use caution and due diligence by conducting further research where it seems appropriate. We wish you success in your endeavors, and we trust that your experience with this book will be both satisfactory and productive.
By scanning the data groups and the unique indexes, you can find the best information to fit your personal research needs. The best major companies are profiled and then ranked using several different groups of specific criteria. Which firms are the biggest employers? Which companies earn the most profits? These things and much more are easy to find. In addition to individual company profiles, an overview of global and domestic research and development and its trends is provided. This book’s job is to help you sort through easy-to-understand summaries of today’s technologies and trends in a quick and effective manner. Whatever your purpose for researching the engineering and research field, you’ll find this book to be a valuable guide. Nonetheless, as is true with all resources, this volume has limitations that the reader should be aware of: •
Financial data and other corporate information can change quickly. A book of this type can be no more current than the data that was available as of the time of editing. Consequently, the financial picture, management and ownership of the firm(s) you are studying may have changed since the date of this book. For example, this almanac includes the most up-to-date sales figures and profits available to the editors as of mid 2003. That means that we have typically used corporate financial data as of mid- to late 2002.
•
Corporate mergers, acquisitions and downsizing are occurring at a very rapid rate. Such events may have created significant change, subsequent to the publishing of this book, within a company you are studying.
•
Some of the companies in THE ENGINEERING 500 are so large in scope and in variety of business endeavors conducted within a parent organization that we have been unable to completely list all subsidiaries, affiliations, divisions and activities within a firm’s corporate structure.
Jack W. Plunkett Houston, Texas July 2003
Plunkett Research, Ltd.
www.plunkettresearch.com
HOW TO USE THIS BOOK
The two primary sections of this book are devoted first to an overview of the engineering and research industry and then to the “Individual Data Listings” for THE ENGINEERING 500. If time permits, you should begin your research in the front chapters of this book. Also, you will find lengthy indexes in Chapter 4 and in the back of the book.
Chapter 3: Engineering and Research Industry Contacts – Addresses, Telephone Numbers and World Wide Web Sites. This chapter covers contacts for important government agencies and industry associations. Included are numerous web sites. THE ENGINEERING 500
THE ENGINEERING AND RESEARCH INDUSTRY Glossary: A short list of engineering and research terms. Chapter 1: Major Trends in the Engineering and Research Industry. This chapter presents an encapsulated view of the major trends that are creating rapid changes in the engineering and research industry today. These trends range from changes in venture capital to fluctuations in research and development spending to the recent emphasis on nanotechnology. Chapter 2: Engineering and Research Industry Statistics. This chapter contains charts and tables tracking the scope of the industry.
Chapter 4: THE ENGINEERING 500: Who They Are and How They Were Chosen. The companies compared in this book (the actual count is 468 firms) were carefully selected from the engineering and research industry, primarily in the United States with 64 major foreign firms also included. For a complete description, see THE ENGINEERING 500 indexes in this chapter. Individual Data Listings: Look at one of the companies in THE ENGINEERING 500’s Individual Data Listings. You’ll find the following information fields: Company Name: The company profiles are in alphabetical order by company name. If you don’t find the company you are seeking, it may be a subsidiary or division of one of the firms covered in this book. Try looking it up in
Plunkett Research, Ltd.
the Index by Subsidiaries, Brand Names and Selected Affiliations in the back of the book. Ranks: Industry Group Code: An NAIC code used to group companies within like segments. (See Chapter 4 for a list of codes.) Ranks Within This Company’s Industry Group: Ranks, within this firm’s segment only, for annual sales and annual profits, with 1 being the highest rank. Business Activities: A grid arranged into five major industry categories and several sub-categories. A “Y” indicates that the firm operates within the sub-category. A complete Index by Industry is included in the beginning of Chapter 4. Types of Business: A listing of the primary types of business specialties conducted by the firm. Brands/Divisions/Affiliations: Major brand names, operating divisions or subsidiaries of the firm, as well as major corporate affiliations – such as another firm that owns a significant portion of the company’s stock. A complete Index by Subsidiaries, Brand Names and Selected Affiliations is in the back of the book. Contacts: The names and titles up to 27 top officers of the company are listed, including human resources contacts. Address: The firm’s full headquarters address, the headquarters telephone, plus toll-free and fax numbers where available. Also provided is the World Wide Web site address. Financials: Annual Sales (2002 or the latest fiscal year available to the editors, plus up to four previous years): These are stated in thousands of dollars (add three zeros if you want the full number). This figure represents consolidated worldwide sales from all operations. 2002 figures may be estimates or may be for only part of the year—partial year figures are appropriately footnoted. Annual Profits (2002 or the latest fiscal year available to the editors, plus up to four previous years): These are stated in thousands of dollars (add three zeros if you want the full number). This figure represents consolidated, after-tax net profit from all operations. 2002 figures may be estimates or may be for only part of the year—partial year figures are appropriately footnoted.
www.plunkettresearch.com
Stock Ticker: When available, the unique stock market symbol used to identify this firm’s common stock for trading and tracking purposes is indicated. Where appropriate, this field may contain “private” or “subsidiary” rather than a ticker symbol. Total Number of Employees: The approximate total number of employees, worldwide, as of the end of 2002 (or the latest data available to the editors). Apparent Salaries/Benefits: A “Y” in appropriate fields indicates “Yes.” Due to wide variations in the manner in which corporations report benefits to the U.S. Government’s regulatory bodies, not all plans will have been uncovered during our effort to research this data. Also, the availability to employees of such plans will vary according to the qualifications that employees must meet to become eligible. For example, some benefit plans may be available only to salaried workers—others only to employees who work more than 1,000 hours yearly. Benefits that are available to employees of the main or parent company may not be available to employees of the subsidiaries. NOTE: Generally, employees covered by wealthbuilding benefit plans do not fully own (“vest in”) funds contributed on their behalf by the employer until as many as five years of service with that employer have passed. Pension Plan: The firm offers a pension plan to qualified employees. The type and generosity of these plans vary widely from firm to firm. Caution: Some employers refer to plans as “pension” or “retirement” plans when they are actually 401(k) savings plans that require a contribution by the employee. True pension plans are rarely offered. ESOP Stock Plan (Employees’ Stock Ownership Plan): This type of plan is in wide use. Typically, the plan borrows money from a bank and uses those funds to purchase a large block of the corporation’s stock. The corporation makes contributions to the plan over a period of time, and the stock purchase loan is eventually paid off. The value of the plan grows significantly as long as the market price of the stock holds up. Qualified employees are allocated a share of the plan based on their length of service and their level of salary. Savings Plan, 401(k): Under this type of plan, employees make a tax-deferred deposit into an account. In the best plans, the company makes annual matching donations to the employees’ accounts, typically in some proportion to deposits made by the employees themselves. A good plan will match onehalf of employee deposits of up to 6% of wages. For example, an employee earning $30,000 yearly might
Plunkett Research, Ltd.
deposit $1,800 (6%) into the plan. The company will match one-half of the employee’s deposit, or $900. The plan grows on a tax-deferred basis, similar to an IRA. A very generous plan will match 100% of employee deposits. However, some plans do not call for the employer to make a matching deposit at all. Other plans call for a matching contribution to be made at the discretion of the firm’s board of directors. Actual terms of these plans vary widely from firm to firm. Generally, these savings plans allow employees to deposit as much as 15% of salary into the plan on a tax-deferred basis. However, the portion that the company uses to calculate its matching deposit is generally limited to a maximum of 6%. Stock Purchase Plan: Qualified employees may purchase the company’s common stock at a price below its market value under a specific plan. Typically, the employee is limited to investing a small percentage of wages in this plan. These plans usually offer a 15% discount, but the discount may range from 5 to 15%. Some of these plans allow for deposits to be made through regular monthly payroll deductions. Profit Sharing: Qualified employees are awarded an annual amount equal to some portion of a company’s profits. In a very generous plan, the pool of money awarded to employees would be 15% of profits. Typically, this money is deposited into a long-term retirement account. Caution: Some employers refer to plans as “profit sharing” when they are actually 401(k) savings plans. True profit sharing plans are rarely offered. Highest Executive Salary: The highest executive salary paid, typically a 2002 amount (or the latest year available to the editors) and typically paid to the Chief Executive Officer. Highest Executive Bonus: The apparent bonus, if any, paid to the above person. Second Highest Executive Salary: The nexthighest executive salary paid, typically a 2002 amount (or the latest year available to the editors) and typically paid to the President or Chief Operating Officer. Second Highest Executive Bonus: The apparent bonus, if any, paid to the above person. Competitive Advantage: A brief statement regarding an outstanding feature that gives the firm an edge in the marketplace. Other Thoughts: Apparent Women Officers or Directors: It is difficult to obtain this information on an exact basis, and employers generally do not disclose the data in a
www.plunkettresearch.com
public way. However, we have indicated what our best efforts reveal to be the apparent number of women who either are in the posts of corporate officers or sit on the board of directors. There is a wide variance from company to company. Hot Spot for Advancement for Women/ Minorities: A “Y” in appropriate fields indicates “Yes.” These are firms that appear either to have posted a substantial number of women and/or minorities to high posts or that appear to have a good record of going out of their way to recruit, train, promote and retain women or minorities. (See the Index of Hot Spots For Women and Minorities in the back of the book.) This information may change frequently and can be difficult to obtain and verify. Consequently, the reader should use caution and conduct further investigation where appropriate. Growth Plans/ Special Features: Listed here are observations regarding the firm’s strategy, hiring plans, plans for growth and product development, along with general information regarding a company’s business and prospects. Locations: A “Y” in the appropriate field indicates “Yes.” Primary locations outside of the headquarters, categorized by regions of the United States and by international locations. A complete index by locations is also in the front of this chapter.
Plunkett Research, Ltd.
www.plunkettresearch.com
Chapter 1 Major Trends in the Engineering and Research Industry Major Trends to Watch 1) 2) 3) 4) 5) 6) 7) 8) 9) 10) 11)
Continued Rapid Growth in the Biotech Sector Continued Caution in Investment in New Technology Startup Companies Continued Growth in the Sharing of R&D Initiatives Among Major Corporate Partners Globalization of the Research Efforts of Major Corporations Emphasis on Research and Development in Nanotechnology Continued Growth in Research Partnerships Between Corporations and Universities Continued Growth in Research and Development Spending in the U.S., Despite the Economic Downturn Growth in Defense Research Post 9/11 Number of Patent Applications Soars Growth in the Automation of Research and Design Energy Technology Research Receives Growing Attention, Particularly in Alternative Energy
A Short History of U.S. Industrial Research & Development Corporate research efforts at an organized level began in the chemical dyes industry in Europe in the mid-1800s and soon were launched at a fairly rapid rate in America. In 1876, at the age of 29, Thomas Alva Edison opened a private laboratory in Menlo
Park, New Jersey. Edison’s efforts led to his recordsetting 1,093 U.S. patents, including those for the phonograph and the incandescent light bulb. Edison’s creativity and drive eventually enabled the birth of what would become the General Electric Company, still one of the world’s premier research and manufacturing organizations. By 1900, about 40 various corporate research facilities were operating in the U.S. Rapid acceleration was fostered by a growing middle class that created demand for new products, and later was especially fueled by the intense demands for leading-edge armaments, transport and other products created by World War II. During the war, a man named Vannevar Bush was posted as the director of the Office of Scientific Research and Development within the U.S. Government. Bush’s mandate was to spur intense innovation that would give America a technological edge in warfare. The results, over an astonishingly short period of time, ranged from advanced radar to the atomic bomb. Bush argued persuasively for a long-term federal commitment to supporting industrial research. By 1962, the Federal Government was subsidizing nearly 60% of America’s corporate research budget, for everything from medical breakthroughs to electronics to defense systems. Thereafter, corporations rapidly increased their own investments in research and development efforts, resulting in a nationwide research base of unprecedented scope and cost. By 1992, however, corporate restructuring and cost cutting led to a brief period of retrenching and corporate research budget slashing.
Plunkett Research, Ltd.
In the mid-1990s, companies creating or embracing new technologies were among the most exciting and successful firms in America. As companies were striving to compete, the floodgates of research dollars were once again cranked open. Corporate America’s investments in R&D have climbed at an impressive rate nearly every year since 1996, while Federal Government investments in research have risen at a steady rate. Today, the Federal Government provides about 30% of all research dollars spent in the U.S. As a result, a disproportionate share of America’s economic growth has been created by the technology sector, and the R&D population has blossomed, such that today there are approximately 15,000 corporate research laboratories in America. They employ about 750,000 professionals and invest about $300 billion yearly in research and development. Approximately 20,000 additional U.S. firms conduct R&D at a significant level outside of dedicated labs. Despite the massive scope and highly competitive nature of corporate research, many major companies succeed without significant research efforts. Instead, they rely on components or processes developed by others. A good example is the personal computer manufacturing industry, where leaders Dell and Gateway grew very rapidly by building and marketing computers constructed from components, like hard drives and semiconductors, that were created through the research and development efforts of their suppliers. (Dell has now grown to the point that it has many engineers on its own staff, but it still relies heavily on components developed by suppliers.) A final important thought about the development of industrial R&D: Depending on the nature of their industries, various firms enter into research with widely varying expectations. For example, while aircraft maker Boeing invests nearly $2 billion in R&D yearly, that effort may yield a completely new aircraft model only once every eight or 10 years. In contrast, semiconductor maker Intel, which invests about $4 billion yearly in R&D, introduces breakthrough chip designs on a continual basis and invests only a tiny amount of its total budget in truly long-term research. (See “Intel” below.) Pharmaceutical makers are accustomed to a research-to-market cycle of as long as 10 years in order to discover, develop and commercially launch a new drug. In short, some companies are driven to vast R&D efforts in order to compete in their own rapidly evolving industries, while others patiently invest in long-term R&D hoping it will pay off handsomely through the introduction of entirely new types of
www.plunkettresearch.com
products several years hence. In 2001, publicly held drug firms in the U.S. invested over $15 billion in research and development—double the amount invested in 1994. Nonetheless, the industry launched only 24 new drugs. Here are 11 Major Trends to Watch in Research and Engineering: 1) Continued Rapid Growth in the Biotech Sector Rapid advances in genomics, proteonics and bioinformatics will lead to the introduction of a large number of new genetically engineered drugs over the mid-term. As of mid-2003, there were already approximately 153 approved drugs and 350 drugs in clinical trials that were developed through biotechnology methods. (That is, the use of technology to identify and alter the biological state of a human patient or an organism, such as the use of a drug to change the nature of a human cell. This is a radically different approach to fighting disease from traditional antibiotic methods such as penicillin.) In the most recent economic boom, particularly during late 1999 and much of 2000, venture capitalists and investment bankers bet heavily on biotech, which they saw as a promising technology-based alternative to investing in information technologies such as the Internet. A veritable frenzy of new financing poured into biotech startup companies and initial public offerings (IPOs) in 2000, which funded very aggressive research, development and marketing plans. New investments in U.S. biotech firms totaled about $32 billion in 2000—more than had been invested during the previous six years combined. The level of funding dropped quickly thereafter, largely as a result of the technology industry crash of 2000. New U.S. biotech capital totaled only $12 billion in 2001 (including venture capital, sales of stock and other means), and about $10 to $12 billion in 2002. Future levels of new funding will depend to a large extent on the ability of young biotech firms to get their new drugs successfully through Phase III trials and into the marketplace. Much of the investment burden will be borne by mature, global drug firms that partner with or acquire smaller biotech companies. The U.S. leads the world in biotechnology R&D. While firms in European nations are making serious biotech efforts, Europe as a whole is leagues behind America in the total amount invested in this field.
Plunkett Research, Ltd.
Stem cell and cloning controversies abound in the U.S. while research in these fields flourishes overseas. During the 1980s, a biologist at Stanford University, Irving L. Weissman, was the first to isolate the stem cell that builds human blood (the mammalian hematopoietic cell). Later, Weissman isolated a stem cell in a laboratory mouse and went on to co-found SysTemix, Inc. (now part of drug giant Novartis) and StemCells, Inc. to continue this work in a commercial manner. In November 1998, two different university-based groups of researchers announced that they had accomplished the first isolation and characterization of the human embryonic stem cell (ESC). James A. Thomson at the University of Wisconsin at Madison led one group. John D. Gearhart at the Johns Hopkins University School of Medicine at Baltimore led the second. The ESC is among the most versatile basic building blocks in the human body. Embryos, when first conceived, begin creating small numbers of ESCs, and these cells eventually differentiate and develop into the 200+ cell types that make up the distinct tissues and organs of the human body, from bones to brains. If scientists can reproduce and then guide the development of these basic ESCs, they could theoretically grow replacement organs and tissues in the laboratory—even such complicated tissue as brain cells or heart cells. Ethical and regulatory difficulties have arisen from the fact that the only source for human embryonic stem cells is, logically enough, human embryos. A laboratory can obtain these cells in one of three ways: 1) By inserting a patient’s DNA into an egg and thus producing a blastocyst that is a clone of the patient— which is then destroyed after only a few days of development; 2) by harvesting stem cells from aborted fetuses; or 3) by harvesting stem cells from embryos that are left over and unused after an in vitro fertilization of a hopeful mother. (Artificial in vitro fertilization requires the creation of a large number of test tube embryos per instance, but only one of these embryos is used in the final process.) A rich source of similar but non-embryonic stem cells is bone marrow. Doctors have been performing bone marrow transplants in humans for years. This procedure essentially harnesses the healing power of stem cells, which proliferate to create healthy new blood cells in the recipient. Several other nonembryonic stem cell sources have great promise (see below). In the fall of 2001, a small biotech company called Advanced Cell Technology announced the first cloning of a human embryo. The announcement set
www.plunkettresearch.com
off yet another firestorm of rhetoric and debate on the scientific and ethical questions that cloning and related stem cell technology inspire. While medical researchers laud the seemingly infinite possibilities stem cells promise for fighting disease and the aging process, conservative theologians, policy makers and pro-life groups decry the harvest of cells from aborted fetuses and the possibility of cloning as an ethical and moral abomination. Congress, under the Bush Administration, has banned the use of federal funding for the creation of new embryonic stem cell lines. This action was taken in spite of impassioned testimony regarding the healing potential of stem cells by physicians, researchers and celebrities, such as actor Michael J. Fox on behalf of research for Parkinson's disease, actor Christopher Reeve for spinal injury study and former first lady Nancy Reagan on behalf of Alzheimer's research. Stem cell research has been underway for years at biotech companies including Stem Cells, Inc., Geron and ViaCell. One company, Osiris Therapeutics, has been at work long enough to have several clinical trial programs in progress. The potential benefits are staggering. Through stem cell therapies, neurological disorders could be reversed with the growth of healthy cells in the brain. Injured cells in the spinal column could be regenerated and function fully again. Damaged organs such as hearts, livers and kidneys could be infused with healthy cells. Stem cell (and cloning) research activity is brisk in certain nations outside the U.S. To begin with, certain institutions around the world have stem cell lines in place, and some make them available for purchase. Groups that own existing lines include the National University of Singapore, Monash University in Australia and Hadassah Medical Centre in Israel. More importantly, several Asian nations, including Singapore, South Korea, Japan and China, are investing intensely in biotech research centered on cloning and the development of stem cell therapies. The global lead in the development of stem cell therapies may eventually pass to China, where the Chinese Ministry of Science and Technology readily sees the commercial potential and is enthusiastically funding research. In addition to funding from the Chinese government, investments in labs and research are being backed by Chinese universities, private companies, venture capitalists and Hong Kong investors. Meanwhile, back in the U.S., in December 2002 Stanford University announced plans to develop a privately funded library of human stem cell lines,
Plunkett Research, Ltd.
which means it will be able to operate outside of the restrictions placed on federally funded ESC research and development. It is the first U.S. university to take this path. Potential methods of developing “post-embryonic” stem cells without the use of human embryos: • • • • •
Parthenogenesis—manipulation of unfertilized eggs. Adult Stem Cells—harvesting of stem cells from bone marrow or brain tissue. Other Cells—harvesting of stem cells from human placentas or other cells. De-Differentiation—use of the nucleus of an existing cell, such as a skin cell, that is altered by an egg that has had its own nucleus removed. Transdifferentiation—making a skin cell dedifferentiate back to its primordial state so that it can then morph into a useable organ cell, such as heart tissue.
ESCs (typically harvested from five-day-old human embryos which are destroyed during the process) are used because of their ability to evolve into any cell or tissue in the body. Their versatility is undeniable, yet the implications of the death of the embryo are at the heart of the ethical and moral concerns. Meanwhile, scientists have discovered that there are stem cells in existence in many diverse places in the adult human body, and they are thus succeeding in creating stem cells without embryos, from “postembryonic” cells. Such cells are already showing the ability to differentiate and function in animal and human recipients. Best of all, these types of stem cells are not plagued by problems found in the use of ESCs, such as the tendency to form tumors when ESCs develop into differentiated cells. For scientists, the biggest challenge at present may be to discover the exact process by which stem cells are signaled to differentiate. (Differentiation is the molecular programming that causes stem cells to grow into specific types of tissue such as heart tissue or brain tissue.) Another immense challenge lies in the fact that broad use of therapeutic cloning may require immense numbers of human eggs in which to grow blastocysts.
www.plunkettresearch.com
2) Continued Caution in Investment in New Technology Startup Companies After the crash in tech company stocks in 2000, investors have been downright skittish about putting money into new technology ventures. In 2002, only $850 million was invested by venture capital firms in 110 new and existing companies (of all types), compared to $13.1 billion invested in 750 companies during the peak year of 2000. As for firms able to go public, the start of 2003 has seen a mere four IPOs of American corporations, tech-based or not, as of the end of April. (There were 158 during the same period in 2000.) However, the dark days of tech companies appear to be waning with recent technological advances and a small rebound of the tech stock market. Slowly, investors are beginning to test the waters again. For example, venture capital firm Draper Fisher Jurvetson has invested $47.5 million in 13 firms involved in the exciting new field of nanotechnology since 2000. Over the mid-term, watch for more careful, slow investment in technology firms that are up and running and have respectable numbers with regard to sales and profits. In order to receive scarce venture capital, tech companies must prove that they understand the importance of the bottom line. This depressed climate in venture capital investment is having a seriously detrimental effect on research and development overall. In recent years, many exciting new technologies were developed thanks to basic and applied research conducted by startup companies that were financed by venture capital firms and later by IPOs. While professional venture capital investors know that only about three out of 10 companies they invest in will succeed to any significant degree, they also know that occasionally research conducted at one of those startup firms will create something truly significant and will reap immense profits. Nonetheless, the venture capital market will remain sluggish until (if ever) the stock market regains serious enthusiasm for initial public stock offerings (IPOs) from young firms. This is due to the fact that selling stock in an IPO is the prime method for reaping a cash profit from a venture capital investment. 3) Continued Growth in the Sharing of R&D Initiatives Among Major Corporate Partners In fields as diverse as telecommunications, semiconductors, alternative energy, aerospace, transportation and pharmaceuticals, major corporations are sharing the increasingly immense costs of research and development. These efforts may
Plunkett Research, Ltd.
www.plunkettresearch.com
InnoCentive, a unique, online collaborative research effort: At www.innocentive.com, drug maker Eli Lilly has created a collaborative research portal. Companies needing answers to research problems can post details regarding their projects, along with a stated fee they are willing to pay for completion of research needs. Scientists and engineers from anywhere in the world can log in to select projects to work on. Fees offered run from a few thousand dollars to $50,000. Participants who log in may choose to view the site in English, Chinese, German, Russian or Spanish. The site was launched in June 2001. By May 2003, 23,000 scientists, graduate students and researchers of various types had participated. InnoCentive’s management expects to have more than 30 corporate clients posting their research requests by the end of 2003. Many of these clients prefer to remain anonymous.
as overnight international courier services and wellestablished jet airliner service to nearly anywhere in the world, helps to spur globalization on. Meanwhile, there are legions of extremely well educated scientists and engineers in areas such as India, China and Eastern Europe who can be hired for salaries that are significantly below those of their U.S.-based peers. These factors all combine to make globalized research efforts attractive for many reasons. For example, a major automotive, pharmaceutical, software or hardware company in the U.S. can create a cost-effective, 24/7 research department by handing off research or design work from America to Russia to India to Japan—it will always be daylight in some part of the world, and collaboration software makes it possible for employees to work together on the same project from anyplace on the planet. The hottest spot for U.S. firms to open foreign research centers is the city of Bangalore in India. Initially a center for writing software code, Bangalore’s supply of highly educated, Englishspeaking residents has enabled the city to evolve into a truly world-class research and development center. The labor pool is not only high-quality but also lowcost. Well-paid software engineers earn in the $10,000 to $15,000 range yearly, with PhDs earning up to $30,000—salaries much lower than those in the U.S. Intel will have 3,000 R&D people working in Bangalore by 2005. Software maker Oracle already has about 2,500, and Microsoft is investing heavily in research within India. India isn’t the only nation enjoying growth in research and engineering jobs fostered by U.S., Japanese or Western European firms. In Eastern Europe, such nations as Hungary, Poland, the Czech Republic and Romania offer well-trained people who speak English and/or German. Russia has a growing assortment of research offices funded by foreigners, and China may become a significant development center for foreign multinationals.
4) Globalization of the Research Efforts of Major Corporations Globalization is deeply affecting the corporate world at all levels. This can be seen in everything from the flood of inexpensive consumer goods flowing into the U.S. from manufacturers in China, to the growing business that American software makers are finding overseas. The advent of extremely fast communication systems, such as the Internet, global fiber-optic lines, e-mail and instant messaging, as well
5) Emphasis on Research and Development in Nanotechnology Nanotechnology is the science of designing, building or utilizing unique structures that are smaller than 100 nanometers. (A nanometer is one-billionth of a meter.) The science involves microscopic structures that might be no larger than the width of some cell membranes. In practical terms, nanotechnology will ultimately allow scientists and engineers to piece atoms together to build all manner of objects, from miniscule semiconductors to medical treatments that
be as simple as a sharing of knowledge between labs or as complex and far-ranging as major research consortia paid for by dues from corporate members, such as the semiconductor industry’s Sematech or MIT’s famous Media Lab. (However, the tough business climate since 2001 has caused many companies to curtail their support of some of these research consortia.) A highly effective research collaboration model has been established within the aircraft industry, where component suppliers, such as manufacturers of jet engines, collaborate with systems suppliers, such as makers of navigation gear (avionics) and airframes to do the R&D necessary to create an entirely new aircraft. This is precisely how the extremely successful Airbus firm was established, with more than a little encouragement from government agencies in the U.K. and France. The automobile industry is likewise benefiting from similar collaborative research and development partnerships to create new or improved cars.
Plunkett Research, Ltd.
work on the molecular level, to the clothes we wear and the structures in which we live. The National Nanotechnology Initiative, established by the Federal Government in 2000, oversees funding for 10 separate government agencies (including the Department of Energy, the Department of Defense, NASA, the National Institutes of Health, USDA and the Food and Drug Administration). Congress passed $849 million in funding for nanotechnology research in 2003, up from the $604 million approved in 2002. U.S. federal funding is expected to exceed $1 billion in the mid-term, due to increasing competition from foreign powers. As with the space race in the 1950s and 1960s, the contest for supremacy in nanotechnology is a key global issue. All associated U.S. departments and agencies plan to focus on nanotech manufacturing processes, uses of nanotechnology for chemical-biological-radioactiveexplosive detection and protection and also on instrumentation and metrology. In the private sector, companies both large and small are investing in the tiny technology in a big way. For example, Motorola Labs, a research subsidiary of telecom company Motorola, Inc., is making strides in carbon nanotechnology for use in flat-panel displays. Concurrently, tiny Sirna Therapeutics is focused on breakthroughs in RNA interference (RNAi) technology to fight disease. Nanotechnology continues to attract a reasonable flow of new money from the venture capital community. Despite the fact that commercialization of nanotech-based products may be a long way off, professional investors see great potential in firms that may become early leaders and patent-holders in this field. Much of the future of technology in general will be based on miniaturization, and nanotechnolgy, the smallest possible level of product development, will play a key role in this miniaturization trend. 6) Continued Growth in Research Partnerships Between Corporations and Universities Corporations have long seen the benefit of tapping the intellectual powers of labs, graduate students and professors at universities that focus on technologyintense disciplines. At the same time, such universities have been anxious to receive corporate funding for their research projects. This has always been a winwin situation. Lately, however, universities have enhanced their position in such partnerships by negotiating research collaboration contracts that are potentially more lucrative than was the norm in years past. Cash-strapped universities are anxious to capitalize on commercial successes that stem from
www.plunkettresearch.com
their research. At the same time, cash-strapped corporations are happy to utilize top grad students who work in university labs at nominal pay. Pharmaceutical giant Pfizer is an excellent example of a major corporation conducting research and development with the assistance of universities. Its Discovery Technology Center, located in Cambridge, Massachusetts, regularly offers fellowships to students from nearby campuses such as Harvard, MIT and the Whitehead Institute. Pfizer is currently involved in a three-year program in computational biology with students from the latter. In addition to academic institutions, Pfizer also has close ties with other companies. BioTrove, a biotech company focusing on nanotechnology within the drug discovery arena, is involved in a two-year collaborative effort with Pfizer. It is hoped that the collaboration will produce nanoscale liquid handling tools that Pfizer will use to develop new drugs. Intel is another example of a company with major in-house R&D efforts as well as external alliances. The technology giant has delivered approximately 500 active research grants to universities, which create small labs or "lablets" that combine the efforts of students and Intel staff. Associated institutions include the University of California at Berkeley, Carnegie Mellon and the University of Washington. 7) Continued Growth in Research and Development Spending in the U.S., Despite the Economic Downturn The general economic downturn in 2001-2002, combined with the terrorist attacks of September 11th and a shift in government priorities with regard to research, had a seriously detrimental effect on total R&D dollars budgeted in the U.S. through 2002, according to widely watched annual studies conducted by the Battelle Memorial Institute and R&D Magazine. These same budgets experienced healthy annual growth previously, with increases of 10.8% in 2000 and approximately 5.4% in 2001. R&D budget growth for 2002 dropped to 3.5%. For 2003, U.S. research and development budgets were forecast by the study to grow about 3.4% to a total of $302 billion, as follows: Federal spending on R&D of $89 billion (up 10.5%); industrial spending at $194 billion (up less than 1%); and university and nonprofit spending combined at $18 billion (up about 7%). In recent months, companies scrambled to cut costs, and in many cases, R&D budgets suffered. In the short-term, many firms were successful in boosting their bottom lines. In the long-term,
Plunkett Research, Ltd.
however, most are rethinking their R&D strategies. In order to stay competitive in the domestic and most certainly in the global marketplace, significant funding for R&D is a vital expense. Tech firms appear to have been the exception to this trend through 2002, spending $100.8 billion from mid-2001 through mid-2002 (up from $86.5 billion for the same period the previous year). The concept behind this continued high investment despite falling revenues is that developing the next great idea will enable a company to grab market share and pull itself into the black. Another change is the way R&D funding is allocated. Strategies are shifting to include more alliances and joint ventures with other companies, more subsidiary spin-offs based on established technologies, more contracts and cooperative efforts with federal labs and projects and higher grants and projects of greater scope on the university level. Investment levels are slowly rising, but companies are also looking for ways to leverage their investment to get more bangs for their bucks. 8) Growth in Defense Research Post 9/11 In the aftermath of the terrorist attacks of September 11, 2001, Congress approved a defense budget of $343 billion for fiscal 2002, a 10% increase from the previous fiscal year. Of that amount, $51 billion was earmarked for research and development, a 13% increase from the previous year. More than $10 billion of those dollars were to be devoted to new technology. Most government funding traditionally goes to defense contractors such as Lockheed Martin, General Dynamics and Raytheon. Post 9/11, a larger and more diverse number of firms in the private sector are receiving more government funding and bearing more of the responsibility for developing new defense technologies. In addition to conventional defense equipment such as aircraft, weapons and enemy detection systems, R&D must now focus on biological warfare and protection from attacks via data systems and the Internet. The establishment of the new Department of Homeland Security has served to focus federal dollars on anti-terrorism defense, including the gathering of intelligence. At the same time, the successes and failures of various defense systems engaged in the wars in Afghanistan and Iraq are creating demand for new defense research initiatives. The U.S. Defense Advanced Research Projects Agency (DARPA), which began as a response to the Soviet launch of the satellite Sputnik in 1957, has a long reputation of over-the-top R&D that has been responsible for a significant number of breakthroughs
www.plunkettresearch.com
since its formation more than 40 years ago. Its projects in large part brought about the Internet, the mouse, telecommunications semiconductors used in cell phones and PCs and radar-absorbent materials that are now found in stealth aircraft. After the September 11th attacks, DARPA created the Information Awareness Office (IAO) with the specific mission of detecting terrorist activities. IAO is currently developing an experimental system that focuses on technologies for language translation; data search and pattern recognition; and collaboration and decision support. As a whole, the project is called Terrorism Information Awareness (TIA) and has a projected 2004 budget of $20 million. The project is a five-year effort, progressing along with the agency's Wargaming the Asymmetric Environment (WAE) program, which focuses on predictive technology relating to observed behaviors of known terrorists. 9) Number of Patent Applications Soars In 2001, the U.S. Patent & Trademark Office (PTO) received 345,732 patent applications, up from 315,015 in 2000 and only 177,830 in 1991. The PTO forecasts that that number will reach 500,000 by 2006. To some extent, patents tend to reflect the health of R&D budgets. The greater the funding, the more patents are filed. At the same time, however, the rapid growth in the number of patent applications reflects today’s increased focus on protection of intellectual property by corporations and universities along with the extremely high traffic from biotech firms attempting to patent gene expressions and other biological discoveries. A patent application leads either to a patent grant or to a denial. The PTO granted 183,975 patents during 2001, up by about 8,000 over the previous year. Of those patents granted, 46% were to foreign applicants. A patent typically takes 18 to 24 months after application to receive a grant. In an effort to keep up with all of this patent activity, the PTO is upgrading its information systems to the extent that it hopes to launch a fully paperless patent system by fiscal 2004. Meanwhile, the overwhelmed PTO hired 768 patent examiners in fiscal 2002, bringing the total to 3,538. The term of patent protection is currently defined as beginning on the date the patent is granted and ending 20 years from the earliest filing date of the application.
Plunkett Research, Ltd.
Internet Research Tip: For the latest official statistics from the U.S. Patent & Trademark Office, visit the website of TAF, the patent office’s Technology Assessment and Forecast branch. www.uspto.gov/web/offices/ac/ido/oeip/taf/ Globally, there are 120 different national patent systems, and recent proposals to create a unified global patent system are creating buzz. "Harmonization" is the word used to describe the effort, and it will be difficult to bring about. According to the World Intellectual Property Organization, 90% of the 7 million applications filed annually worldwide are filed in more than one country, which multiplies application fees, legal fees and hours spent exponentially (fees for multinational applications can surpass $75,000, and legal fess often reach $200,000 or more). IBM, the company that holds more patents than any other company in the world, spends more than $200 million annually on the protection of its intellectual property both at home and abroad. An aborted 1989 attempt to establish an international system bogged down when the U.S. could not agree with most other participating countries on a simple first-to-file regulation when awarding patents to filers with similar claims. In the U.S., the practice has traditionally been to award a patent to the filer who can prove to be the first to conceive an idea and develop it. Although fair, the system can prove costly as applicants spend time and money in the court systems to prove who was first with an idea. Another critical difference between the U.S. patent system and those elsewhere around the globe is the one-year waiting period, during which American filers may publish or speak at public forums about their ideas without jeopardizing their patent rights. Abroad, filers are required to keep their ideas top secret until a patent is awarded. Yet another point of argument centers on patent subject matter. In the U.S., just about anything or any idea can be patented. Business practices, for example, are commonly patented, such as Amazon.com's "oneclick" technology, as well as genetic discoveries and treatments. The latter is a particularly sticky point for developing nations such as those in Latin America and Africa. Their participation in a global patent effort may well hinge on the protection of their natural resources from exploitation by foreign companies. The debate continues, but proponents of a global patent body hope to have a treaty written by late 2004. In June 2002, the Director of the U.S. Patent & Trademark Office published a comprehensive plan,
www.plunkettresearch.com
titled “21st Century Strategic Plan,” outlining his official efforts to enhance the effectiveness of the office while making it more efficient for U.S. companies to obtain patent protection abroad. Among competing tech companies, patents are something like badges of honor. Patents protect ideas and technologies as well as exclude competitors from making strides in particular areas of research. IBM leads the pack in the total number of patents awarded each year, with 3,431 new patents granted during 2001. Patents are an immense asset to IBM, and it garners more than $1.5 billion in yearly licensing revenue from the patents it holds. IBM is followed by a short list of Japanese firms including Canon (1,937 patents in 2002), NEC (1,920 patents in 2002) and Hitachi (1,882 patents in 2002). Other top patent winners in 2002 were Micron Technology (1,851), GE (1,681) and Sony (1,601). Not only do these extraordinary numbers of patents give these companies substantial bragging rights, the revenues generated can often make the difference between red and black ink in a difficult economy. As a result, watch for continued growth in the number of patent applications. 10) Growth in the Automation of Research and Design The news in automated research tools is excellent, and many firms that manufacture such tools are enjoying booming times. Advances in CAD (computer aided design) and CAE (computer aided engineering) hybrids are revolutionizing the way in which new designs are tested and enhanced. The combination of disciplines creates virtual prototypes on computers that make R&D faster and more efficient than ever before. Finite element analysis (FEA) checks a computergenerated model for flaws. It analyzes how the model would react to extremes in heat, vibration and pressure by breaking a model down into small pieces or cells in a three-dimensional grid. The computer applies simulated stimuli to one cell in the model and then tracks the response of that cell and those that surround it. The results often keep a flawed design from progressing to production and distribution. The next big thing in automated R&D is design of experiments (DOE). This statistical technology helps researchers program FEA to concentrate on particularly vulnerable areas, rather than running thousands of scans on all parts of a model, which may not be necessary. Another stride in automation is behavioral modeling. It is a software application that takes the
Plunkett Research, Ltd.
results found by the combination of FEA and DOE into family trees of cause and effect scenarios. Major variables such as model size and power are represented by large limbs, which branch out into scenarios showing how those variables react to different situations. The process allows researchers to isolate deal-breaking problems early on and pinpoint exact circumstances in which problems will likely occur. Industries adopting this new technology include automotive manufacturing, aerospace and shipyards. Meanwhile, combinatorial chemistry, DNA chips and myriad other technology-intense tools have largely automated research in biotechnology to the extent that the field has been accelerated dramatically. 11) Energy Technology Research Receives Growing Attention, Particularly in Alternative Energy Overall, the energy sector has been running far behind other industries in terms of research and development. For example, a recent study showed that of the total number of patents granted in the U.S. during the 20-year period from 1976 through 1996, only about 100 per year were energy-specific patents. Energy-specific R&D expenditures plummeted from about $12 billion during 1980 to about $4 billion during 1996, despite the fact that 1) energy is a vital and strategic sector, and 2) energy conservation, utilization, generation and production can all benefit greatly from new technologies, and those technologies will be developed only through significant R&D efforts. Here’s the bottom line: The energy sector has barely begun to tap the potential of new technologies. It is critical that R&D efforts are accelerated and that the money to back them begins to flow in larger total amounts. Post 9/11, a focus on national security, combined with concerns about clean air, global warming, trade deficits and unstable governments in the Middle East and Africa, have put a renewed emphasis on R&D focused on energy development and conservation of all types. Suddenly, both corporate and government dollars are flooding into research on fuel cells, solaror wind-generated power and energy management. In addition, research is intensifying on methods to drill extremely deep offshore wells along with technology for enhancing the flow of oil and gas from existing fields. An interesting new nuclear technology, called pebble bed reactors, is being developed, while superconductor technology has also seen renewed interest.
www.plunkettresearch.com
As a niche, energy management has tremendous potential to create profit-generating new technologies by developing synergies between advanced electronics/communications and traditional heating, cooling and refrigeration systems. For example, Alameda, California-based Silicon Energy, www.siliconenergy.com, manufactures software solutions that interact between energy sources and major commercial/industrial energy users to reduce energy usage, lower costs and optimize the energy procurement process. Energy management professionals at Oracle’s headquarters in California wear pagers that alert them if electricity demand is nearing an overload condition. U.S.-based Echelon is working on a project with a utility company in Italy to enable residential electricity consumers to regulate their home energy usage remotely via the wireless web. Meanwhile, both gas and electric utilities are using computers and wireless technology to cut operating costs. For example, millions of wireless transmitters are now installed on electric meters around the nation, automatically sending usage data to computers for billing and tracking purposes, without the use of human meter readers. By 1999, soaring oil and gas prices created a renewed interest in all things energy-efficient. Smaller cars, high-efficiency homes and even solar power are once again part of popular culture. After all, if you’ve been enduring a rolling electricity blackout in California or New York, alternative energy sources must seem extremely interesting. At the same time, renewable energy sources and cleaner-burning fuels are of great appeal to the large number of American consumers who have developed a true interest in protecting the environment. Some surveys have shown that consumers would even be willing to pay somewhat more for electricity if they knew it was coming from non-polluting, renewable sources. Alternative energy is of growing interest to some investors. Analysts at the research firm of Clean Edge, based in Oakland, California, estimate that alternative energy firms raised $2 billion during 2000 from public stock offerings and venture capital funds. Government is once again keenly interested in promoting renewable, alternative energy sources. Many states have created rebates and other incentives to encourage investment in renewable energy systems, and 33 states have new net metering policies that require electric utility companies to pay customers for generating electricity at the same price that they charge those customers for consuming it. In other words, consumers who use solar, microturbines or
Plunkett Research, Ltd.
other methods to generate more electricity than they need from time to time could see their electric meters running backwards. This is a big step forward when you consider the fact that utilities previously purchased such power from consumers at wholesale rates, which may only be 30% or 40% of the retail price. Fuel Cells: One of the hottest alternative energy technologies is the fuel cell. The fuel cell, in basic terms, consists of quantities of hydrogen and oxygen which are separated by a catalyst. Inside the cell, a chemical reaction within the catalyst generates electricity. Byproducts of this reaction may include heat, carbon dioxide and water. In other words, fuel cells do no create the toxic emissions that we currently live with from gasoline engines. Most fuel cells are based on hydrogen as a fuel, extracted from such sources as natural gas, gasoline or methanol. Each source has its advantages and disadvantages. Unfortunately, creating a hydrogen supply from fossil fuel sources such as gasoline can create emission problems. Ideally, fuel cells would burn hydrogen that is derived by using renewable energy sources, such as solar or wind, to break down water molecules into their basic components: hydrogen and oxygen. The potential market for fuel cells encompasses diverse uses in fixed applications (such as providing an electric generating plant for a home or a neighborhood), portable systems (such as portable generators for construction sites) or completely mobile uses (including the obvious use of powering an automobile). One of the greatest potential advantages of fuel cells is the fact that they are generally clean, efficient energy sources. Fuel cells are already in wide use, even powering a U.S. Post Office in Alaska. General Motors, Ford, Honda, DaimlerChrysler and Toyota all have significant fuel-cell research initiatives. In fact, GM recently exhibited a full-size pickup truck sporting a prototype fuel-cell engine that runs on hydrogen extracted from gasoline. Automakers may have a fuel-cell-powered car, perhaps a fuel-cell/electric hybrid, on the market as early as 2010, especially if the Federal Government provides substantial sponsorship for research. Not only is the automotive industry keenly interested in fuel-cell power for automobiles and trucks, it is also betting on the use of fuel cells for many other purposes. In mid-2001, General Motors made the remarkable announcement that it is developing an affordable fuel-cell-powered electric generator for ownership by individual consumers and businesses.
www.plunkettresearch.com
Meanwhile, fuel cells remain grossly expensive due to their limited production and industry’s currently low-technology base, with the estimated price for a fuel-cell-powered car hovering around $700,000. Moreover, hydrogen is not readily available to drivers. California's South Coast Air Quality Management District plans a minimum of six hydrogen-fueling stations by early 2004. Despite these difficulties, Honda and Toyota are both testing fuel-cell-powered cars in California. Five Honda cars are leased to the city of Los Angeles, each at $500 per month, while Toyota is leasing a fuel cell version of its Highlander SUV to UC Irvine and UC Davis, for which private donations have made a lease of $10,000 per month per vehicle feasible. Fuel cells may not be in wide use in automobiles until seven to 20 years have passed. However, they are currently used with great success in many special situations. For example, fuel-cell-powered electric generators currently power many remote sites. The Japanese automakers are outpacing U.S. rivals in fuel cell advances. GM hopes to market a line of fuel-cell-powered cars by 2010. The company is planning a wide variety of car and truck bodies that will mount onto a single, radical “skateboard” chassis design. The skateboard stores fuel-cell stacks and hydrogen supplies as well as circuitry that manages the flow of electric power through the various systems necessary to stop, start and maneuver the vehicle. The chassis will include a docking port that links the body above to the electronic systems. The working name for the groundbreaking design is Autonomy. Each vehicle will be equipped with software that corresponds to the type of driving associated with the selected body style. Sporty cars and light trucks will have software that provides rapid acceleration, responsive steering and rigid suspension. The software for family cars and touring sedans will provide less pickup, easier steering and a more comfortable ride even though the underlying chassis would be the same. The electric utility industry may become a large user of fuel-cell technology over the long-term. For example, the nation of Japan plans to generate a significant portion of its electricity needs by fuel cell by the year 2010. Also, fuel-cell-powered generating plants of immense size may become practical as upgrades for aging oil-, gas- or nuclear-powered generating facilities. If the concept of distributed power catches on, fuel cells could easily be the neighborhood- or home-based generator of choice in the U.S. by 2015, especially if the electric utilities
Plunkett Research, Ltd.
become involved in the manufacture or distribution of such units.
Spotlight: IBM While IBM has had its detractors in recent years (because of its difficulties in fighting off disruptive competition in many facets of the computer business), no one could ever doubt this premier firm’s leadership in the arenas of research and development. In terms of sheer numbers, IBM rules in research. During the early 1990s, the firm refocused its research efforts and boosted R&D budgets while slashing jobs and budgets throughout the rest of the company structure. By 2001, for example, the company marked the ninth year in a row of receiving more U.S. patents than any other organization—3,411, up from 2,886 patents during 2000. (At the time, IBM was the first company ever to obtain 3,000 patents in one year.) IBM's 2002 corporate R&D budget of approximately $5 billion represents about 6% of the company's annual sales. Big Blue traces its roots to an innovative entrepreneur who used machines running on punch cards to tabulate the U.S. Census of 1890. IBM’s research division traces its beginnings to 1944, when a “Pure Science Department” was launched with a handful of people. By the early 1950s, the effort had grown to about 120 people. Today, IBM has eight major research facilities scattered around the globe, employing about 3,000 researchers, including two Nobel Prize recipients. The firm is not resting on past success. Its IBM Life Sciences division created a highly sophisticated database called Design Link, which effectively manages experimental data for drug companies that is stored on up to 13 incompatible systems. The database is part of the division's larger mission to fashion IT systems that assist biotech and pharmaceutical companies in new drug development and testing. More recently, IBM is putting cuttingedge computer technology to work scanning Internet data and making intelligent analysis of market patterns and trends. The new division, called Web Fountain, has the potential to revolutionize traditional marketing efforts. Another new concept in R&D at IBM is the depth of customer involvement. Researchers are now spending up to 25% of their time working with customers, seeking opinions and ideas.
www.plunkettresearch.com
Spotlight: Lucent/Bell Labs Lucent is the telecommunications equipment manufacturer that once was a division of AT&T. During the 1990s, the breakup of “Ma Bell” created the “Baby Bells” and led to the eventual 1996 spin-off of what is now Lucent Technologies, Inc. to operate the telecom equipment business. Lucent also received a prize asset: Bell Labs—once the world’s premier telecom research organization. Bell Labs began in the early 1900s, as a descendant of the small laboratory operated by telephone inventor Alexander Graham Bell, with a $3,500 annual budget and a handful of workers. It eventually grew to become one of the most innovative and productive research organizations the world has ever known. Today, Lucent, like IBM, is a mature organization that faces daunting, and sometimes painful, competition from upstarts. Unlike IBM, the company cut its R&D budget as part of a corporate cost-cutting program. Lucent’s annual R&D budget fell from $3.5 billion in 2001 to $2.3 billion in 2002. Despite the cut, the company's budget is still ranked 21st in a list of the largest R&D budgets among U.S. companies compiled by Schonfeld & Associates. Lucent recently received its 30,000th patent. Through the years, Bell Labs/Lucent Labs has helped to develop breakthroughs such as the transistor, the laser, the orbiting communications satellite and the molecular transistor, and 11 employees have won the Nobel Prize in Physics.
Spotlight: Intel By far the world’s leader in the semiconductor industry, Intel didn’t establish its separate, central research laboratory, named Microprocessor Research Labs (MRL), until late in the game in 1995. Instead, research and development have been continuous efforts within the many units operated by the firm. In fact, the effort to produce faster, more powerful generations of semiconductors is a major daily focus of the entire semiconductor industry. Research director David Tennenhouse, a veteran of DARPA, brought to Intel a new, broader outlook with regard to research when he joined the firm in 1999. As has traditionally been the practice at DARPA, Tennenhouse expanded the scope of Intel's research beyond a focus on semiconductors. Today, Intel employs 7,000 researchers in more than 75 labs in universities and cities around the globe. In addition to the study of semiconductors, the company's $4-billion budget covers research in networking and communications, software technology
Plunkett Research, Ltd.
and computing platforms. Intel maintains U.S. labs in California, Oregon, Arizona, Washington and Massachusetts, with international facilities in Israel, Malaysia, India, China and Russia. These labs are concerned primarily with component development and design. Additional facilities in Arizona and Malaysia study potential improvements in assembly and test processes. Intel’s unique MRL research effort is divided between facilities in Santa Clara, California and Hillsboro, Oregon. It also has efforts in Israel and China. MRL is focused on long-term, blue-sky projects that may be very speculative in nature. Intel has introduced entirely new chips every one to four years. Beginning with the “4004” chip in 1971 that ran at a snail-like pace and had a small number of transistors, the company leapt to the 386 in 1985 (275,000 transistors) to the Pentium II (7.5 million transistors) in 1997 and has introduced rapidly evolving families of chips in the early 2000s that approach 1 billion transistors per chip. As of April 2003, Intel had shipped over a billion x86 processors to customers around the world.
Spotlight: Microsoft Logically enough, the world’s leading software firm is one of the world’s leading practitioners of research and development. While Microsoft has a scientific staff of only a few hundred people, it also has thousands of highly skilled engineers. Together, these R&D employees do everything from searching for innovative ideas that may lead to future services or products to writing code in development of the next edition of MS Office. In terms of pure research, few organizations can top Microsoft’s computer science labs, which rank near those of IBM, Lucent, Carnegie Mellon and MIT. Microsoft’s internal research organization (sometimes referred to as “Bill Labs” as a play on the name of famous Bell Labs) was launched early in the company’s history in 1991. The research organization grew by 50% from 1999 to 2000, to reach a total of 600 professionals on staff. The company currently has 55 separate research projects in operation, studying everything from .NET to natural language processing to wireless technology. Microsoft has increased its R&D budget significantly in recent years (to $5.3 billion in 2002) and boasts a formidable roster of talent. At its Redmond, Washington facility, for example, the firm currently has 150 interns with Ph.D.s. Current projects include Gestures, special stylus movements when using a tablet PC that approximate using keyboard
www.plunkettresearch.com
shortcuts on a desktop PC; a spam filter for e-mail; and MyLifeBits, a technology in which a computer captures episodes in human life and stores them for later access.
Spotlight: Xerox Xerox, founder of the Palo Alto Research Center (PARC), is, at the same time, one of the most admired and least admired research organizations in the world. It is among the most admired because of PARC’s development of such ground-breaking technologies for the computer industry as the graphical user interface (GUI), the process now known as local area networking (also known as LAN or Ethernet) and the laser printer. Xerox sometimes ranks among the least admired due to management’s failure to fully capitalize on some of these groundbreaking innovations. For example, while Xerox did introduce an unpopular computer (Star) using a graphical user interface, it took the upstart Apple computer company to successfully introduce GUI to the world, creating an entire culture around the Macintosh computer. PARC is so focused on innovation in business machines and business processes that it has developed a full-time staff of anthropologists whose job is to study the way that people in offices and factories interact with the machines that are supposed to serve them. The result is logical interfaces between man and machine that are sometimes the envy of other firms. While Xerox has been assaulted by fierce competition on all sides, that competition was brought on by the attention caused by its many successes. Xerox literally enabled the masses to benefit from plain paper copying at reasonable cost. As a result, it became the first U.S. firm in business history to achieve $1 billion in yearly revenues in less than 10 years—and it reached that achievement back in 1968 when $1 billion was a lofty goal for any company. Recent successes include Xerox’s incredibly profitable Docutech system. Docutech is an entire printing plant with bindery in one easy-to-operate unit that is based on highly advanced laser copying. For most of its history, PARC was an internal business unit at Xerox, but in 2002 its status was changed to that of a wholly owned subsidiary.
Spotlight: Genentech Research at the booming drug company Genentech is a very different world than that at most major drug companies. Instead of developing new drugs that treat large numbers of people, such as Pfizer's Lipitor (which helps lower cholesterol levels)
Plunkett Research, Ltd.
and Schering-Plough's Clarinex (for allergy sufferers), Genentech targets small sets of patients with specific problems. For example, take its recent successful trials of colorectal cancer drug Avastin, which treats malignant tumors through the highly novel method of cutting off their blood supply. Another Genentech drug, Herceptin, treats specific types of breast cancer, which occur in only about 25% of breast cancer patients—patients who have a distinct genetic makeup that can be identified prior to treatment to see whether they are likely to benefit from the drug. The results of this targeted R&D are higher success rates in cancer treatment and impressive sales that topped $2.7 billion in 2002. Its Founders Research Center is an $85-million research facility that was recently expanded to a total of 500,000 square feet in South San Francisco. An additional 420,000-square-foot facility is located in Vacaville, California. A relatively small company, Genentech's R&D budget for 2002 was $623.5 million, up from $526.2 million the previous year.
Spotlight: Pfizer Drug giant Pfizer's R&D illustrates the opposite end of the spectrum from Genentech. With 10 blockbuster drugs in its extensive product line that each generate more than $1 billion in annual sales, Pfizer is focused on developing drugs that will enjoy widespread use and reap huge revenues. Pfizer's $5.3 billion R&D budget for 2003 is the largest within the pharmaceutical sector. The company pioneered robotic high-throughput chemical compound screening, and uses it along with a variety of other cutting-edge technologies to study and develop new drugs. Pfizer employs approximately 12,500 researchers and scientists around the world with locations in La Jolla, California; Ann Arbor, Michigan; New London and Groton, Connecticut; and Cambridge, Massachusetts. There are also international facilities in Canada, the U.K., France and Japan. The company has lofty goals for sales growth. In order to meet those goals, it must continue to develop blockbuster drugs at a steady pace.
Spotlight: DuPont Once highly regarded as a laboratory that regularly developed products with global impact (e.g., nylon, lycra), DuPont R&D has dropped the ball in recent years with regard to new products. The company is the victim of narrow thinking, focusing primarily on improving productivity as opposed to
www.plunkettresearch.com
developing new products. The company sold DuPont Pharmaceuticals to Bristol-Meyers Squibb in 2001, thereby divesting itself of significant R&D efforts and facilities. In 2003, the company announced its plans to restructure its R&D labs, allocating half the $1.2billion annual research budget to new products (twothirds of the budget previously went to improving productivity for existing products). Researchers are to seek customer input at all stages of product development on the 75 selected projects deemed the most promising. DuPont maintains 40 research and development labs in the U.S. and an additional 35 labs in 11 other countries. Its main facilities are in Wilmington, Delaware, split between its Experimental Station, Chestnut Run and Stine-Haskell Research Center laboratories. Together, they employ more than 1,500 researchers and scientists.
Spotlight: General Electric Innovation and a renewed emphasis on R&D have been the story at GE since Jeffrey Immelt became CEO in 2001. GE's R&D efforts historically have been groundbreaking, including work in magnetic resonance imaging (MRI), fiber optics, synthetic diamonds and the 1909 tungsten filament still in use in light bulbs today. After a brief period in the ‘90s when the conglomerate appeared to devote more funding and attention to its lucrative entertainment and financial services subsidiaries, R&D is once again a major concern for GE's plethora of manufacturing arms (which include aerospace, appliances, lighting, generators, nuclear reactors and plastics, to name a few). Its Niskayuna, New York facility received a $100million facelift in 2002. The 500-plus-acre campus now boasts new laboratories and meeting facilities. GE owns and operates other facilities as part of its Global Research arm in Bangalore, India and Shanghai, China. Moreover, GE recently broke ground on a new research center in Munich, Germany. In total, the company employs more than 2,000 researchers working in a wide variety of disciplines. Long-term research areas receiving the lion's share of funding are nanotechnology, light sources, advanced propulsion and molecular imaging. Approximately 20% of the $2.6-billion annual research budget is devoted to long-range projects.
Plunkett Research, Ltd.
www.plunkettresearch.com
Chapter 2 ENGINEERING AND RESEARCH INDUSTRY STATISTICS CONTENTS: IV. U.S. Research and Development Comparative Measures of Growth for Gross Domestic Product and R&D Federally Funded Research and Development Centers' R&D Expenditures: 2001 National Expenditures for Applied Research, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Applied Research, from Funding Sectors to Performing Sectors: 1993-2002 National Expenditures for Basic Research, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Basic Research, from Funding Sectors to Performing Sectors: 1993-2002 National Expenditures for Development, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Development, from Funding Sectors to Performing Sectors: 1993-2002 National Expenditures for R&D, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for R&D, from Funding Sectors to Performing Sectors: 1993-2002 Trends in Federal and Non-Federal R&D Expenditures as a Percentage of Total R&D: 1953-2002 Trends in U.S. Research & Development (R&D) and Federal Outlays: 1970, 1980, 1990, 2000 and 2002 U.S. Federal Basic Research Budget Authority, by Budget Function: Fiscal Years 1995–2001 U.S. Federal R&D Budget Authority, by Budget Function: FY 1980–2001 V. Research and Development by States-U.S. California Research & Development (R&D) Profile, 1999-2000 Illinois Research & Development (R&D) Profile, 1999-2000 Maryland Research & Development (R&D) Profile, 1999-2000 Massachusetts Research & Development (R&D) Profile, 1999-2000 Michigan Research & Development (R&D) Profile, 1999-2000 New Jersey Research & Development (R&D) Profile, 1999-2000 New York Research & Development (R&D) Profile, 1999-2000 Pennsylvania Research & Development (R&D) Profile, 1999-2000 Texas Research & Development (R&D) Profile, 1999-2000 Washington Research & Development (R&D) Profile, 1999-2000 State Distribution of Expenditures for R&D, by Performing Sector and Source of Funding: 2000 Top 10 U.S. States in Total R&D Performance, Size of R&D by Performer and R&D as a Percentage of Gross State Product: 2000
p. 23
VI. International Research and Patents
p. 55
International R&D Expenditures in Constant Dollars and as a Percentage of GDP: 1981–2001 Top 20 Global Patenting Organizations, Calendar Year 2001 Top 20 Patenting Countries, 2001
p. 24 p. 25 p. 27 p. 28 p. 29 p. 30 p. 31 p. 32 p. 33 p. 34 p. 35 p. 37 p. 38 p. 39
p. 41 p. 42 p. 43 p. 44 p. 45 p. 46 p. 47 p. 48 p. 49 p. 50 p. 51 p. 52 p. 54 p. 56 p. 58 p. 59
Plunkett Research, Ltd.
www.plunkettresearch.com
I.
U.S. Research and Development
Plunkett Research, Ltd.
www.plunkettresearch.com
Comparative Measures of Growth for Gross Domestic Product and R&D (Federally-funded, Nonfederal and Total): 1993-2002 Gross domestic product (GDP)
GDP in billions of current dollars Calendar year
R&D
R&D as a percent of GDP Federal support Nonfederal Federal GDP in R&D in R&D in GDP for R&D support support Nonfederal billions millions for R&D in millions implicit for support in of of of price millions millions of R&D as a percent of GDP R&D as for R&D as constant constant current deflator of a percent constant a 1996 1996 (1996=1.00) constant 1996 percent of GDP dollars dollars dollars of GDP dollars 1996 dollars
1993
6,642
0.9405
7,063 165,716 176,200
64,344
111,856
2.49
0.91
1.58
1994
7,054
0.9601
7,348 169,217 176,249
63,318
112,931
2.40
0.86
1.54
1995
7,401
0.9810
7,544 183,614 187,170
64,182
122,988
2.48
0.85
1.63
1996
7,813
1.0000
7,813 197,344 197,344
63,397
133,947
2.53
0.81
1.71
1997
8,318
1.0195
8,160 212,156 208,098
63,348
144,750
2.55
0.78
1.77
1998
8,782
1.0320
8,509 226,367 219,340
64,322
155,017
2.58
0.76
1.82
1999
9,274
1.0469
8,859 243,562 232,654
64,013
168,641
2.63
0.72
1.90
2000
9,825
1.0689
9,191 264,616 247,561
61,940
185,620
2.69
0.67
2.02
2001
10,082
1.0942
9,215 281,767 257,520
66,645
190,875
2.79
0.72
2.07
2002
10,441
1.1064
9,437 291,663 263,617
73,215
190,402
2.79
0.78
2.02
Note: Data are preliminary for 2001 and 2002. See the historical database provided in Table D for the full series of historical data, arranged by the same data columns as defined in this and other tables. Source: Department of Commerce, Bureau of Economic Analysis; Office of Management and Budget, and National Science Foundation/Division of Science Resources Statistics tabulations.
Plunkett Research, Ltd.
www.plunkettresearch.com
Federally Funded Research and Development Centers' R&D Expenditures: Fiscal Year 2001 (Latest Data Available) FFRDC
Total R&D
Federal R&D
Administrator
Sponsoring agency
Thousands of dollars All FFRDCs, total
9,997,231
9,615,716
University-administered FFRDCs, total Ames Laboratory
5,944,110 22,916
5,771,399 22,916
Argonne National Laboratory
478,391
452,860
Iowa State University of Sci. and Tech. University of Chicago
Ernest Orlando Lawrence Berkeley National Laboratory
408,487
337,757
University of California
Department of Energy
Fermi National Accelerator Laboratory
310,928
310,928
Department of Energy
Jet Propulsion Laboratory
1,355,461
1,355,461
Universities Research Association, Inc. California Institute of Technology
Lawrence Livermore National Laboratory
1,090,875
1,049,675
Lincoln Laboratory Los Alamos National Laboratory
380,200 1,333,194
University of California
370,616 Massachusetts Inst. of Technology 1,312,974 University of California
Department of Energy Department of Energy
National Aeronautics and Space Administration Department of Energy DoD, Department of the Air Force Department of Energy
National Astronomy and Ionosphere Center
10,986
10,979
Cornell University
National Center for Atmospheric Research
119,846
116,553
University Corporation for National Science Foundation Atmospheric Research
National Optical Astronomy Observatory
37,364
37,364
National Radio Astronomy Observatory
34,208
34,043
Princeton Plasma Physics Laboratory
76,021
75,387
Associatiation of National Science Foundation Universities for Research in Astronomy, Inc. Associated Universities, National Science Foundation Inc. Princeton University Department of Energy
Software Engineering Institute
37,052
37,052
Stanford Linear Accel Center
145,979
145,979
Thomas Jefferson National Accelerator Facility
102,202
100,855
1,887,833
1,805,952
Idaho National Engineering and Enviornmental Laboratory
14,547
13,610
Bechtel BWXT Idaho, LLC Department of Energy
National Cancer Institute at Frederick
187,222
183,478
1,598,900
1,521,700
87,164
87,164
SAIC; Charles River Department of Health and Human Laboratories, Inc.; Data Services, National Institutes of Management Services, Inc. Health Sandia Corporation, a Department of Energy subsidiary of Lockheed Martin Corporation Westinghouse Savannah Department of Energy River Co.
Industry-administered FFRDCs, total
Sandia National Laboratory Savannah River Technology Nonprofit-administered FFRDCs, total
2,165,288
2,038,365
Aerospace FFRDC
17,600
5,600
Arroyo Center
24,317
Brookhaven National Laboratory C3I FFRDC
National Science Foundation
Carnegie Mellon University DoD, Office of the Secretary of Defense Leland Stanford, Jr. Department of Energy University Southeastern Universities Department of Energy Research Association, Inc.
Aerospace Corporation
DoD, Department of the Air Force
24,317
RAND Corporation
DoD, Department of the Army
454,500
435,400
Department of Energy
29,458
29,458
Brookhaven Science Associates, Inc. MITRE Corporation
DoD, Office of the Secretary of Defense
Plunkett Research, Ltd.
www.plunkettresearch.com
Federally Funded Research and Development Centers' R&D Expenditures: Fiscal Year 2001 (Latest Data Available) (cont.) Center for Advanced Aviation System Development
5,683
5,683
Center for Naval Analyses
69,102
66,616
The CNA Corporation
DoD, Department of the Navy
Center for Nuclear Waste Regulatory Analyses
14,977
14,135
Southwest Research Institute
Nuclear Regulatory Commission
Institute for Defense Analyses Communications and Computing
43,100
43,100
Institute for Defense Analysis
National Security Agency
Institute for Defense Analysis Studies
92,930
92,930
1,161
1,161
Institute for Defense Analysis MITRE Corporation
DoD, Office of the Secretary of Defense Department of Treasury, Internal Revenue Service
National Defense Research Institute
25,512
25,512
RAND Corporation
National Renewable Energy Laboratory
207,230
205,665
DoD, Office of the Secretary of Defense Midwest Research Institute Department of Energy
Oak Ridge National Laboratory
581,046
540,116
UT-Battelle, LLC
Pacific Northwest National Laboratory
562,000
512,000
Battelle Memorial Institute Department of Energy
Project Air Force
29,361
29,361
RAND Corporation
DoD, Department of the Air Force
7,311
7,311
RAND Corporation
National Science Foundation
Internal Revenue Service (IRS) FFRDC
The Science and Technology Policy Institute
MITRE Corporation
Department of Transportation, Federal Aviation Administration
Department of Energy
Key: FFRDC = Federally funded research and development center; DoD = Department of Defense. Note: More information about the 36 FFRDCs can be found on the National Science Foundation website (www.nsf.gov/sbe/srs/ffrdc/start.htm). Source: National Science Foundation/Division of Science Resources Stastistics, Survey of Academic Research and Development Expenditures: Fiscal Year 2001.
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Applied Research, by Performing Sector and Source of Funding: 1993-2002 Performing Total Federal sector: U.S. Govt. Industry Funding sector: Calendar year5
Industry Universities FFRDCs & colleges1
Federal Total Federal Federal U.S. Govt. Total Govt.2 Industry3 Govt.2
Total
U&C FFRDCs Federal Nonfed. Non- Federal Govt. govt. Industry U&C profits Govt.4
Millions of current dollars
1993
37,286
4,838 24,251
4,295
19,956
435
5,146
2,539
496
443 1,181
487
969
1994
36,614
4,985 22,988
3,616
19,372
503
5,387
2,640
517
464 1,256
508
981
1995
40,999
4,952 26,919
3,164
23,755
535
5,653
2,775
559
494 1,311
516
1,119
1996
43,178
4,872 29,010
3,640
25,370
231
5,878
2,859
583
524 1,390
522
1,283
1997
46,689
4,997 32,430
2,648
29,782
213
5,630
2,635
557
523 1,399
516
1,364
1998
S
5,146
S
S
S
230
5,350
2,376
533
527 1,396
519
1,326
1999
S
5,530
S
S
S
274
5,945
2,776
558
556 1,494
562
1,267
2000
S
5,938
S
S
S
198
6,855
3,425
596
581 1,639
615
1,329
2001 Prelim
S
6,483
S
S
S
223
7,555
3,852
632
601 1,807
664
1,465
2002 Prelim Calendar year5
S
7,175
S
S
S
268
8,330
4,372
654
620 1,974
711
1,586
Millions of constant 1996 dollars
1993
39,645
5,144 25,785
4,567
21,219
463
5,471
2,699
527
471 1,256
518
1,030
1994
38,136
5,192 23,943
3,766
20,177
524
5,610
2,750
539
484 1,308
530
1,022
1995
41,793
5,048 27,440
3,225
24,215
545
5,763
2,828
569
503 1,336
526
1,140
1996
43,178
4,872 29,010
3,640
25,370
231
5,878
2,859
583
524 1,390
522
1,283
1997
45,796
4,901 31,810
2,597
29,212
209
5,522
2,585
546
513 1,372
506
1,338
1998
S
4,986
S
S
S
223
5,184
2,302
516
510 1,353
503
1,285
1999
S
5,282
S
S
S
262
5,679
2,651
533
531 1,427
537
1,210
2000
S
5,556
S
S
S
185
6,413
3,204
557
543 1,533
576
1,243
2001Prelim
S
5,925
S
S
S
204
6,905
3,521
577
549 1,652
606
1,339
2002 Prelim
S
6,485
S
S
S
242
7,529
3,951
591
560 1,784
642
1,433
Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 2 Historically, expenditures of industry FFRDCs for 1953-63 were not separated from total Federal support to the industrial sector. Thus, the figure for Federal support to industry includes support to FFRDCs or those years. The same is true for expenditures of nonprofit FFRDCs, which are included in Federal support for nonprofit institutions in 1953-87. 3 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 4 Includes all R&D expenditures of FFRDCs administered by academic institutions. 5 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscal-year data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Source: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Applied Research, from Funding Sectors to Performing Sectors: 1993-2002 Funding sector:
Total U.S.
Performing Total sector U.S. Calendar year5
Federal Government
Total
Industry
U&C
Industry U&C Non- Nonprofit NonFederal Govt. Industry FFRDCs U&C2 FFRDCs3 profits FFRDCs Total Industry4 U&C2 profits U&C2 Millions of current dollars
1993
37,286 14,078
4,838
4,295
435 2,539
969
900
103 20,547
19,956
443
148 1,181
1994
36,614 13,797
4,985
3,616
503 2,640
981
960
111 19,995
19,372
464
158 1,256
1995
40,999 13,608
4,952
3,164
535 2,775
1,119
934
129 24,418
23,755
494
170 1,311
1996
43,178 13,967
4,872
3,640
231 2,859
1,283
960
122 26,076
25,370
524
182 1,390
1997
46,689 12,996
4,997
2,648
213 2,635
1,364
1,011
128 30,510
29,782
523
205 1,399
1998
S 12,794
5,146
S
230 2,376
1,326
1,060
123
S
S
527
223 1,396
1999
S 14,717
5,530
S
274 2,776
1,267
1,301
130
S
S
556
247 1,494
2000
S 15,776
5,938
S
198 3,425
1,329
1,810
209
S
S
581
279 1,639
2001 prelim
S 17,485
6,483
S
223 3,852
1,465
2,098
302
S
S
601
294 1,807
2002 prelim Calendar year5
S 19,442
7,175
S
268 4,372
1,586
2,326
275
S
S
620
295 1,974
Millions of constant 1996 dollars
1993
39,645 14,968
5,144
4,567
463 2,699
1,030
957
109 21,847
21,219
471
157 1,256
1994
38,136 14,370
5,192
3,766
524 2,750
1,022
999
116 20,826
20,177
484
165 1,308
1995
41,793 13,871
5,048
3,225
545 2,828
1,140
952
131 24,891
24,215
503
173 1,336
1996
43,178 13,967
4,872
3,640
231 2,859
1,283
960
122 26,076
25,370
524
182 1,390
1997
45,796 12,748
4,901
2,597
209 2,585
1,338
992
126 29,926
29,212
513
201 1,372
1998
S 12,396
4,986
S
223 2,302
1,285
1,027
119
S
S
510
216 1,353
1999
S 14,058
5,282
S
262 2,651
1,210
1,243
124
S
S
531
236 1,427
2000
S 14,759
5,556
S
185 3,204
1,243
1,694
195
S
S
543
261 1,533
2001prelim
S 15,980
5,925
S
204 3,521
1,339
1,918
276
S
S
549
269 1,652
2002 prelim
S 17,573
6,485
S
242 3,951
1,433
2,102
248
S
S
560
266 1,784
Because of limitations in the survey information, data on nonfederal government funding to other performers are not available and are consequently included in other sectors' support for their own R&D performance. For example, nonfederal government support to nonprofits included in nonprofits' is support for their own R&D. 2 Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 3 Includes all R&D expenditures of FFRDCs administered by academic institutions. 4 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 5 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscalyear data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Sources: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Basic Research, by Performing Sector and Source of Funding: 1993-2002 Industry Universities FFRDCs & colleges1
Performing Total Federal sector: U.S. Govt. Industry Funding sector: Calendar year5
Federal Total Federal Federal U.S. Govt. Total Govt. Industry2 Govt.
Total
U&C FFRDCs Non- Federal Federal Nonfed. Govt. govt.3 Industry U&C profits Govt.4
Millions of current dollars
1993
28,754
2,621
6,427
466
5,961
492
13,643
8,637
952
851 2,268
936
2,968
1994
29,580
2,547
6,514
436
6,078
503
14,393
9,135
991
889 2,405
973
2,870
1995
29,562
2,689
5,569
190
5,379
530
15,139
9,629
1,069
945 2,509
987
2,661
1996
32,816
2,680
7,498
650
6,848
708
16,033 10,087
1,148
1,032 2,738 1,028
2,632
1997
36,741
2,746
9,795
1,029
8,766
625
17,485 10,788
1,242
1,170 3,129 1,156
2,660
1998
S
3,003
S
S
S
568
19,135 11,746
1,323
1,308 3,468 1,290
2,684
1999
S
3,347
S
S
S
634
20,799 12,723
1,421
1,416 3,806 1,432
2,798
2000
S
3,683
S
S
S
459
22,909 14,093
1,531
1,493 4,211 1,581
2,927
2001prelim
S
3,978
S
S
S
516
25,300 15,821
1,617
1,539 4,626 1,699
2,997
2002 prelim Calendar year5
S
4,437
S
S
S
620
27,797 17,665
1,675
1,586 5,052 1,819
3,057
Millions of constant 1996 dollars
1993
30,573
2,787
6,834
495
6,338
523
14,506
9,183
1,012
905 2,411
995
3,156
1994
30,809
2,653
6,785
454
6,331
524
14,991
9,515
1,032
926 2,505 1,014
2,989
1995
30,134
2,741
5,677
194
5,483
540
15,432
9,815
1,090
963 2,558 1,006
2,713
1996
32,816
2,680
7,498
650
6,848
708
16,033 10,087
1,148
1,032 2,738 1,028
2,632
1997
36,038
2,693
9,608
1,009
8,598
613
17,151 10,582
1,219
1,148 3,069 1,133
2,609
1998
S
2,909
S
S
S
550
18,541 11,382
1,282
1,268 3,360 1,250
2,601
1999
S
3,197
S
S
S
606
19,868 12,154
1,357
1,353 3,636 1,368
2,672
2000
S
3,446
S
S
S
429
21,432 13,184
1,432
1,397 3,940 1,479
2,738
2001prelim
S
3,636
S
S
S
472
23,123 14,459
1,477
1,406 4,228 1,552
2,739
2002 prelim
S
4,010
S
S
S
560
25,124 15,966
1,514
1,434 4,566 1,644
2,763
Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 2 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 3 Because of limitations in the survey information, data on nonfederal government funding to other performers are not available and are consequently included in other sectors' support for their own R&D performance. For example, nonfederal government support to nonprofits is included in nonprofits' support for their own R&D. 4 Includes all R&D expenditures of FFRDCs administered by academic institutions. 5 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscal-year data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Sources: National Science Foundation/Division of Science Resources Statistics. Data was derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Basic Research, from Funding Sectors to Performing Sectors: 1993-2002 Funding sector:
Total U.S.
Performing Total sector U.S. Calendar year5
Federal Government Total
Industry
U&C
Industry U&C NonFederal Non- Nonprofit Govt. Industry FFRDCs U&C2 FFRDCs3 profits FFRDCs Total Industry4 U&C2 profits U&C2 Millions of current dollars
1993
28,754 16,412
2,621
466
492 8,637
2,968
1,157
72 7,136
5,961
851
324 2,268
1994
29,580 16,702
2,547
436
503 9,135
2,870
1,137
75 7,323
6,078
889
356 2,405
1995
29,562 16,945
2,689
190
530 9,629
2,661
1,170
75 6,714
5,379
945
390 2,509
1996
32,816 18,083
2,680
650
708 10,087
2,632
1,248
79 8,308
6,848 1,032
428 2,738
1997
36,741 19,272
2,746
1,029
625 10,788
2,660
1,317
108 10,385
8,766 1,170
449 3,129
1998
S 21,001
3,003
S
568 11,746
2,684
1,461
213
S
S 1,308
489 3,468
1999
S 23,639
3,347
S
634 12,723
2,798
1,734
397
S
S 1,416
541 3,806
2000
S 26,630
3,683
S
459 14,093
2,927
2,054
616
S
S 1,493
612 4,211
2001prelim
S 29,529
3,978
S
516 15,821
2,997
2,326
903
S
S 1,539
644 4,626
2002 prelim Calendar year5
S 32,670
4,437
S
620 17,665
3,057
2,613
921
S
S 1,586
645 5,052
Millions of constant 1996 dollars
1993
30,573 17,451
2,787
495
523 9,183
3,156
1,230
77 7,587
6,338
905
344 2,411
1994
30,809 17,396
2,653
454
524 9,515
2,989
1,184
78 7,627
6,331
926
370 2,505
1995
30,134 17,273
2,741
194
540 9,815
2,713
1,193
77 6,844
5,483
963
398 2,558
1996
32,816 18,083
2,680
650
708 10,087
2,632
1,248
79 8,308
6,848 1,032
428 2,738
1997
36,038 18,903
2,693
1,009
613 10,582
2,609
1,291
106 10,186
8,598 1,148
440 3,069
1998
S 20,349
2,909
S
550 11,382
2,601
1,415
206
S
S 1,268
473 3,360
1999
S 22,580
3,197
S
606 12,154
2,672
1,656
379
S
S 1,353
517 3,636
2000
S 24,913
3,446
S
429 13,184
2,738
1,922
576
S
S 1,397
573 3,940
2001prelim
S 26,988
3,636
S
472 14,459
2,739
2,126
825
S
S 1,406
588 4,228
2002 prelim
S 29,529
4,010
S
560 15,966
2,763
2,361
832
S
S 1,434
583 4,566
Because of limitations in the survey information, data on nonfederal government funding to other performers are not available and are consequently included in other sectors' support for their own R&D performance. For example, nonfederal government support to nonprofits is included in nonprofits' support for their own R&D. 2 Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 3 Includes all R&D expenditures of FFRDCs administered by academic institutions. 4 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 5 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscalyear data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Sources: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Development, by Performing Sector and Source of Funding: 1993-2002 Performing Total Federal sector: U.S. Govt. Industry
Industry Universities FFRDCs & colleges1
U&C FFRDCs
Federal Funding Total Federal Federal Federal Nonfed. Non- Federal Govt. govt. Industry U&C profits Govt.3 sector: U.S. Govt. Total Govt. Industry2 Govt. Total Calendar Millions of current dollars year4 1993
99,677
9,071
84,757 16,083
68,674
1,038
1,698
1,126
109
97 259
107
1,346
1994
103,023
8,823
87,890 16,209
71,681
1,196
1,814
1,212
114
102 276
112
1,466
1995
113,053
9,262
97,342 17,824
79,518
1,208
1,810
1,178
123
108 288
113
1,592
1996
121,350
9,033 105,863 17,066
88,797
1,358
1,789
1,127
128
115 305
115
1,495
1997
128,726
9,077 113,184 18,121
95,063
1,292
1,750
1,092
122
115 307
113
1,462
1998
S
9,214
S
S
S
1,280
1,677
1,024
117
116 306
114
1,577
1999
S
8,974
S
S
S
1,412
1,412
717
122
122 328
123
1,595
2000
S
7,847
S
S
S
1,021
1,210
457
131
127 360
135
1,546
2001 prelim
S
8,670
S
S
S
1,149
1,319
506
139
132 397
146
1,479
2002 prelim
S
9,954
S
S
S
1,380
1,364
495
144
136 433
156
1,416
Calendar year4
Millions of constant 1996 dollars
1993
105,982
9,645
90,119 17,100
73,019
1,104
1,806
1,197
116
103 276
114
1,431
1994
107,305
9,190
91,543 16,883
74,660
1,246
1,890
1,262
118
106 287
116
1,526
1995
115,242
9,441
99,227 18,169
81,058
1,231
1,845
1,201
125
110 293
115
1,623
1996
121,350
9,033 105,863 17,066
88,797
1,358
1,789
1,127
128
115 305
115
1,495
1997
126,264
8,903 111,019 17,774
93,245
1,267
1,716
1,071
120
113 301
111
1,434
1998
S
8,928
S
S
S
1,240
1,625
992
113
112 297
110
1,528
1999
S
8,572
S
S
S
1,349
1,349
685
117
117 313
118
1,523
2000
S
7,341
S
S
S
956
1,132
428
122
119 337
126
1,446
2001 prelim
S
7,924
S
S
S
1,050
1,206
463
127
121 363
133
1,352
2002 prelim
S
8,997
S
S
S
1,247
1,232
447
130
123 392
141
1,280
Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 2 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures.2 3 Includes all R&D expenditures of FFRDCs administered by academic institutions. 4 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscalyear data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Sources: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development 'Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Development, from Funding Sectors to Performing Sectors: 1993-2002 Funding sector:
Total U.S.
Performing sector Calendar year5
Total U.S.
Federal Government Total
Industry
U&C
U&C Non- Nonprofit Federal Industry NonGovt. Industry FFRDCs U&C2 FFRDCs3 profits FFRDCs Total Industry4 U&C2 profits U&C2 Millions of current dollars
1993
99,677 30,026
9,071
16,083
1,038 1,126
1,346
787
574 68,866
68,674
97
95
259
1994
103,023 30,293
8,823
16,209
1,196 1,212
1,466
815
573 71,886
71,681
102
103
276
1995
113,053 32,410
9,262
17,824
1,208 1,178
1,592
744
603 79,738
79,518
108
111
288
1996
121,350 31,347
9,033
17,066
1,358 1,127
1,495
698
571 89,032
88,797
115
120
305
1997
128,726 32,315
9,077
18,121
1,292 1,092
1,462
687
585 95,332
95,063
115
155
307
1998
S 32,589
9,214
S
1,280 1,024
1,577
760
507
S
S
116
168
306
1999
S 28,658
8,974
S
1,412
717
1,595
726
467
S
S
122
187
328
2000
S 23,802
7,847
S
1,021
457
1,546
515
640
S
S
127
211
360
2001 prelim
S 25,907
8,670
S
1,149
506
1,479
580
948
S
S
132
222
397
2002 prelim Calendar year5
S 28,891
9,954
S
1,380
495
1,416
587
926
S
S
136
222
433
Millions of constant 1996 dollars
1993
105,982 31,925
9,645
17,100
1,104 1,197
1,431
836
611 73,223
73,019
103
101
276
1994
107,305 31,552
9,190
16,883
1,246 1,262
1,526
849
596 74,873
74,660
106
107
287
1995
115,242 33,038
9,441
18,169
1,231 1,201
1,623
758
615 81,282
81,058
110
113
293
1996
121,350 31,347
9,033
17,066
1,358 1,127
1,495
698
571 89,032
88,797
115
120
305
1997
126,264 31,697
8,903
17,774
1,267 1,071
1,434
673
573 93,509
93,245
113
152
301
1998
S 31,578
8,928
S
1,240
992
1,528
736
491
S
S
112
163
297
1999
S 27,375
8,572
S
1,349
685
1,523
693
446
S
S
117
178
313
2000
S 22,268
7,341
S
956
428
1,446
482
599
S
S
119
197
337
2001 prelim
S 23,678
7,924
S
1,050
463
1,352
530
866
S
S
121
203
363
2002 prelim S 26,113 8,997 S 1,247 447 1,280 530 837 S S 123 201 392 of limitations in the survey information, data on nonfederal government funding to other performers are not available and are consequently included in other sectors' support for their own R&D performance. For example, nonfederal government support to nonprofits is included in nonprofits' support for their own R&D. 2 Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 1 Because
3 Includes 4 Industry
all R&D expenditures of FFRDCs administered by academic institutions.
sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 5 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscal-year data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Sources: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development 'Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997.
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for R&D, by Performing Sector and Source of Funding: 1993-2002 Performing Total Federal sector: U.S. Govt. Industry Funding sector: Calendar year4
U&C FFRDCs
Industry Universities FFRDCs & colleges1
Total Federal Federal Federal U.S. Govt. Total Govt. Industry2 Govt.
Total
Federal Nonfed. Non- Federal Govt. govt. Industry U&C profits Govt.3
Millions of current dollars
1993
165,716
16,531 115,435
20,844
94,591
1,965
20,487
12,301
1,557
1,391 3,708
1,530
5,283
1994
169,217
16,355 117,392
20,261
97,131
2,202
21,594
12,987
1,622
1,456 3,937
1,594
5,317
1995
183,614
16,904 129,830
21,178
108,652
2,273
22,602
13,582
1,750
1,547 4,108
1,616
5,372
1996
197,344
16,585 142,371
21,356
121,015
2,297
23,701
14,072
1,860
1,671 4,433
1,665
5,410
1997
212,156
16,819 155,409
21,798
133,611
2,130
24,865
14,516
1,921
1,807 4,836
1,785
5,486
1998
226,367
17,362 167,102
22,086
145,016
2,078
26,162
15,146
1,973
1,951 5,170
1,923
5,588
1999
243,562
17,851 180,390
20,214
160,176
2,321
28,157
16,215
2,101
2,094 5,628
2,118
5,660
2000
264,616
17,469 197,861
17,440
180,421
1,678
30,974
17,975
2,257
2,201 6,210
2,331
5,801
2001 prelim 281,767
19,130 208,068
18,625
189,442
1,888
34,175
20,179
2,387
2,272 6,830
2,508
5,940
2002 prelim 291,663
21,566 210,848
20,933
189,915
2,268
37,491
22,531
2,473
2,342 7,459
2,686
6,059
Calendar year4
Millions of constant 1996 dollars
1993
176,200
17,576 122,738
22,163
100,575
2,089
21,783
13,079
1,655
1,479 3,943
1,627
5,617
1994
176,249
17,035 122,271
21,103
101,168
2,294
22,491
13,527
1,689
1,516 4,100
1,660
5,538
1995
187,170
17,231 132,345
21,588
110,756
2,317
23,039
13,845
1,784
1,577 4,187
1,647
5,476
1996
197,344
16,585 142,371
21,356
121,015
2,297
23,701
14,072
1,860
1,671 4,433
1,665
5,410
1997
208,098
16,497 152,436
21,381
131,055
2,089
24,390
14,238
1,885
1,773 4,743
1,751
5,381
1998
219,340
16,823 161,915
21,400
140,514
2,013
25,350
14,676
1,911
1,890 5,010
1,863
5,414
1999
232,654
17,052 172,311
19,309
153,002
2,217
26,896
15,489
2,007
2,001 5,376
2,023
5,406
2000
247,561
16,343 185,108
16,316
168,792
1,570
28,978
16,816
2,112
2,059 5,809
2,181
5,427
2001 prelim 257,520
17,484 190,163
17,023
173,140
1,725
31,234
18,443
2,181
2,076 6,242
2,292
5,429
2002 prelim 263,617
19,493 190,573
18,920
171,653
2,050
33,886
20,365
2,235
2,117 6,741
2,428
5,476
Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. Data for 1998 and later years are not directly comparable to data for 1997 and earlier years. For fiscal year 1998, $479 million in passthrough funds were reported. For fiscal year 2002, $881 million in passthrough funds are estimated. 2 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 3 Includes all R&D expenditures of FFRDCs administered by academic institutions. 4 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscal-year data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges. Sources: National Science Foundation/Division of Science Resources Statistics. Data was derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for R&D, from Funding Sectors to Performing Sectors: 1993-2002 Funding sector:
Total U.S.
Performing sector Calendar year4
Total U.S.
Federal Government Total
Industry
U&C Federal Industry Non- Nonprofit Govt. Industry FFRDCs U&C1 FFRDCs2 profits FFRDCs
U&C
NonTotal Industry3 U&C1 profits U&C1
Millions of current dollars
1993
165,716 60,516 16,531
20,844
1,965 12,301
5,283
2,843
749
96,549
94,591 1,391
567 3,708
1994
169,217 60,792 16,355
20,261
2,202 12,987
5,317
2,911
758
99,203
97,131 1,456
617 3,937
1995
183,614 62,963 16,904
21,178
2,273 13,582
5,372
2,847
808 110,870 108,652 1,547
671 4,108
1996
197,344 63,397 16,585
21,356
2,297 14,072
5,410
2,906
772 123,416 121,015 1,671
730 4,433
1997
212,156 64,583 16,819
21,798
2,130 14,516
5,486
3,014
821 136,227 133,611 1,807
809 4,836
1998
226,367 66,383 17,362
22,086
2,078 15,146
5,588
3,281
843 147,847 145,016 1,951
880 5,170
1999
243,562 67,014 17,851
20,214
2,321 16,215
5,660
3,761
993 163,245 160,176 2,094
975 5,628
2000
264,616 66,208 17,469
17,440
1,678 17,975
5,801
4,380
1,465 183,724 180,421 2,201
1,103 6,210
2001 prelim 281,767 72,920 19,130
18,625
1,888 20,179
5,940
5,005
2,153 192,873 189,442 2,272
1,160 6,830
2002 prelim 291,663 81,004 21,566 Calendar year4
20,933
2,268 22,531
6,059
5,525
2,121 193,420 189,915 2,342
1,163 7,459
Millions of constant 1996 dollars
1993
176,200 64,344 17,576
22,163
2,089 13,079
5,617
3,023
796 102,657 100,575 1,479
603 3,943
1994
176,249 63,318 17,035
21,103
2,294 13,527
5,538
3,032
790 103,326 101,168 1,516
642 4,100
1995
187,170 64,182 17,231
21,588
2,317 13,845
5,476
2,902
823 113,017 110,756 1,577
684 4,187
1996
197,344 63,397 16,585
21,356
2,297 14,072
5,410
2,906
772 123,416 121,015 1,671
730 4,433
1997
208,098 63,348 16,497
21,381
2,089 14,238
5,381
2,956
805 133,622 131,055 1,773
793 4,743
1998
219,340 64,322 16,823
21,400
2,013 14,676
5,414
3,179
817 143,257 140,514 1,890
853 5,010
1999
232,654 64,013 17,052
19,309
2,217 15,489
5,406
3,592
948 155,934 153,002 2,001
931 5,376
2000
247,561 61,940 16,343
16,316
1,570 16,816
5,427
4,098
1,371 171,883 168,792 2,059
1,032 5,809
2001 prelim 257,520 66,645 17,484
17,023
1,725 18,443
5,429
4,574
1,968 176,276 173,140 2,076
1,060 6,242
2002 prelim 263,617 73,215 19,493
18,920
2,050 20,365
5,476
4,994
1,917 174,821 171,653 2,117
1,051 6,741
Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. Data for 1998 and later years are not directly comparable to data for 1997 and earlier years. For fiscal year 1998, $479 million in passthrough funds were reported. For fiscal year 2002, $881 million in passthrough funds are estimated. 2 Includes all R&D expenditures of FFRDCs administered by academic institutions. 3 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 4 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscal-year data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges Sources: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
Trends in Federal and Non-Federal R&D Expenditures as a Percentage of Total R&D: 1953-2002 Federal Calendar year
Total Federal
Defense related
Space related Percent
Civilian related
Nonfederal
1953
53.9
48.0
1.0
4.9
46.1
1954
55.2
49.0
1.0
5.2
44.8
1955
57.4
48.7
1.0
7.7
42.6
1955
58.6
49.7
1.0
7.9
41.4
1957
62.9
53.2
0.9
8.8
37.1
1958
63.9
53.1
1.1
9.7
36.1
1959
65.4
54.3
2.6
8.6
34.6
1960
65.0
52.6
3.2
9.3
35.0
1961
65.1
50.4
5.6
9.2
34.9
1962
64.8
49.1
6.6
9.1
35.2
1963
66.5
41.9
13.6
11.0
33.5
1964
66.8
37.0
19.0
10.9
33.2
1965
65.1
33.2
20.9
11.1
34.9
1966
64.2
32.4
19.6
12.2
35.8
1967
62.4
35.3
14.4
12.7
37.6
1968
60.7
34.7
13.6
12.4
39.3
1969
58.6
34.7
11.5
12.4
41.4
1970
57.0
33.4
10.3
13.3
43.0
1971
56.4
32.7
9.6
14.1
43.6
1972
55.8
33.0
7.9
14.9
44.2
1973
53.6
32.0
6.7
14.8
46.4
1974
51.8
29.3
6.9
15.6
48.2
1975
52.0
27.6
7.5
16.8
48.0
1976
51.5
26.9
7.7
16.9
48.5
1977
51.0
27.2
6.6
17.2
49.0
1978
50.2
25.9
6.2
18.0
49.8
1979
49.2
24.8
5.6
18.8
50.8
1980
47.5
24.3
5.3
17.9
52.5
1981
46.7
24.4
5.2
17.0
53.3
1982
46.1
26.1
4.9
15.0
53.9
1983
46.2
27.7
4.2
14.2
53.8
1984
45.5
28.7
3.0
13.8
54.5
1985
46.0
29.9
3.2
12.9
54.0
1986
45.5
31.5
3.0
10.9
54.5
1987
46.4
31.8
3.2
11.4
53.6
1988
44.9
30.5
3.4
11.0
55.1
1989
42.6
27.9
3.7
11.0
57.4
1990
40.6
25.4
4.2
11.0
59.4
1991
37.8
22.6
4.5
10.8
62.2
1992
36.8
21.6
4.3
11.0
63.2
1993
36.5
21.6
4.4
10.6
63.5
1994
35.9
19.9
4.4
11.6
64.1
1995
34.3
18.5
4.5
11.2
65.7
1996
32.1
17.6
4.1
10.5
67.9
1997
30.4
16.8
4.1
9.6
69.6
Plunkett Research, Ltd.
www.plunkettresearch.com
Trends in Federal and Non-Federal R&D Expenditures as a Percentage of Total R&D: 1953-2002 (cont.) Federal Calendar year
Total Federal
Defense related
Space related Percent
Civilian related
Nonfederal
1998
29.3
15.9
3.9
9.6
70.7
1999
27.5
14.6
3.5
9.4
72.5
2000
25.0
13.5
2.4
9.1
75.0
2001 prelim
25.9
13.6
2.3
9.9
74.1
2002 prelim 27.8 15.0 2.5 10.3 72.2 Note: Data are preliminary for 2001 and 2002. Details may not sum totals because of rounding. Source: National Science Foundation/Division of Science Resources Statistics
Plunkett Research, Ltd.
www.plunkettresearch.com
Trends in U.S. Research & Development (R&D) and Federal Outlays: 1970, 1980, 1990, 2000 and 2002 (Estimate) Composition of Federal Outlays
1970
1980
1990
2002 (estimate)
2000
Billions of Current US$ Total Federal outlays
195.6
590.9
1,253.2
1,788.8
1,960.6
1
Mandatory programs
61.0
262.1
568.2
950.8
1,080.7
Net interest
14.4
52.5
184.4
223.2
188.1
120.3
276.3
500.6
614.8
691.7
81.9
134.6
300.1
295.0
319.2
8.0
14.6
41.1
41.1
46.8
4.0
12.8
19.1
21.3
24.5
N/A
N/A
N/A
N/A
N/A
34.4
128.9
181.4
298.6
348.0
7.1
15.6
22.7
32.9
40.4
15.1
30.2
63.8
74.0
87.2
Total discretionary Defense discretionary R&D outlays International discretionary R&D outlays Domestic discretionary R&D outlays Total Federal R&D outlays
Total U.S. Federal Outlays (Percent) Total Federal outlays
100.0
100.0
100.0
100.0
100.0
1
31.2
44.4
45.3
53.2
55.1
7.4
8.9
14.7
12.5
9.6
61.5
46.8
39.9
34.4
35.3
41.9
22.8
23.9
16.5
16.3
4.1
2.5
3.3
2.3
2.4
2.0
2.2
1.5
1.2
1.2
N/A
N/A
N/A
N/A
N/A
17.6
21.8
14.5
16.7
17.7
3.6
2.6
1.8
1.8
2.1
7.7
5.1
5.1
4.1
4.4
Mandatory programs Net interest Total discretionary
Defense discretionary R&D outlays International discretionary R&D outlays Domestic discretionary R&D outlays Total Federal R&D outlays
U.S. Federal R&D Outlays as Proportion of Corresponding Discretionary Outlays (Percent) Total Federal R&D as a percent of total discretionary outlays
12.6%
10.9%
12.7%
12.0%
12.6%
Defense as a percent of defense outlays
9.8%
10.8%
13.7%
13.9%
14.7%
Domestic as a percent of domestic outlays
20.7%
12.1%
12.5%
11.0%
11.6%
N/A = not available 1
Includes Social Security, Medicare, Medicaid, and other programs.
Sources: U.S. Office of Management and Budget, Historical Tables, Budget of the United States Government: Fiscal Year 2002 (Washington, DC, U.S. Government Printing Office). Science & Engineering Indicators – 2002.
Plunkett Research, Ltd.
www.plunkettresearch.com
U.S. Federal Basic Research Budget Authority, by Budget Function: Fiscal Years 1995–2001 (latest data available) US$ Mil. Budget function
1995
1996
1997
1998
1999
2000
2001
Millions of Current US$ Total
Health General science Space research and tech. National defense Energy Agriculture Natural resources and env. Transportation Education, training, employment and social services Commerce & housing credit Vet. benefits and services Administration of justice Community and regional dev. General government International affairs Income security
13,772 6,068 2,622 1,614 1,181 930 565 187 389
14,442 6,395 2,662 1,685 1,165 1,182 547 147 456
14,961 6,852 2,753 1,653 1,090 1,288 548 153 420
15,523 7,356 4,121 1,610 1,067 34 571 145 411
17,433 8,634 4,464 1,667 1,110 36 602 142 358
18,965 9,834 4,648 1,737 1,205 37 659 155 255
20,259 10,399 5,272 1,761 1,262 46 702 162 202
153 35 16 9 3 0 0 0
140 37 13 12 0 0 2 0
142 34 14 13 0 0 2 0
133 35 23 16 0 0 1 0
99 41 263 18 0 0 0 0
106 41 268 21 0 0 0 0
112 53 268 19 0 0 0 0
Millions of Constant FY 1996 US$ Total
Health General science Space research and tech. National defense Energy Agriculture Natural resources and env. Transportation Education, training, employment and social services Commerce & housing credit Vet. benefits and services Administration of justice Community and regional dev. General government International affairs Income security
14,037 6,185 2,673 1,646 1,204 948 576 190 397
14,442 6,395 2,662 1,685 1,165 1,182 547 147 456
14,711 6,738 2,707 1,625 1,072 1,266 539 150 413
15,071 7,142 4,000 1,563 1,036 33 554 141 399
16,708 8,275 4,278 1,597 1,063 34 577 136 343
17,908 9,286 4,389 1,641 1,138 35 622 146 241
18,755 9,627 4,880 1,631 1,168 43 650 150 187
156 36 16 9 3 0 0 0
140 37 13 12 0 0 2 0
140 33 14 13 0 0 2 0
129 34 23 16 0 0 1 0
95 39 252 17 0 0 0 0
100 38 253 20 0 0 0 0
104 49 248 18 0 0 0 0
Notes: Data for 1995–99 are actual budget authority. Data for 2000 are preliminary estimates, and data for 2001 are proposed based on FY 2001 budget. See Appendix table 4-1 for fiscal year gross domestic product implicit price deflators used to convert current dollars to constant 1996 dollars. Beginning in FY 1998, a number of Department of Energy programs were reclassified from energy to general science. Beginning FY 1999, the increase in the Veterans Administration basic research totals was a result of data reclassifications. Source: National Science Foundation, Division of Science Resources Studies (NSF/SRS), Federal R&D Funding by Budget Function: Fiscal Years 1999–2001, NSF 01-316 (Arlington, VA, 2001).
Plunkett Research, Ltd.
www.plunkettresearch.com
U.S. Federal R&D Budget Authority, by Budget Function: FY 1980–2001
4,890 5,065 3,932 3,110 3,233 3,708 3,845 4,394 4,612 5,493 6,700 7,283 7,351 7,440 7,726 8,074 7,844 7,694 7,928 7,864
Millions of Constant 1996 US$ 6,435 2,202 1,784 1,584 1,045 5,700 2,182 1,727 1,415 1,073 4,583 2,068 1,468 1,204 1,054 3,757 2,189 1,388 1,277 1,086 3,628 2,356 1,354 1,462 1,071 3,251 2,534 1,441 1,402 1,138 3,037 2,489 1,411 1,218 1,083 2,655 2,641 1,465 1,174 1,063 2,662 2,705 1,453 1,122 1,104 2,917 2,861 1,513 1,283 1,094 3,168 2,801 1,611 1,214 1,104 3,303 2,947 1,770 1,377 1,177 3,437 2,898 1,840 1,660 1,259 2,850 2,865 1,918 1,813 1,226 2,994 2,826 1,944 1,967 1,243 2,901 2,850 2,028 1,870 1,218 2,521 2,846 1,802 1,795 1,176 2,327 2,888 1,850 1,751 1,180 917 4,217 1,794 1,773 1,208 1,079 4,473 1,757 1,645 1,228
General Gov't
6,598 6,303 5,887 6,264 6,718 7,372 7,394 8,478 8,861 9,373 9,655 10,320 10,960 10,944 11,456 11,635 11,867 12,428 13,130 14,834
Income security
26,421 24,946 21,371 20,160 20,983 22,029 21,689 23,170 23,800 25,865 27,723 29,720 30,864 30,485 31,854 32,218 31,248 31,449 32,636 34,650
Admin. of justice
26,694 29,979 33,582 36,345 41,168 45,854 49,065 50,630 50,212 49,035 46,397 43,991 43,692 43,915 39,354 37,948 37,801 38,834 38,514 39,395
Millions of Current US$ 1,233 999 887 585 1,340 1,061 869 659 1,359 965 791 693 1,502 952 876 745 1,676 963 1,040 762 1,862 1,059 1,030 836 1,873 1,062 917 815 2,042 1,133 908 822 2,160 1,160 896 882 2,373 1,255 1,064 907 2,410 1,386 1,045 950 2,635 1,582 1,231 1,052 2,659 1,688 1,523 1,155 2,691 1,802 1,703 1,152 2,712 1,865 1,888 1,193 2,794 1,988 1,833 1,194 2,846 1,802 1,795 1,176 2,944 1,886 1,785 1,203 4,360 1,855 1,833 1,249 4,690 1,842 1,725 1,288 4,885 1,906 1,570 1,405 5,529 1,932 1,665 1,450
Commerce & housing credit Community & reg. Development
1980 53,115 1981 54,925 1982 54,953 1983 56,505 1984 62,151 1985 67,883 1986 70,753 1987 73,799 1988 74,012 1989 74,901 1990 74,121 1991 73,711 1992 74,556 1993 74,400 1994 71,208 1995 70,166 1996 69,049 1997 70,282 1998 71,150 1999 74,046
Agriculture Educ., training, employ. & social serv.
3,603 3,501 3,012 2,578 2,581 2,389 2,286 2,053 2,126 2,419 2,726 2,953 3,153 2,677 2,873 2,844 2,521 2,372 948 1,131 1,112 1,184
Transportation
2,738 3,111 2,584 2,134 2,300 2,725 2,894 3,398 3,683 4,555 5,765 6,511 6,744 6,988 7,414 7,916 7,844 7,844 8,198 8,245 8,447 8,732
International affairs Vets benefits & services
Natural resources & environment
Energy
3,694 3,871 3,869 4,298 4,779 5,418 5,565 6,556 7,076 7,773 8,308 9,226 10,055 10,280 10,993 11,407 11,867 12,670 13,576 15,553 17,762 18,858
General science
Space research & technology
14,793 15,322 14,045 13,832 14,927 16,189 16,323 17,917 19,007 21,450 23,856 26,570 28,315 28,635 30,567 31,587 31,248 32,062 33,746 36,331 38,887 41,316
Total defense 14,946 18,413 22,070 24,936 29,287 33,698 36,926 39,152 40,099 40,665 39,925 39,328 40,083 41,249 37,764 37,204 37,801 39,591 39,823 41,306 41,846 41,414
Total
1980 29,739 1981 33,735 1982 36,115 1983 38,768 1984 44,214 1985 49,887 1986 53,249 1987 57,069 1988 59,106 1989 62,115 1990 63,781 1991 65,898 1992 68,398 1993 69,884 1994 68,331 1995 68,791 1996 69,049 1997 71,653 1998 73,569 1999 77,637 2000 80,733 2001 82,730
Year
Health
Total non-defense
(latest data available)
468 298 228 189 200 220 248 267 285 347 374 433 365 348 373 369 331 373 444 403 476 497
125 160 165 177 192 210 211 223 224 279 375 378 371 382 254 287 252 190 163 190 142 114
126 143 139 157 218 193 183 215 195 212 216 219 245 250 265 257 259 267 587 644 655 655
101 106 104 107 110 114 111 110 122 128 140 178 192 220 380 525 432 409 398 432 373 516
119 104 63 44 46 50 88 99 108 74 67 88 95 57 68 70 50 48 42 59 46 63
45 34 31 37 24 47 41 49 51 45 44 51 51 49 46 59 56 59 72 88 77 74
47 43 32 32 26 21 14 25 23 27 33 30 37 36 45 43 16 9 18 38 25 42
22 22 10 6 8 17 14 17 17 15 17 4 4 1 0 1 2 2 2 3 6 6
836 485 347 275 281 299 330 345 357 418 435 484 398 370 389 376 331 366 429 384
223 261 251 258 270 286 280 288 280 336 436 423 404 407 265 293 252 186 158 181
225 233 212 229 306 263 243 278 244 256 251 245 267 266 276 262 259 262 568 614
180 173 158 156 155 155 147 142 153 154 163 199 209 234 396 535 432 401 385 412
213 169 96 64 65 68 117 128 135 89 78 98 104 61 71 71 50 47 41 56
80 55 47 54 34 64 54 63 64 54 51 57 56 52 48 60 56 58 70 84
84 70 49 47 37 29 19 32 29 33 38 34 40 38 47 44 16 9 17 36
39 36 15 9 11 23 19 22 21 18 20 4 4 1 0 1 2 2 2 3
Plunkett Research, Ltd.
www.plunkettresearch.com
U.S. Federal R&D Budget Authority, by Budget Function: FY 1980–2001 (cont.)
2000 75,543 39,156 2001 75,823 37,956
Millions of Current US$ 36,387 16,620 7,904 1,041 4,571 1,783 1,469 1,315 37,866 17,283 8,003 1,085 5,067 1,771 1,526 1,329
445 456
133 104
613 600
349 473
43 58
72 68
23 38
General Gov't
Income security
Admin. of justice
Commerce & housing credit Community & reg. Development
International affairs Vets benefits & services
Agriculture Educ., training, employ. & social serv.
Transportation
Natural resources & environment
General science
Energy
Space research & technology
Health
Total non-defense
Total defense
Total
Year
(latest data available)
6 5
Notes: Data for 1980–99 are actual budget authority, data for 2000 are preliminary estimates, and data for 2001 are proposed based on fiscal year 2001 budget. See Appendix table 4-1 for fiscal year GDP implicit price deflators used to convert current dollars to constant 1996 dollars. Beginning in fiscal year 1998, a number of Department of Energy programs were reclassified from energy to general science. Sources: National Science Foundation, Division of Science Resources Studies (NSF/SRS), Federal R&D Funding by Budget Function: Fiscal Years 1999–2001, NSF 01–316 (Arlington, VA, 2001). Science & Engineering Indicators – 2002.
Plunkett Research, Ltd.
www.plunkettresearch.com
II. Research and Development by States-U.S.
Plunkett Research, Ltd.
www.plunkettresearch.com
California Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
66,800
518,670
1
19,980
107,100
1
3,321
25,979
1
of which, in life sciences
22%
26%
in engineering
22%
21%
17%
14%
6,009
41,548
1
43,907
435,612
1
Population, 2000 (thousands)
33,872
285,231
1
Civilian labor force, 2000 (thousands)
17,091
142,172
1
Personal income per capita, 2000
$32,225
$29,451
9
Total expenditures, 2000 (millions)
$175,751
$1,615,468
1
R&D obligations, 1999 (millions)
$15,600
$73,718
1
Total R&D performance, 1999 (millions)
$47,965
$231,832
1
Industry R&D, 1999 (millions)
$39,047
$177,171
1
Academic R&D, 1999 (millions)
$3,573
$27,038
1
of which, in life sciences
56%
57%
in engineering
15%
15%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Federal spending
in physical sciences
12%
9%
$15,707
$125,236
1
Number of SBIR awards, 1995-2000
5,510
26,424
1
Patents issued to state residents, 2000
17,492
85,068
1
Gross state product, 1999 (billions)
$1,229
$9,369
1
of which, agriculture
2%
1%
manufacturing, mining, construction
19%
22%
transportation, communication, utilities
7%
8%
wholesale and retail trade
16%
16%
finance, insurance, real estate
22%
19%
services
23%
21%
government
11%
12%
Public higher education current-fund expenditures, 1997 (millions)
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Illinois Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
20,540
518,670
7
4,020
107,100
9 5
1,345
25,979
of which, in life sciences
22%
26%
in engineering
22%
21%
18%
16%
1,225
41,548
8
23,370
435,612
4
Population, 2000 (thousands)
12,419
285,231
5
Civilian labor force, 2000 (thousands)
6,419
142,172
5
$31,842
$29,451
11
Total expenditures, 2000 (millions)
$60,008
$1,615,468
7
R&D obligations, 1999 (millions)
$1,316
$73,718
16
Total R&D performance, 1999 (millions)
$9,719
$231,832
8
Industry R&D, 1999 (millions)
$7,715
$177,171
8
Academic R&D, 1999 (millions)
$1,087
$27,038
7
54%
57%
in engineering
15%
15%
in physical sciences
11%
9%
$4,713
$125,236
7
393
26,424
19
Patents issued to state residents, 2000
3,833
85,068
5
Gross state product, 1999 (billions)
$446
$9,369
4
of which, agriculture
1%
1%
manufacturing, mining, construction
21%
22%
transportation, communication, utilities
9%
8%
wholesale and retail trade
16%
16%
finance, insurance, real estate
20%
19%
services
23%
21%
government
10%
12%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending
of which, in life sciences
Public higher education current-fund expenditures, 1997 (millions) Number of SBIR awards, 1995-2000
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Maryland Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
21,510
518,670
6
3,440
107,100
10 13
635
25,979
of which, in life sciences
29%
26%
in engineering
22%
21%
17%
16%
1,572
41,548
6
9,563
435,612
13
Population, 2000 (thousands)
5,296
285,231
19
Civilian labor force, 2000 (thousands)
2,805
142,172
18
$33,621
$29,451
6
Total expenditures, 2000 (millions)
$45,089
$1,615,468
10
R&D obligations, 1999 (millions)
$8,094
$73,718
2
Total R&D performance, 1999 (millions)
$8,087
$231,832
10
Industry R&D, 1999 (millions)
$1,700
$177,171
22
Academic R&D, 1999 (millions)
$1,380
$27,038
6
42%
57%
in engineering
23%
15%
in physical sciences
13%
9%
Public higher education current-fund expenditures, 1997 (millions)
$2,353
$125,236
18
Number of SBIR awards, 1995-2000
1,255
26,424
4
Patents issued to state residents, 2000
1,355
85,068
20
Gross state product, 1999 (billions)
$175
$9,369
16
of which, agriculture
1%
1%
manufacturing, mining, construction
14%
22%
transportation, communication, utilities
7%
8%
wholesale and retail trade
15%
16%
finance, insurance, real estate
21%
19%
services
24%
21%
government
17%
12%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending
of which, in life sciences
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Massachusetts Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
24,880
518,670
4
4,850
107,100
4 4
1,452
25,979
of which, in life sciences
25%
26%
in engineering
22%
21%
21%
16%
5,468
41,548
2
22,530
435,612
5
Population, 2000 (thousands)
6,349
285,231
13
Civilian labor force, 2000 (thousands)
3,237
142,172
13
$37,710
$29,451
3
Total expenditures, 2000 (millions)
$40,824
$1,615,468
14
R&D obligations, 1999 (millions)
$3,129
$73,718
6
Total R&D performance, 1999 (millions)
$12,190
$231,832
5
Industry R&D, 1999 (millions)
$9,314
$177,171
6
Academic R&D, 1999 (millions)
$1,381
$27,038
5
44%
57%
in engineering
18%
15%
in physical sciences
13%
9%
Public higher education current-fund expenditures, 1997 (millions)
$1,740
$125,236
28
Number of SBIR awards, 1995-2000
3,958
26,424
2
Patents issued to state residents, 2000
3,463
85,068
8
Gross state product, 1999 (billions)
$263
$9,369
11
of which, agriculture
1%
1%
manufacturing, mining, construction
18%
22%
transportation, communication, utilities
6%
8%
wholesale and retail trade
15%
16%
finance, insurance, real estate
24%
19%
services
27%
21%
government
9%
12%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending
of which, in life sciences
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Michigan Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
13,770
518,670
13
4,530
107,100
7 8
993
25,979
of which, in life sciences
27%
21%
in engineering
22%
26%
17%
16%
1,108
41,548
11
17,407
435,612
9
Population, 2000 (thousands)
9,938
285,231
8
Civilian labor force, 2000 (thousands)
5,201
142,172
8
$29,071
$29,451
19
$46,823
$1,615,468
9
$840
$73,718
22
Total R&D performance, 1999 (millions)
$18,799
$231,832
2
Industry R&D, 1999 (millions)
$17,714
$177,171
2
$914
$27,038
9
of which, in life sciences
58%
57%
in engineering
20%
15%
in physical sciences
9%
5%
$5,987
$125,236
4
525
26,424
15
Patents issued to state residents, 2000
3,724
85,068
6
Gross state product, 1999 (billions)
$308
$9,369
9
of which, agriculture
1%
1%
manufacturing, mining, construction
31%
22%
transportation, communication, utilities
7%
8%
wholesale and retail trade
17%
16%
finance, insurance, real estate
14%
19%
services
20%
21%
government
10%
12%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending Total expenditures, 2000 (millions) R&D obligations, 1999 (millions)
Academic R&D, 1999 (millions)
Public higher education current-fund expenditures, 1997 (millions) Number of SBIR awards, 1995-2000
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
New Jersey Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
19,740
518,670
8
4,750
107,100
6 14
597
25,979
of which, in life sciences
25%
26%
in engineering
22%
21%
18%
16%
672
41,548
18
11,110
435,612
12
Population, 2000 (thousands)
8,414
285,231
9
Civilian labor force, 2000 (thousands)
4,188
142,172
9
$37,112
$29,451
4
Total expenditures, 2000 (millions)
$43,469
$1,615,468
11
R&D obligations, 1999 (millions)
$2,661
$73,718
8
Total R&D performance, 1999 (millions)
$10,536
$231,832
7
Industry R&D, 1999 (millions)
$9,453
$177,171
5
$521
$27,038
17
47%
57%
in engineering
18%
15%
in physical sciences
11%
9%
$3,148
$125,236
11
803
26,424
10
Patents issued to state residents, 2000
3,889
85,068
4
Gross state product, 1999 (billions)
$332
$9,369
8
of which, agriculture
1%
1%
manufacturing, mining, construction
16%
22%
transportation, communication, utilities
10%
8%
wholesale and retail trade
17%
16%
finance, insurance, real estate
24%
19%
services
23%
21%
government
10%
12%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending
Academic R&D, 1999 (millions) of which, in life sciences
Public higher education current-fund expenditures, 1997 (millions) Number of SBIR awards, 1995-2000
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
New York Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic
State
U.S.
Rank
41,230
518,670
2
6,230
107,100
3
2,217
25,979
2
of which, in life sciences
25%
26%
in engineering
20%
16%
16%
14%
3,925
41,548
3
36,420
435,612
2
Population, 2000 (thousands)
18,976
285,231
3
Civilian labor force, 2000 (thousands)
8,941
142,172
3
$34,502
$29,451
5
$110,333
$1,615,468
2
$2,689
$73,718
7
Total R&D performance, 1999 (millions)
$14,110
$231,832
3
Industry R&D, 1999 (millions)
$11,388
$177,171
3
Academic R&D, 1999 (millions)
$2,029
$27,038
2
of which, in life sciences
66%
57%
in engineering
11%
15%
in physical sciences
10%
9%
Public higher education current-fund expenditures, 1997 (millions)
$6,872
$125,236
3
Number of SBIR awards, 1995-2000
1,112
26,424
6
Patents issued to state residents, 2000
6,083
85,068
3
Gross state product, 1999 (billions)
$755
$9,369
2
of which, agriculture
0%
1%
manufacturing, mining, construction
13%
22%
transportation, communication, utilities
7%
8%
wholesale and retail trade
13%
16%
finance, insurance, real estate
33%
19%
services
23%
21%
government
10%
12%
Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending Total expenditures, 2000 (millions) R&D obligations, 1999 (millions)
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Pennsylvania Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic
State
U.S.
Rank
23,820
518,670
5
4,290
107,100
8
1,240
25,979
6
of which, in life sciences
25%
21%
in engineering
23%
26%
16%
14%
2,582
41,548
5
19,609
435,612
6
12,281
285,231
6
Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Population, 2000 (thousands) Civilian labor force, 2000 (thousands)
5,972
142,172
6
$29,533
$29,451
17
Total expenditures, 2000 (millions)
$73,715
$1,615,468
5
R&D obligations, 1999 (millions)
$1,907
$73,718
13
Total R&D performance, 1999 (millions)
$10,695
$231,832
6
Industry R&D, 1999 (millions)
$8,932
$177,171
7
Academic R&D, 1999 (millions)
$1,389
$27,038
4
of which, in life sciences
57%
57%
in engineering
17%
15%
in physical sciences
7%
5%
$4,941
$125,236
5
889
26,424
9
Patents issued to state residents, 2000
3,636
85,068
7
Gross state product, 1999 (billions)
$383
$9,369
6
of which, agriculture
1%
1%
Personal income per capita, 2000 Federal spending
Public higher education current-fund expenditures, 1997 (millions) Number of SBIR awards, 1995-2000
manufacturing, mining, construction
24%
22%
transportation, communication, utilities
9%
8%
wholesale and retail trade
15%
16%
finance, insurance, real estate
18%
19%
services
22%
21%
government
10%
12%
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Texas Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic
State
U.S.
Rank
27,170
518,670
3
8,340
107,100
2
1,572
25,979
3
of which, in life sciences
28%
26%
in engineering
25%
21%
12%
14%
2,583
41,548
4
29,314
435,612
3
20,852
285,231
2
Civilian labor force, 2000 (thousands)
10,325
142,172
2
Personal income per capita, 2000
$27,722
$29,451
25
$106,493
$1,615,468
3
$3,853
$73,718
4
Total R&D performance, 1999 (millions)
$12,429
$231,832
4
Industry R&D, 1999 (millions)
$9,935
$177,171
4
Academic R&D, 1999 (millions)
$1,801
$27,038
28
of which, in life sciences
63%
57%
in engineering
15%
15%
in physical sciences
8%
9%
Public higher education current-fund expenditures, 1997 (millions)
$8,758
$125,236
2
Number of SBIR awards, 1995-2000
1,004
26,424
7
Patents issued to state residents, 2000
6,323
85,068
2
Gross state product, 1999 (billions)
$687
$9,369
3
1%
1%
Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Population, 2000 (thousands)
Federal spending Total expenditures, 2000 (millions) R&D obligations, 1999 (millions)
of which, agriculture manufacturing, mining, construction
24%
22%
transportation, communication, utilities
11%
8%
wholesale and retail trade
18%
16%
finance, insurance, real estate
15%
19%
services
20%
21%
government
11%
12%
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Washington Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic
State
U.S.
Rank
13,250
518,670
15
2,370
107,100
13
406
25,979
21
of which, in life sciences
32%
26%
in engineering
20%
21%
16%
16%
1,168
41,548
9
6,210
435,612
24
5,894
285,231
15
Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Population, 2000 (thousands) Civilian labor force, 2000 (thousands)
3,045
142,172
15
$31,129
$29,451
12
Total expenditures, 2000 (millions)
$33,897
$1,615,468
16
R&D obligations, 1999 (millions)
$1,307
$73,718
17
Total R&D performance, 1999 (millions)
$8,336
$231,832
9
Industry R&D, 1999 (millions)
$7,231
$177,171
9
$580
$27,038
48
of which, in life sciences
68%
57%
in engineering
11%
6%
in physical sciences
8%
15%
$3,127
$125,236
12
661
26,424
11
Patents issued to state residents, 2000
1,821
85,068
15
Gross state product, 1999 (billions)
$209
$9,369
14
of which, agriculture
2%
1%
Personal income per capita, 2000 Federal spending
Academic R&D, 1999 (millions)
Public higher education current-fund expenditures, 1997 (millions) Number of SBIR awards, 1995-2000
manufacturing, mining, construction
18%
22%
transportation, communication, utilities
8%
8%
wholesale and retail trade
17%
16%
finance, insurance, real estate
17%
19%
services
25%
21%
government
13%
12%
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
State Distribution of Expenditures for R&D, by Performing Sector and Source of Funding: 2000 (Latest Available Data) Performing sector: Funding sector: State
Total R&D Total R&D
Federal Govt. Federal Govt.
Rank
U&C Universities & colleges1 FFRDCs
Industry Federal Total2 Govt.2 Industry3 Thousands of current dollars
264,616,008 17,468,589 199,539,000 19,118,000 180,421,000
United States, total
Gross state R&D product intensity6 Rank % Rank 30,973,891 5,801,2299,941,551,000 2.66 Total
Alabama
27
Alaska
47
196,448
75,446
9,000
D
D
107,417
Arizona
19
3,107,291
145,601
2,445,000
153,000
2,292,000
465,777
Arkansas
42
454,401
45,489
273,000
D
D
45,769,000 4,229,000
41,540,000
California
1,730,117
664,981
1 55,092,936 1,655,628
607,000
184,000
423,000
428,122
Federal Govt.4
0 119,921,000
31
27,747,000
460.71
45
36,409 156,303,000
231.99
19
67,724,000
340.67
47
4,053,042 2,812,1341,344,623,000
14.10
8
130,894
0
251.44
0
Colorado
17
4,229,501
241,771
3,140,000
D
D
544,204
115,510 167,918,000
212.52
15
Connecticut
14
4,888,469
19,373
4,371,000
127,000
4,244,000
468,435
0 159,288,000
223.07
12
Delaware
28
1,532,130
7,598
1,444,000
7,000
1,437,000
78,126
0
36,336,000
444.22
6
D.C.
24
2,296,233 1,722,640
112,000
46,000
67,000
245,828
0
59,397,000
363.87
10
Florida
15
4,662,727
573,140
3,212,000
498,000
2,714,000
851,932
0 472,105,000
40.99
36
Georgia
21
2,796,192
273,713
1,579,000
83,000
1,496,000
926,749
0 296,142,000
100.94
37
Hawaii
46
291,409
58,658
44,000
17,000
27,000
161,300
0
42,364,000
400.69
46
Idaho
30
1,433,567
21,722
1,338,000
D
D
73,726
0
37,031,000
423.87
9
6 12,767,496
85,344
10,661,000
37,000
10,624,000
1,170,625
759,002 467,284,000
52.73
13
Illinois Indiana
18
3,252,494
71,630
2,668,000
75,000
2,593,000
509,141
Iowa
34
1,017,300
34,586
538,000
D
D
418,263
Kansas
31
1,420,089
20,162
1,140,000
D
D
Kentucky
35
866,052
7,500
582,000
1,000
581,000
Louisiana
38
626,793
99,196
126,000
1,000
125,000
399,411
Maine
45
318,726
4,755
201,000
53,000
148,000
57,753
Maryland
10
8,633,558 4,869,668
2,032,000
428,000
1,604,000
0 192,195,000
151.69
25
301.14
33
23,281
89,600,000
258,336
0
85,063,000
311.67
26
274,238
0 118,508,000
270.73
43
0 137,700,000
240.46
49
0
35,981,000
450.89
38
1,507,549
0 186,108,000
164.64
4
Massachusetts
5 13,004,427
259,172
8,032,000
1,485,792
348,339 284,934,000
114.56
5
Michigan
2 18,892,070
239,543
17,640,000
80,000
17,559,000
995,756
0 325,384,000
95.81
1
9,863,000 1,831,000
Minnesota
16
4,298,967
32,014
3,722,000
173,000
3,550,000
416,411
0 184,766,000
172.33
17
Mississippi
39
512,789
186,799
101,000
19,000
83,000
217,064
0
350.76
42
Missouri
23
2,583,036
43,851
1,893,000
18,000
1,876,000
614,101
0 178,845,000
181.44
30
Montana
48
169,856
35,344
28,000
D
D
99,069
0
21,777,000
480.78
41
Nebraska
43
438,996
25,082
199,000
D
D
208,480
0
56,072,000
370.78
40
Nevada
44
377,412
20,696
248,000
D
D
106,340
0
74,745,000
320.50
48
New Hampshire
36
775,004
35,717
586,000
D
D
150,982
0
47,708,000
391.62
27
4 13,133,222
567,666
New Jersey
417,685
12,062,000
253,000
11,809,000
New Mexico
20
3,085,199
320,838
1,158,000
D
D
New York North Carolina North Dakota
3 13,555,586 13 5,045,250 49 145,671
176,034 262,003 25,842
10,539,000 1,773,000 3,672,000 30,000 51,000 D
8,766,000 3,641,000 D
Ohio
11
7,661,540
615,458
5,962,000
539,000
Oklahoma
37
659,684
58,619
333,000
3,000
67,315,000
65,305 363,089,000
83.62
11
54,364,000
385.68
2
2,290,812 1,040,017 67,406
0 799,202,000 0 281,741,000 0 18,283,000
21.70 121.79 510.80
24 22 39
5,423,000
918,500
0 372,640,000
72.06
18
331,000
252,419
0
290.72
44
246,258 1,333,194
91,773,000
Plunkett Research, Ltd.
www.plunkettresearch.com
State Distribution of Expenditures for R&D, by Performing Sector and Source of Funding: 2000 (Latest Available Data) (cont.) Performing sector: Funding sector: State Oregon
Total R&D
Federal Govt.
Total R&D
Federal Govt.
Rank
U&C Universities & colleges1 FFRDCs
Industry Federal Total2 Govt.2 Industry3 Thousands of current dollars
Total
Gross state R&D product intensity6 Rank % Rank
Federal Govt.4
25
2,116,232
88,618
1,651,000
7,000
1,644,000
346,149
0 118,637,000
261.78
23
Pennsylvania
9
9,841,912
151,955
7,873,000
460,000
7,412,000
1,549,050
55,955 403,985,000
62.44
16
Rhode Island
29
1,500,828
240,862
1,090,000
D
D
129,697
0
36,453,000
434.12
7
South Carolina
33
1,126,164
45,754
781,000
D
D
294,184
0 113,377,000
280.99
35
South Dakota
50
84,801
13,232
44,000
16,000
28,000
27,269
0
23,192,000
470.37
50
Tennessee
26
2,057,293
88,947
1,215,000
D
D
405,013
0 178,362,000
191.15
32
7 11,552,437
464,699
8,961,000
230,000
8,731,000
2,039,642
0 742,274,000
31.56
28
Texas Utah
32
1,360,644
69,871
979,000
D
D
308,059
0
68,549,000
331.98
20
Vermont
40
465,349
3,599
396,000
D
D
64,762
0
18,411,000
502.53
14
Virginia
12
5,069,481 1,449,209
Washington
8 10,516,331
2,718,000
800,000
1,918,000
587,718
79,342 261,355,000
131.94
21
258,718
9,265,000
D
D
642,934
0 219,937,000
144.78
3
411.08
34
West Virginia
41
457,128
102,958
235,000
D
D
73,420
Wisconsin
22
2,692,876
37,816
1,981,000
18,000
1,963,000
661,470
Wyoming Other unknown
51
60,969
7,298
7,000
0
7,000
43,094
35,536
42,271,000
0 173,478,000
201.55
29
0
490.32
51
19,294,000
NA 12,130,343 42,207 11,994,000 1,094,000 10,900,000 81,969 11,268 NA NA NA NA Adjustment NA 7,630,582 949,548 1,000 NA NA 911,520 125,954 NA NA NA NA 1Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another at the national level. State-level university R&D data have not been adjusted to correct for this double counting. 2Includes performance at industry FFRDCs. 3Industry sources of R&D expenditures include all non-Federal sources of industry R&D expenditures. 4Includes all R&D expenditures of the FFRDCs, over 95% of these expenditures are Federally funded nationally. 5R&D intensity is the ratio of total R&D performed in a state to the GSP of the state. KEY: FFDRCs = federally funded research and development centers U&C = universities and colleges NA = not available D = data withheld to avoid disclosing operations of individual companies NOTES: Industry R&D data are in reference to calendar years; other R&D data are in reference to fiscal years but may serve as approximations to calendar year data. The "other unknown" category reflects reported data that could not be assigned to a geographic location. The "adjustment" category reflects the difference in state totals (and other unknown) when reported on a fiscal year basis and the U.S. Totals that have been adjusted to calendar year estimates. SOURCE: National Science Foundation/Division of Science Resources Statistics. These data were derived from four NSF surveys: Survey of Industrial R&D; Survey of R&D Expenditures at Universities and Colleges, Survey of Federal Funds for R&D, and Survey of R&D Funding and Performance by Nonprofit Organizations. Gross State Product data are from the U.S. Bureau of Economic Analysis.
Plunkett Research, Ltd.
www.plunkettresearch.com
Top 10 U.S. States in Total R&D Performance, Size of R&D by Performer and R&D as a Percentage of Gross State Product: 2000 Rank
State
Top 10 States in Total R&D Performance1 Total R&D (Mil. of Current US$)
1
California
55,092.94
2
Michigan
18,892.07
3
New York
13,555.59
4
New Jersey
13,133.22
5
Massachusetts
13,004.43
6
Illinois
12,767.50
7
Texas
11,552.44
8
Washington
10,516.33
9
Pennsylvania
9,841.91
10
Maryland
8,633.56
Rank 1 2 3 4 5 6 7 8 9 10
Top 10 States in Size of R&D, by Type of Performing Sector Universities & Colleges3 Federal Government4 Sector Industry Sector Sector California California Maryland Michigan New York District of Columbia New Jersey Texas California Illinois Pennsylvania Virginia New York Maryland Alabama Massachusetts Massachusetts Ohio Washington Illinois Florida Texas North Carolina Texas Pennsylvania Michigan New Jersey Ohio Georgia New Mexico 2
Top 10 States in R&D Intensity (States with the Highest R&D/GSP Ratio)
Rank 1 2 3 4
Michigan New Mexico Washington Maryland
5.81 5.68 4.78 4.64
GSP (Bil. of Current US$) 325.4 54.4 219.9 186.1
5 6
Massachusetts Delaware
4.56 4.22
284.9 36.3
7 8
Rhode Island California
4.12 4.10
36.5 1,344.6
9 10
Idaho District of Columbia
3.87 3.87
37.0 59.4
State
R&D/GSP (percent)
Note: GSP = gross state product; FFRDC = federally funded research and development center. Reliability of the estimates of industry R&D varies by state because the sample allocation was not based on geography. Rankings do not take into account the margin of error of estimates from sample surveys. 1 Includes in-state total R&D performance of industry, universities, Federal agencies, FFRDCs, and federally financed nonprofit R&D. 2 Includes R&D activities of industry-administered FFRDCs located within these states. 3 Excludes R&D activities of university-administered FFRDCs located within these states. 4 Includes costs associated with the administration of intramural and extramural programs by Federal personnel as well as actual intramural performance. Sources: National Science Foundation/Division of Science Resources Statistics, National Patterns of R&D Resources, annual series; GSP data are from the U.S. Bureau of Economic Analysis.
Plunkett Research, Ltd.
www.plunkettresearch.com
III. International Research and Patents
Plunkett Research, Ltd.
www.plunkettresearch.com
International R&D Expenditures in Constant Dollars and as a Percentage of GDP: 1981–2001 (Selected Nations) Total R&D expenditures U.S.
Japan2
Year
Germany3
France
Billions of constant 1996
U.K.
Italy
Canada
dollars4
1981
115.9
40.4
28.6
17.4
19.1
7.9
6.1
1985
155.8
55.6
33.6
21.5
20.1
10.9
7.9
1986
159.8
56.6
34.7
21.8
21.1
11.2
8.3
1987
162.8
60.6
36.4
22.7
21.4
12.2
8.3
1988
167.0
65.3
37.7
23.8
22.0
12.9
8.6
1989
170.4
71.4
39.1
25.3
22.6
13.5
9.2
1990
175.8
77.2
39.6
26.9
22.7
14.4
9.6
1991
179.5
79.0
42.2
27.2
21.6
13.9
9.8
1992
180.1
78.1
41.0
27.7
21.2
13.5
10.3
1993
176.2
76.1
39.6
27.7
22.0
12.7
10.8
1994
176.2
75.3
38.9
27.6
22.5
12.1
11.7
1995
187.2
80.1
39.6
27.6
22.5
11.9
11.9
1996
197.3
85.5
39.9
27.8
22.3
12.1
11.7
1997
208.1
89.0
41.1
27.4
22.1
12.9
12.4
1998
219.3
91.3
42.3
27.6
22.7
13.3
13.5
1999
232.7
91.8
45.5
28.7
24.2
13.2
14.3
2000
247.6
95.4
47.7
29.0
24.6
NA
15.3
2001
257.5
NA
48.7 NA Percent of national GDP
NA
NA
16.2
1981
2.31
2.11
2.47
1.93
2.38
0.88
1.24
1985
2.72
2.54
2.75
2.22
2.24
1.12
1.44
1986
2.70
2.51
2.77
2.21
2.26
1.13
1.47
1987
2.66
2.57
2.87
2.24
2.20
1.19
1.42
1988
2.62
2.60
2.86
2.24
2.14
1.22
1.40
1989
2.59
2.70
2.86
2.29
2.15
1.24
1.47
1990
2.62
2.78
2.75
2.37
2.15
1.29
1.53
1991
2.69
2.75
2.53
2.37
2.07
1.23
1.59
1992
2.62
2.70
2.41
2.38
2.02
1.18
1.65
1993
2.49
2.62
2.35
2.40
2.05
1.13
1.70
1994
2.40
2.57
2.26
2.34
2.01
1.05
1.76
1995
2.48
2.69
2.26
2.31
1.95
1.00
1.73
1996
2.53
2.77
2.26
2.30
1.88
1.01
1.69
1997
2.55
2.83
2.29
2.22
1.81
1.05
1.70
1998
2.58
2.94
2.31
2.17
1.80
1.07
1.79
1999
2.63
2.94
2.44
2.19
1.88
1.04
1.80
2000
2.69
2.98
2.48
2.15
1.86
NA
1.84
2001 2.79 NA 2.52 NA NA NA 1.93 1Nondefense R&D data are estimates. Foreign nondefense R&D/GDP ratios are obtained directly from OECD reports or are estimated by NSF from OECD data for: Japan for 1995 and later years; Germany for 1990 and earlier years; United Kingdom for 1988 and earlier years (except 1985); Italy for 1986 and earlier years; and Canada for 1990 and later years. NOTE: See continued table on the next page for further footnotes.
Plunkett Research, Ltd.
www.plunkettresearch.com
International R&D Expenditures in Constant Dollars and as a Percentage of GDP: 1981–2001 (Selected Nations) (Cont.) Total non-defense R&D expenditures1 U.S.
Japan2
Germany3 France U.K. Billions of constant 1996 dollars4
Year
Italy
Canada
1981
88
40
28
14
15
8
6
1985
109
55
32
17
16
10
8
1986
109
56
33
18
17
11
8
1987
111
60
35
18
18
12
8
1988
116
65
36
19
19
13
8
1989
123
71
37
21
17
13
9
1990
131
76
38
22
18
14
9
1991
139
78
41
22
18
14
10
1992
141
77
40
23
18
13
10
1993
138
75
38
24
19
13
11
1994
141
74
38
23
19
12
12
1995
152
79
38
24
19
12
12
1996
163
85
38
24
19
12
12
1997
173
88
40
25
19
13
12
1998
185
90
41
25
19
13
13
1999
199
91
45
26
21
13
14
2000
214
95
47
NA
21
NA
NA
2001
222
NA
48 NA Percent of National GDP
NA
NA
NA
1981
1.7
2.1
2.4
1.6
1.9
0.9
1.2
1985
1.9
2.5
2.6
1.8
1.8
1.1
1.4
1986
1.9
2.5
2.6
1.8
1.8
1.1
1.4
1987
1.8
2.6
2.7
1.8
1.8
1.2
1.4
1988
1.8
2.6
2.7
1.8
1.8
1.2
1.3
1989
1.9
2.7
2.7
1.9
1.7
1.2
1.4
1990
2.0
2.8
2.6
1.9
1.7
1.3
1.5
1991
2.1
2.7
2.4
1.9
1.7
1.2
1.6
1992
2.1
2.7
2.3
2.0
1.7
1.2
1.6
1993
2.0
2.6
2.3
2.0
1.7
1.1
1.7
1994
1.9
2.5
2.2
2.0
1.7
1.0
1.7
1995
2.0
2.7
2.2
2.0
1.7
1.0
1.7
1996
2.1
2.7
2.2
2.0
1.6
1.0
1.7
1997
2.1
2.8
2.2
2.0
1.5
1.1
1.7
1998
2.2
2.9
2.3
2.0
1.5
1.1
1.8
1999
2.2
2.9
2.4
2.0
1.6
1.0
1.8
2000
2.3
3.0
2.4
NA
1.6
NA
NA
2001 2.4 NA 2.5 NA NA NA NA 2 Due to changes in methodology, data on Japanese R&D in 1996 and later years may not be consistent with data in earlier years. 3 Germany's data for 1981-90 are for West Germany. Conversions of foreign currencies to U.S. dollars are calculated with OECD purchasing power parity exchange rates. Constant 1996 dollars are based on OECD implicit GDP price indices. Key: GDP = gross domestic product; NA = not available Sources: Organisation for Economic Co-operation and Development, Main Science and Technology Indicators data base (Paris, May 2002) and National Science Foundation/ Division of Science Resources Statistics.
4
Plunkett Research, Ltd.
www.plunkettresearch.com
Top 20 Global Patenting Organizations, Calendar Year 2001 Based on Number of U.S. Utility Patents Received
Rank
Organization
Number of Patents, 2001
1
International Business Machines Corp.
3,411
2
NEC Corp.
1,953
3
Canon Kabushiki Kaisha
1,877
4
Micron Technology, Inc.
1,643
5
Samsung Electronics Co., Ltd.
1,450
6
Matsushita Electric Industrial Co., Ltd.
1,440
7
Sony Corp.
1,363
8
Hitachi, Ltd.
1,271
9
Mitsubishi Denki Kabushiki Kaisha
1,184
10
Fujitsu Limited
1,166
11
Toshiba Corp.
1,149
12
Lucent Technologies, Inc.
1,109
13
General Electric Co.
1,107
14
Advanced Micro Devices, Inc.
1,086
15
Hewlett-Packard Co.
978
16
Intel Corp.
809
17
Texas Instruments, Inc.
799
18
Siemens
793
19
Motorola, Inc.
778
20
Eastman Kodak Co.
719
Note: Patent information presented reflects patent ownership at patent grant and does not include ownership changes that occur after the patent grant. Where more than one assignee (owner) exists, patents are attributed to the first-named assignee. No attempt has been made to combine data based on subsidiary relationships. However, where possible, spelling variations and variations based on name changes have been merged into a single name. While every effort is made to accurately identify all organizational entities and to report data by a single organization name, achievement of a totally clean record is not expected, particularly in view of the many variations that occur in corporate identifications. Source: U.S. Patent and Trademark Office, Technology Assessment and Forecast.
Plunkett Research, Ltd.
www.plunkettresearch.com
Top 20 Patenting Countries, 2001 (latest data available) Based on Number of U.S. Patents Received from Country of Headquarters Location Rank
Country
Number of Patents Received, 2001
1
United States of America
87,607
2
Japan
33,223
3
Germany
11,260
4
Taiwan
5,371
5
France
4,041
6
United Kingdom
3,965
7
Canada
3,606
8
South Korea
3,538
9
Sweden
1,743
10
Italy
1,709
11
Switzerland
1,420
12
Netherlands
1,332
13
Israel
970
14
Australia
875
15
Finland
732
16
Belgium
718
17
Austria
589
18
Denmark
479
19
Singapore
296
20
Spain Total Number of Patents
269 166,039
Source: U.S. Patent and Trademark Office, Technology Assessment and Forecast.
Plunkett Research, Ltd.
www.plunkettresearch.com
Chapter 3 ENGINEERING AND RESEARCH INDUSTRY CONTACTS World Wide Web Sites, Publications and Industry Associations I. II. III. IV. V. VI. VII. VIII. IX. X. XI. XII. XIII. XIV. XV. XVI. XVII.
Automotive Associations-Consumer and Safety Automotive-Parts and Supplies Biotech Associations Biotech Careers Biotech Resources Computer/Technology Careers Corporate Information E-Commerce and Internet Industry Associations E-Commerce Education and Training Economic Data and Research Electrical Engineering Industry Associations Energy Associations Energy Education Links Engineering Associations Engineering Indices Engineering Software Film and Television Associations
XVIII. XIX. XX. XXI. XXII. XXIII. XXIV. XXV. XXVI. XXVII. XXVIII. XXIX. XXX.
First Time Jobs/New Grads Food Industry Associations Health Care Careers Industry Associations-Automotive Industry Associations-Construction Industry Research/Market Research Internet Business/Technology Internet Organizations-International Job Listings, General Job Reference Tools Laboratories/Research Microelectronics Industry Associations Satellite-Related Professional Organizations XXXI. Telecommunications Industry Associations XXXII. Telecommunications Information, General XXXIII. Testing Resources XXXIV. U.S. Government Agencies
Plunkett Research, Ltd.
I.
Automotive Associations-Consumer and Safety
American Traffic Safety Services Institute (ATSSA) 15 Riverside Pkwy., Ste. 100 Fredericksburg, VA 22406-1022 Phone: 540-368-1701 Fax: 540-368-1717 Toll Free: 800-272-8772 Web Address: http://www.atssa.com/ ATSSA members provide the majority of safety features, services and materials used on our nation's roadways.
www.plunkettresearch.com
V.
BioTech Web Address: http://biotech.icmb.utexas.edu This site offers a comprehensive dictionary of biotech terms, plus extensive research data regarding biotechnology. Biotech Rumor Mill E-Mail:
[email protected] Web Address: http://www.biofind.com/rumor An open discussion forum that attracts participants from the many biotech disciplines. VI.
II.
Biotech Associations
Biotechnology Industry Organization 1625 K St. NW, Ste. 1100 Washington, DC 20006 Phone: 202-962-9200 Web Address: http://www.bio.org/ The BIO is involved in the research and development of health care, agricultural, industrial and environmental biotechnology products. IV.
Computer/Technology Careers
Automotive-Parts and Supplies
Automotive